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ABSTRACT

DIFFUSE TRAUMATIC AXONAL INJURY WITHIN THE VISUAL SYSTEM: IMPLICATIONS
FOR VISUAL PATHWAY REORGANIZATION

By Jiaqiong Wang, Ph.D. Candidate

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University

Virginia Commonwealth University, 2012

Major Director: John T. Povlishock, Ph.D.
Professor and Chairman
Department of Anatomy and Neurobiology

Traumatic brain injury is a major health problem with much of its morbidity associated
with traumatic axonal injury (TAI). To date, significant insight has been gained into the initiating
pathogenesis of TAI. However, the specific anterograde and retrograde sequelae of TAI are
poorly understood because the diffuse nature of TAI complicates data analysis. To overcome this
limitation, we subjected transgenic mice expressing yellow fluorescent protein (YFP) within the
visual system to central fluid percussion injury, and consistently generated diffuse TAI within
the optic nerve that could easily be followed in the organized YFP positive fibers. We
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demonstrated progressive axonal swelling, disconnection and proximal and distal axonal
dieback, with regression and reorganization of the proximal swellings, and the persistence of the
distal disconnected and degenerating swellings. Antibodies targeting the C-terminus of amyloid
precursor protein, a marker of TAI, mapped to the proximal axonal segments without distal
targeting.

Antibodies

targeting

microglia/macrophages,

revealed

activated

microglia/

macrophages closely encompassing the distal disconnected, degenerating axonal segments at 7 28 days post injury, suggesting their role in the delayed axonal degeneration. In contrast, in the
proximal reorganizing axonal segments, microglia/macrophages appeared less reactive with their
processes paralleling preserved axonal profiles. Concomitant with these events, YFP
fluorescence quenching also occurred, complicating data analysis. This quenching mapped to
Texas-Red-conjugated-IgG immunoreactive loci, suggesting that blood–brain barrier disruption
and its attendant edema participated in fluorescence quenching. This was confirmed through
antibodies targeting endogenous YFP, which identified the retention of intact axons despite YFP
fluorescent loss. Paralleling these events, TAI was not accompanied by retrograde retinal
ganglion cell (RGC) death. Specifically, no TUNEL+ or cleaved caspase-3 immunoreactive
RGCs were observed from 2 days to 3 months post-TBI. Further, Brn3a immunoreactive RGC
quantification revealed no significant RGC loss. This RGC preservation was accompanied by the
persistent phospho-c-Jun expression for up to 3 months post-TBI, a finding linked to neuronal
survival and potential axonal repair. Parallel ultrastructural study again failed to identify RGC
death. Collectively, this study provides unprecedented insight into the evolving pathobiology
associated with TAI, and offers advantages for future studies focusing on its therapeutic
management and neuronal reorganization.

CHAPTER ONE
GENERAL INTRODUCTION

Traumatic brain injury
Traumatic brain injury (TBI) is a major national and global health problem which leads to
death and serious neurological dysfunction. According to Centers for Disease Control and
Prevention (CDC), each year in the United States, approximately 1.7 million people suffer from
a TBI, resulting in 52,000 deaths, 275,000 hospitalization, and 1,365 million emergency rooms
visits. The cost of TBI reached $76.5 billion in the United States in 2000 both directly and
indirectly (Coronado et al., 2012; Finkelstein et al., 2006). Similarly, TBI has the high incidence
in United Kingdom, Australia, France, Sweden and China (Fearnside and Simpson, 1997). Both
males and females are affected by TBI at different ages. These sobering statistics mandate the
call for intensive research to increase our understanding of TBI while developing therapeutic
strategies to ameliorate the deficits associated with TBI.
TBI is acquired when sudden trauma damages the brain. According to CDC, falls are the
primary cause of TBI, which account for 35.2% of injuries. Motor vehicle accidents involving
motorcycles, bicycles and pedestrians, compose of 17.3% of total TBI, and they are the biggest
cause of TBI-related deaths (31.8%). Other causes originate from blasts (war, terrorism), sportsrelated accidents (horseback riding, boxing, football and basketball) (Fearnside and Simpson,
1997), suicide, homicide, child abuse, domestic abuse, elder abuse, and natural disasters (Chu et
al., 2011; Heather et al., 2012; Lee et al., 2003).

1

Pathology of Traumatic Brain Injury
Most investigators consider the pathobiology of TBI in the context of focal as well as
diffuse change, with the diffuse pathologies being recognized as the major determinants of the
adverse outcomes associated with TBI (Povlishock and Katz, 2005). It is accepted that focal
brain injury is more likely due to direct contact, while the diffuse brain damage is more likely
caused by rapid acceleration / deceleration of the brain during motor vehicle accidents or falls
(Graham and Gennarelli, 2000). Focal TBI include cerebral contusion, laceration and
hemorrhage (Adams et al., 1980; Gennarelli and Thibault, 1985; Granacher RP, 2007; Hardman
and Manoukian, 2002; Huang et al., 2011; Jamieson and Yelland, 1968; Zimmerman and
Bilaniuk, 1982). Diffuse TBI refers to non-localized, scattered damage in the brain, including
diffuse traumatic axonal injury (TAI), diffuse vascular injury (DVI)(Adams et al., 1980;
Iwamura et al., 2012, Pittella and Gusmao, 2003), diffuse hypoxic-ischemic damage (Dietrich et
al., 1994; Maxwell et al., 1988 and 1991), and diffuse brain swelling (Aldrich et al., 1992;
Donkin and Vink, 2010; Jayakumar et al., 2011; Lang, et al., 1994; Liang et al., 2007;
Marmarow, 2007; Unterberg et al., 2004).
Much of the morbidity and mortality associated with TBI are associated with diffuse
traumatic axonal injury (Christman et al., 1994; Li et al, 2009; Li et al., 2010; Zemlan et al.,
1999). TBI patients who have cognitive impairment, particularly difficulty with memory and
information processing, typically reveal the evidence of TAI (Lipton et al., 2008), with the
demonstration of TAI in subcortical white matter, corpus callosum and internal capsule in
addition to other brain sites (Blumbergs et al., 1989; Graham et al., 2002).

Pathogenesis of Diffuse Traumatic Axonal Injury
2

Diffuse traumatic axonal injury (TAI) presents in the form of damaged axons scattered
throughout the central nervous system (CNS) (Buki and Povlishock, 2006). Despite traditional
thought that the diffusely injured axons were torn at the injury moment (Strich, 1956), more
recent findings do not support this premise. Rather, it has been demonstrated that diffuse
axotomy is associated with transient focal changes in axolemmal permeability (Pettus and
Povlishock, 1996), which are related to local calcium dysregulation and subsequent proteasemediated cytoskeletal disruption (Buki et al., 1999) and mitochondrial dysfunction (Buki et al.,
2000). Together, these events compromise local axonal transport, result in the focal
accumulation of organelles and proteins with progressive axonal swelling, leading to delayed
disconnection and downstream Wallerian degeneration (Kelley et al., 2006; Pettus et al., 1994;
Povlishock, 1992).
Alteration in axolemmal permeability and calcium dysregulation in TAI
Traditionally, it has been believed that increased axolemmal permeability is the direct
result of the shear and tensile injury forces. Early experiments showed that horseradish
peroxidase (HRP, molecular weight 40kDa), a tracer normally excluded by axolemma, was
present in injured axons which also revealed local neurofilament compaction and microtubule
loss as early as 5 minutes post injury (Pettus et al., 1994; Pettus and Povlishock, 1996). These
findings supported the premise that axolemmal mechanoporation is responsible for this process
with transient membrane pore formation in the initial pathogenesis of axonal damage. In addition
to overt local membrane disruption, Kilinc et al (2008, 2009) applied fluid shear stress on
cultured CNS neurons, and observed an increased flux of Ca2+ as early as 5-30 minutes post
injury, which led to the activation of calpain as well as local axonal beading. Interestingly, these
events were blocked by Poloxamer 188, a membrane sealing material (Kilinc et al., 2007;
3

Serbest et al., 2005; Serbest et al., 2006), again suggesting that altered axolemmal permeability
precipitated axonal damage.
As noted, increased axonal membrane permeability has been linked to an increased
intracellular calcium ion concentration ([Ca2+]i) following injury (Fineman et al., 1993; LaPlaca
et al., 1998). One explanation of the rise of intracellular calcium is the influx of calcium from the
extracellular space through the axolemmal pores generated at the moment of injury (Büki and
Povlishock, 2006; Gennarelli, 1993; Gennarelli et al., 1998). Alternatively, another source for the
increased intra-axonal ([Ca2+]i maybe related to the dysfunction of the calcium store - smooth
endoplasmic reticulum (SER) and mitochondrial (Nikolaeva et al., 2005; Stys, 2005; Weber et
al., 1999 and 2001). In vitro studies using the stretch injured cortical neurons, showed that
[Ca2+]i increased rapidly after injury, the neuronal calcium stores did not respond 15 min after
injury, which was prevented by phospholipase C (PLC) inhibitor (Weber et al., 1999 and 2001).
In vitro ischemia of optic nerve axons has also demonstrated that the release of intra-axonal Ca2+
was from the inositol trisphosphate (IP3) receptors and ryanodine receptors on SER, as well as
the mitochondrial Na+/ Ca2+ exchanger, all of which were Na+ - dependent (Nikolaeva et al.,
2005; Stys, 2005).
In addition to calcium influx from the mechanoporation and the calcium release from
SER and mitochondrial, the observed [Ca2+]i increase following axonal injury may also be
related to an injury induced channelopathy. Employing an in vitro unmyelinated axonal stretch
injury model, Wolf et al. (2001) observed an immediate increase in intra-axonal calcium after
injury that was completely reversed by either tetrodotoxin(TTX) - the sodium channel blocker,
ω–conotoxin MVIIC, a voltage-gated calcium channel(VGCC) blocker, or bepridil, a blocker of
the Na+- Ca2+ exchanger also participate in decreasing intra-axonal Ca2+. All these studies
4

indicated that mechanically sensitive Na+ channels, the VGCCs and the Na+- Ca2+ exchanger are
involved in calcium dysregulation. Using the same model, Iwata et al. (2004) observed
proteolysis of the NaCh α-subunit at 5 and 20 min after trauma, resulting in persistent elevations
in [Ca2+]i. Further, von Reyn et al. (2009) proved that this proteolysis was dependent on Ca2+ and
calpain activity at 6h after mechanical injury, which is relatively late compared to the early loss
of NaCh (Iwata et al., 2004). Despite the proteolysis, there was no fragment formation or
internalization, which may contribute to further calcium elevation, subsequent calpain activation
and probably later axonal degeneration (Iwata et al., 2004; von Reyn et al., 2009). Of note is the
fact that all the results originating from the stretch injury model employed unmyelinated axons in
vitro. In vitro, Reeves et al. (2005) showed significant and sustained depression of the compound
action potentials (CAP) associated with the unmyelinated axon population within the rat corpus
callosum following fluid percussion injury. This suppression in unmyelinated axons persisted 7
days post injury, while in myelinated axons the CAP recovered to control levels 7 days post
injury, suggesting that unmyelinated axons may be more vulnerable to TBI than myelinated
axons, and that the corresponding pathogenesis mechanism may be different (Reeves et al., 2005;
Reeves et al., 2007). Further investigation is required to determine whether the mechanically
sensitive Na+ channels, the VGCCs and the Na+- Ca2+ exchanger play a role in the pathological
change of these in vivo unmyelinated axons, similar to those described in the in vitro stretch
injured unmyelinated fibers.
Calcium-induced calpain-mediated spectrin proteolysis, microtubule disorganization and
neurofilament compaction in TAI
Irrespective of the initial causative mechanisms, it is now well appreciated that Ca2+
overloading and subsequent activation of proteases and phosphatases, Ca2+ -induced proteolytic
pathways are pivotal players in the ensuing axonal pathology. Ca2+-activated neutral protease,
5

calpain, exclusively cleaves the axonal membrane cytoskeleton protein, spectrin. To date, µcalpain and m-calpain have been identified, although no known difference has been found
between their role in trauma. Physiologically, calpain participates in remodeling of
cytoskeletal/membrane attachment, cell signaling and synaptic activity (Goll et al., 2003; Wu
and Lynch, 2006). Calpain breakdown products have been observed in rat axons of damaged
white matter tracts following lateral fluid percussion brain injury (Saatman et al., 1996), in rat
spinal cord from contusion injury (Springer et al., 1997), in rat pyramidal tract and medial
lemnisci at the level of pontomedullary and cervicolmedullary junction sustaining weight drop
injury (Buki et al., 1999), in the rat neocortex, subcortical white matter, corpus callosum,
thalamus and hippocampus sustaining moderate midline fluid percussion injury (McGinn et al.,
2009; Reeves et al., 2010), as well as in mice optic nerves from stretch injury (Saatman et al.,
2003; Serbest et al., 2007).

Besides animal studies, calpain-mediated breakdown of the

cytoskeleton has also been found in the corpus callosum from patients died of close head injury
(McCracken et al., 1999).
In addition to the brain parenchyma, calpain-specific spectrin breakdown products
(SBDPs), 150kDa and 145kDa fragments were also found to be elevated in cerebrospinal fluid
(CSF). Specifically, the 145kDa SBDPs were increased in rat CSF following moderate midline
fluid percussion injury (McGinn et al., 2009). 150kDa and 145kDa SBDPs were found in CSF
from severe TBI patients (Farkas et al., 2005; Mondello et al., 2010; Pineda et al., 2007). The
mean SBDP densitometry values obtained shortly after TBI were correlated with the severity of
injury and the outcome half a year post-injury, suggesting that SBDPs were meaningful clinical
biomarker of severe TBI patients (Pineda et al., 2007).

6

Of note is the fact that the calpain mediated spectrin proteolysis (CMSP) has been
identified in the subaxolemmal domain as early as 15min post injury, and then transferred to the
axoplasm proper at 30-120 min post injury, supporting the role of local CMSP in the
pathogenesis of DAI (Buki et al., 1999). Interestingly, Saatman and coworkers (2003) observed
biphasic calpain activation in traumatic injured axons in mice optic nerve after stretch injury.
Calpains were acutely activated in the first 20 minutes to hours post injury, followed by a
delayed phase of calpain-mediated proteolysis at 4 days post injury possibly participating in
axonal degeneration and neuronal death (Saatman et al., 2003).
Further evidence to support the involvement of calpain is found in the protective function
of calpain inhibitors in attenuating axonal damage. For example, calpain inhibitor CEP-4143,
given before spinal cord injury, inhibited calpain activation, decreased neurofilament NF200
dephosphorylation, attenuated axonal damage, and improved behavior (Schumacher et al., 2000).
Similarly, the calpain inhibitor SJA6017, when administered at 20 min or delayed to 4 h post
injury, improved mice functional outcome after diffuse brain injury (Kupina et al., 2001). Lastly,
the calpain inhibitor MDL-28170, when given intravenously before an impact acceleration TBI,
also reduced the number of damaged axons in the rat brainstem (Buki et al., 2003).
In addition to calpain-mediated spectrin proteolysis, calpain can also proteolize tubulin,
GAP-43, microtubule-associated proteins (MAP), such as MAP1A, MAP1B and MAP2
(Saatman et al., 1998; Saatman et al., 2010; Taft et al., 1992; Thompson et al., 2006). Calpain
also cleaves tau protein and generates a toxic 17-kDa tau fragment in cultured hippocampal
neurons (Park et al., 2005).
Calpain also mediates degradation of neurofilaments. For example, in the corpus
callosum, NF200 and NF68 were found to be decreased in head-injured patients compared to
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control patients (McCracken et al., 1999; Saatman et al., 1998). Serbest et al (2007) also
observed the decrease of NF200 and NF68 in the mice optic nerve following stretch injury.
In addition to the above calpain-mediated events, Ca2+ can also activate calcineurin,
which dephosphorylates both neurofilament (NF) subunits and microtubule associated proteintau, thereby altering the interaction between adjacent NFs and between NFs and microtubules
(Mata et al., 1997). Consequently, the repelling forces between the NF side-arms are decreased,
resulting in neurofilament compaction (NFC), disrupting the organization of microtubules, and
compromising axonal transport (Buki and Povlishock 2006; Mata et al., 1997; Okonkwo et al.,
1998). Neurofilament dephosphorylation was also observed in the optic nerve following stretch
injury (Saatman et al., 2003). Okonkwo et al. (1998) showed that NFC was spatially and
temporally correlated with intra-axonal calpain-mediated spectrin-proteolysis (CMSP). NFC was
also observed in optic nerve stretch model (Maxwell et al., 2003).
Collectively, the increased intra-axonal calcium promotes spectrin-proteolysis, disruption
of microtubules and neurofilament compaction.
Mitochondrial damage in TAI
Concomitant with above changes, local mitochondrial swelling has been observed in the
injured axonal segment in diffuse TBI models (Büki et al., 1999; Büki et al., 2000; Büki and
Povlishock, 2006; Povlishock et al., 1997; Wang et al., 2011). Mitochondria also are found to
accumulate abnormally in swollen axonal segments in cultured primary chick forebrain neurons
following fluid shear stress injury (Kilinc et al., 2008). In a rat lateral head rotation model,
axonal damage was observed in medulla oblongata, associated with Ca2+ overloading with many
axons revealing an abundance of Ca2+ associated with swollen mitochondria (He et al., 2004).
These findings suggest that Ca2+ overloading by itself may lead to mitochondrial dysfunction.
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Physiologically, the level of total mitochondrial calcium within neurons is approximately
0.1 mM and the level of free mitochondrial calcium approximates 100 nM (Babcock and Hille,
1998; Pivovarova and Andrews 2010; Pozzo-Miller et al., 1997). When stimulated, mitochondria
accumulate large amounts of calcium (Montero et al., 2000; Pivovarov et al., 1999), which
maybe mediated by the mitochondrial ryanodine receptor, the mitochondrial uncoupling proteins,
the Letm1 Ca2+/H+ exchanger, as well as the mitochondrial Ca2+ uniporter (MCU) and its Ca2+
sensing regulatory subunit MICU1(Pan et al., 2011). Mitochondria release Ca2+ primarily by
Na+/Ca2+ exchanger (Crompton and Costi, 1978; Nicholls, 2005) and Na+/H+ exchanger
(Nicholls, 2005; Starkov, 2010). Normal oscillation of Ca2+ in mitochondria participates in ATP
production, axonal transport, excitability and synaptic transmission (MacAskill et al., 2010;
Pivovarova and Andrews 2010; Starkov, 2010). However, when Ca2+ overloading is so severe, it
depolarizes mitochondria, opening mitochondrial permeability transition pores (MPTP), resulting
in neuronal degeneration (Bezprozvanny, 2009) as well as axonal damage. Further, this axonal
damage was attenuated by agents providing mitochondrial protection via their targeting of
MPTP. Specifically cyclosporin A (CsA) and FK506 have been shown to preserve mitochondria,
attenuate axonal injury and improve axonal function (Büki et al., 1999; Marmarow and
Povlishock, 2006; Okonkwo and Povlishock, 1999; Reeves et al., 2007; Singleton et al., 2001).
Although the exact molecular components of MPTP are unclear, several different
components have been identified, including cyclophilin D (CyP-D),

adenine nucleotide

translocator (ANT), the mitochondrial phosphate carrier (PiC), and the voltage-dependent anion
channel (VDAC) (Halestrap, 2009; Leung and Halestrap, 2008). As noted previously, the
opening of MPTP is triggered by mitochondria matrix Ca2+. The addition of Ca2+ in vitro has
been shown to open the MPTP while Ca2+ chelation can induce the closure of MPTP (Crompton
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et al., 1987; Crompton and Costi, 1988 and 1990; Haworth and Hunter, 1979). This Ca2+
triggered MPTP opening was facilitated by cyclophilin D, a matrix peptidyl-prolyl cis–trans
isomerase (PPIase) (Connern and Halestrap, 1992; Johnson et al., 1999). CsA and its analogues
bind to cyclophilin D and inhibit MPTP opening (Griffiths and Halestrap, 1995; Waldmeier et
al., 2002), without interfering with the activity of calcineurin.
The opening of MPTP and subsequent mitochondrial depolarization can also be induced
and/or facilitated by free radicals (Brustovetsky et al., 2003) as well as the activity of proteinase,
calpain (Aguilar et al., 1996). Besides cytosolic calpain, there have also been reports that
mitochondrial calpain is involved in mitochondrial dysfunction. Arrington et al (2006) reported
that calpain 10, a mitochondrial calpain, could cleave Complex I subunit NDUFV2 and ND6,
activate MPTP, and result in mitochondrial dysfunction, which were blocked by calpain
inhibitors.
Upon the opening of MPTP, Ca2+ influx becomes unregulated, resulting in mitochondria
depolarization. Concomitantly, water is drawn in by the colloidal osmotic pressure, related to the
high concentration of proteins and Ca2+ within the mitochondrial matrix. Collectively, this leads
to mitochondrial swelling and dysfunction (Halestrap et al., 1998; 2004; Halestrap and Pasdois
2009).
Ultimately, the failure of mitochondrial function results in local bioenergetic deficiency
together with impairment of local axonal transport. Ahmed and coworkers (2000) reported that
mitochondrial membrane potentials decreased in cultured neurons 15 min after severe stretch
injury, and ATP content declined 22–28% in mixed cultures of neuron and astrocytes 15 min
following stretch. N-Acetylaspartate (NAA), which is synthesized by the mitochondria, was
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reduced gradually based on the severity of the impact acceleration insult on adult rats (Signoretti
et al., 2001).
Activation of the caspase cascade and corresponding cytoskeletal damage in TAI
Following the MPTP formation and the subsequent mitochondria dysfunction, the
apoptosis activating factor, cytochrome-c and caspase enzymes are released into the axonal
cytosol, activating the caspase cascade in the traumatically injured axonal segments (Buki and
Povlishock, 2006; Buki et al., 2000). Cytochrome-c release increases parallel to caspase-3
activation over time after injury (Buki et al., 2000). Caspase-3 cleaves spectrin into 120kDa
segment (SBDP-120-kDa), the signature protein of caspase-3 activation. SBDP-120-kDa has
been found to colocalize with cytochrome-c release and calpain activation in severely damaged
segments, suggesting that cytochrome-c, caspase-3 and calpain are involved in the terminal
cascade of TAI. Compared to calpain-mediated spectrin proteolysis, which targets the alpha
chain of spectrin, caspase-3 also degrades the beta chain of subaxolemmal spectrin followed by
changes in axonal morphology and axolemmal permeability (Buki and Povlishock, 2006; Wang
et al., 1998).
Besides the proteolysis of spectrin, active caspase-3 cleaves tau into a 50-kDa truncated
tau segment (Gamblin et al., 2003), which is different from calpain mediated 17-kDa toxic tau
fragments. All these truncated tau proteins probably facilitate microtubule disorganization,
disrupting axonal transport.
Additionally, it has been reported that caspase-3 also mediates the cleavage of protein
kinase N 1 (PKN1), which has been recognized to be important in neurofilament organization
and transport (Manser et al., 2008). Collectively, these findings indicate that activation of

11

caspase-3 may contribute to disrupting NF organization and axonal transport. Thus, caspaseinhibitors may be a potential therapeutic approach in TAI.
In sum, following diffuse axon injury, axolemmal permeability increases followed by
calcium influx. This leads to calcium overloading, which activates proteinase calpain mediated
spectrin proteolysis and tau cleavage. Also proteolytic NF-sidearm modification or Ca2+ -induced
activation of calcineurin alters the NF-sidearm phosphorylation state, both promotes
neurofilament compaction. Concomitantly, Ca2+ overloading damages mitochondria both
morphologically and functionally, followed by the release of pro-apoptotic factors which trigger
caspase mediated proteolysis of spectrin, tau and PKN1. These sequences of events ultimately
destroy axonal cytoskeleton and disrupt axonal transport.
Impairment of axonal transport, organelle accumulation and axonal swelling
As discussed above, in diffuse axonal injury animal and humans suffering from brain
trauma, calcium-activated proteases calpain and caspase, destroy cytoskeletal proteins tubulin,
neurofilament polypeptides and spectrin, consequently blocking axonal transport and resulting in
organelle and protein accumulation, triggering axonal swelling.
Focal axonal swellings are the morphological hallmarks of altered axonal transport.
Proteins and organelles, such as β-amyloid precursor protein (APP), mitochondria, microtubules,
and profiles of smooth endoplasmic reticulum, accumulate in the swollen axonal segment
(Povlishock and Christman, 1995). The development of axonal swelling is a time-dependent
process. From initiation up to 1 hour post-injury, some axons show initial focal swellings, some
containing swollen mitochondria, and others NFs revealing oblique to the axon long axis,
precipitating impaired axonal transport (Yaghmai and Povlishock, 1992). In 2-3 h following
injury, axonal swelling continues, with a total blockage of axonal transport in the proximal and
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distal segments, suggesting focal axonal dysfunction and disconnection (Pettus et al., 1994;
Povlishock et al., 1983). At 3 h post-injury, most axons appear disconnected with continued
expansion to form a mature swollen bulb due to accumulation of organelles (Pettus et al., 1994).
By 12–48 h post-injury, axonal swellings became more mature and expanded with axonal
disconnection now dominant (Pettus et al., 1994).
Maxwell and Graham (1997) demonstrated that the sites of microtubule loss correlated
with the sites of axonal swellings in the stretch injured optic nerve. Further, positive staining of
antibody specific to kinesin, a motor protein important for anterograde axonal transport, was
identified in swollen axonal bulbs in all cases of TBI patients of both the short-term survival
period (mean 64 h post injury) and long-term survival period (mean 245 days post injury) (Chen
et al., 2009), confirming that these axonal swellings were due to the blockage of vesicles
transported anterogradely at the injured axonal segment.
Further evidence of the axonal disconnection is found in the work of Saatman et al (2003)
who showed decreased retrograde labeling of the RGCs by fluorescent tracer placed in the
superior colliculi after the optic nerve stretch injury. Utilizing YFP-H transgenic mice, Greer et
al (2011) observed both proximal and distal axonal swelling in the cerebral cortex after the
central fluid percussion injury. Greer (2011) showed that the antibodies targeting the C terminus
of APP labeled only the proximal swollen segment, without labeling of the distal swollen
segment. Additionally, the proximal APP immunostaining disappeared at 48 hours post injury, in
contrast to the distal endogenous YFP fluorescence positive swellings which persisted days after
injury. This disappearance of APP labeling over time could be due to the degradation of APP in
the injured axonal segment, but the possibility could not be excluded that anterograde axonal
transport is converted into retrograde transport (Martz et al., 1989; Sahenk and Lasek, 1988).
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Limitations of current research on the pathogenesis of TAI and new directions
As noted above, majority of previous studies focused on the initial pathological
mechanisms associated with TAI, particularly the initiating intraaxonal cellular and subcellular
mechanisms.

While these studies are important and well established targets for potential

therapeutic intervention, they have left unaddressed the important consequences of TAI in terms
of the long term fate of those neurons linked to the TAI as well as the potential for
anterograde/retrograde dieback of the diffusely damaged axons. This unaddressed information
will be vital for future studies exploring the potential for regeneration and repair following TAI.
Accordingly, in following passages, we address what limited information exists in relation to
these issues in the context of TAI.

Evidence for axonal dieback following TAI
Axonal dieback is a phenomenon whereby axons retract from the initial site of injury.
While virtually no information exists on the process of axonal dieback following TAI, some
comparisons can be drawn from studies of axonal transection.
Axonal dieback has been reported in spinal cord injury (SCI). Retrograde axonal dieback
(of the proximal segment) was observed in the rat corticospinal tract (CST) after thoracic spinal
cord transection (Seif et al., 2007), and similarly, in the mice CST after thoracic SCI (Yoshimura
et al., 2011). Utilizing time-lapse imaging of green fluorescent protein (GFP) fluorescent axons
that run superficially in the dorsal spinal cord of living transgenic mice, Kerschensteiner et al
(2005) observed acute axonal degeneration (AAD) over 200-300µm within 30 minutes. The
AAD was identical in the proximal and distal axon ends, after transection of selected axons
mostly originating from the dorsal root ganglion (DRG). In part, the underling mechanism of
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AAD may be similar to Wallerian degeneration since it was significantly decreased in transgenic
mice with “Wallerian degeneration slow” mutation (Kerschensteiner et al., 2005). Additionally,
AAD was blocked by calpain inhibitors, suggesting the involvement of calpain protease in AAD
(Kerschensteiner et al., 2005). Overtime, the proximal end remained stable, or showed early
sprouting as early as 6-24 hours after lesion (Kerschensteiner et al., 2005). In contrast, the distal
end underwent continued Wallerian degeneration (Kerschensteiner et al., 2005).
Besides the activity of calpain and Wallerian degeneration, axonal dieback after SCI has
also in part been linked to chronic macrophage activation (Busch et al., 2009; Busch et al., 2010;
Horn et al., 2008). Horn and his colleagues (2008) observed spatiotemporal correlation between
macrophage infiltration and injured ascending dorsal column sensory axon retraction from 7 to
28 days after injury, which was reduced by administration of liposomal clodronate - an inhibitor
of macrophage infiltration. Using an in vitro model of macrophage-axon interaction, they also
demonstrated that there were direct adhesive contacts between activated macrophages and
dystrophic axons, and that extensive axonal retraction could be induced only when macrophages
were activated (Horn et al., 2008). Further, Busch and his colleagues (2009) tried several
methods to attenuate macrophage induced retraction. One approach was through the inactivation
of matrix metalloproteinases (MMP), specifically MMP-9, while another approach was to
modify substrate, for example, the digestion of the aggrecan substrate by chondroitinase ABC.
Both of these two methods have been effective in blocking macrophage-induced axonal
retraction (Busch et al., 2009). Taken together, it appears now that axonal dieback is a complex
process, involving chronic macrophage activation and attachment to the dystrophic axons, as
well as the secretion of MMP and chondroitin sulfate proteoglycans.
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In addition to macrophage activation, oligodendrocyte and microglia/macrophage death
(Stirling et al., 2004) and myelin degeneration (McPhail et al., 2004) have also been implicated
in axonal dieback. Fourteen days after transection of the dorsal columns at the cervical C7-C8
level, apoptotic oligodendrocytes and microglia/macrophages were observed in the proximal
descending corticospinal tract (CST) and the distal degenerating, ascending sensory tract (AST)
(Stirling et al., 2004). Minocycline, which is an anti-inflammatory and neuroprotective
medication, inhibiting microglial activation (Yrjänheikki et al., 1998), attenuated MMPs
(Brundula et al., 2002) and inhibited caspase expression (Chen et al., 2000). When administered
intraperitoneally, minocycline was effective in reducing the number of ED1-positive
microglia/macrophages within the degenerating axonal segments at 7 d after injury. This strategy
prevented CST axonal dieback, reducing lesion size, and promoting functional outcome at both 7
and 14 days after spinal cord injury (Stirling et al., 2004).
Of note, distinct macrophage subsets, proinflammatory type (M1) and anti-inflammatory
type (M2), were activated differentially following SCI (Kigerl et al., 2009). Previous studies
have demonstrated that, by the stimulation of lipopolysaccharide and interferon-γ (IFN- γ), the
macrophage differentiated into the M1 phenotype, producing nitric oxide, superoxide and other
proinflammatory cytokines, mediating neuronal death (Block et al., 2007; Kigerl et al., 2009). In
contrast, via the stimulation of interleukin-4 (IL-4) or IL-13, the macrophage differentiated into
the M2 phenotype, promoting axonal growth (Barrette et al., 2008; Kigerl et al., 2009; Yin et al.,
2003; Yin et al., 2006), the phagocytosis of myelin (Vallie`res et al., 2006), and the maturation of
oligodendrocytes and remyelination (Schonberg et al., 2007). Temporally, the M1 macrophages
were activated rapidly and were maintained up to 28d post spinal cord injury, while in contrast,
the M2 macrophages were activated transiently and returned to preinjury levels by 14d post
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injury (Kigerl et al., 2009).

At the lesion site, the ratio of M1/M2 cells shifted from

approximately equal at 1–3 dpi, toward an M1 macrophage phenotype dominant phase after the
first week (Kigerl et al., 2009). This downregulation of M2 macrophage phenotype has been
linked to the lesion-derived factors in the microenvironment, based upon the fact that the percent
of M2 phenotype macrophage remained unchanged when injected into intact spinal cord, while
they became reduced by 20-40% when injected into the spinal cord contusion lesion (Kigerl et
al., 2009). Interestingly, a shift from M1 to M2 macrophages has been observed in equine tendon
repair (Dakin et al., 2012), the healing cutaneous wound site (Deonarine et al., 2007) and the
healing myocardium (Lambert et al., 2008; Nahrendorf et al., 2007), implicating that inducing
M2 macrophage formation is a potential therapeutic strategy to promote axonal regeneration and
CNS repair. Supporting evidence has already existed in preclinical models of SCI employing
peroxisome proliferator activated receptor (PPAR) agonists, which have been approved by the
Food and Drug Administration (FDA) to treat diabetes. It has been shown that PPAR agonists
could also facilitate the differentiation of macrophages into the M2 phenotype through IL-4
(Odegaard et al., 2007; Villanueva and Tontonoz, 2010), and promote anatomical and functional
repair after SCI (McTigue et al., 2007).
Activation of microglia has also been observed in brain injury. Specifically, in a mice
midline closed skull injury model, which induces diffuse axonal injury in the corpus callosum,
the activation of different subpopulation of microglia has been observed both acutely and
chronically (1d - 28d post injury) (Venkatesan et al., 2010). Particularly, some activated galectin3/Mac-2 immunoreactive microglia engulfed injured axonal segments, consistent with the role of
myelin phagocytosis during CNS inflammation (Reichert and Rotshenker, 1999; Venkatesan et
al., 2010; Walther et al., 2000). At the same time, activated galectin-3/Mac-2 immunoreactive
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microglia expressed nerve growth factor (Venkatesan et al., 2010), which is believed to have a
beneficial role, such as promoting neuronal repair, axon sprouting and oligodendrocyte
proliferation (Althaus et al., 1992; Frielingsdorf et al., 2007; Kromer, 1987; Sofroniew et al.,
2001). However, a detrimental role of nerve growth factor also exists, such as its association with
oligodendrocyte death (Casaccia-Bonnefil et al., 1996; Frade et al., 1996; Yune et al., 2007).
Thus, the real function of microglia/macrophage activation in axonal damage is still unclear.
Specifically, it is required to study whether they are associated with axonal dieback and/or
axonal regeneration/repair following diffuse traumatic axonal injury.

Anterograde degeneration following TAI
Previous experimental animal models of TBI as well as human studies have shown that,
following axonal damage and disconnection, the downstream distal axonal segments undergo
Wallerian degeneration, with subsequent deafferentation of the target tissue (Kelley et al., 2006;
Povlishock 1992; Povlishock et al., 1992). For example, in a rodent model of DAI, the distal
segment and its related synaptic terminals manifest an increase in electron density and/or
neurofilamentous hyperplasia, with detachment from their normal target sites within 24-48 hours
of injury (Povlishock 1992; Povlishock et al., 1992). Such axonal degeneration and
deafferentation may be linked to the neurological dysfunction and long-term deficits associated
with DAI.
However, other data also suggest that this same diffuse deafferentation may set the stage
for the subsequent sprouting of related intact nerve fibers which may be involved in synaptic
plasticity (Erb and Povlishock, 1991; Greer et al., 2011) and/or maladaptive modification
(Phillips et al., 1994; Reeves et al., 2003). In a feline model of mild to moderate TBI, Erb and
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Povlishock reported that the post-TBI diffuse pattern of axon terminal degeneration and
subsequent deafferentation in the dorsal lateral vestibular nucleus was followed by a prolonged
adaptive recovery process that occurred 2-6 months post injury (Erb and Povlishock, 1991).
Utilizing the entorhinal cortical lesion model coupled to TBI, a more severe injury paradigm,
Phillip and Reeves observed maladaptive sprouting of the crossed temporodentate fibers and
synaptogenesis after the clearance of the axonal debris (Phillips et al., 2001; Reeves et al., 2003).
Taken together, these results suggest that in cases of diffuse degeneration and deafferentation
induced by mild/moderate TBI, as opposed to more severe injury, the injured brain may in fact
harbor a permissive environment for the adaptive sprouting of nerve fibers and resultant synaptic
input to the previously deafferented targets.

Retrograde effect of TAI on the neuronal cell body
Again, our understanding of the retrograde consequences of TAI is incomplete. The
retrograde response of neuronal cell body to axonal injury is influenced by several factors, (1)
the type of the neuron sustaining axotomy, (2) how the axon is injured, transection (primary)
versus stretch during acceleration and deceleration (secondary), and (3) the distance from the
axonal lesion to the neuronal soma. This issue is of direct relevance to the issue of axonal
dieback, in that if the sustaining neuronal cell body dies, the fate of its downstream axonal
segment is a forgone conclusion.
The type of the neuron influences the retrograde response to axonal injury
The neuronal response to axonal injury is vastly different between the peripheral nervous
system (PNS) and the central nervous system (CNS). The PNS neuron has the capacity to
regenerate axons after the peripheral nerve lesion in the growth permissive environment.

19

Postinjury, the morphology of the cell body of axotomized PNS neurons transitions to
“chromatolysis”, which includes the restructuring of the granular endoplasmic reticulum and the
lateralization of the nucleus, which are related to mRNA synthesis alteration and protein
expression modification (Fenrich and Gordon, 2004; Gordon, 1983; Kreutzberg, 1995;
Kreutzberg, 1996). Evidence exists as to the up-regulation of the cytoskeletal proteins, such as
tubulin and actin (Tetzlaff et al., 1991), and the growth associated proteins, GAP-43, as well as
cytoskeleton-associated protein-23 (CAP-23, Bomze et al., 2001), which play an important role
in growth cone elongation (Bomze et al., 2001; Bulsara et al., 2002; Igarashi et al, 1995; Piehl et
al., 1998; Strittmatter et al., 1994). The denervated Schwann cells, the glial cells in PNS,
transition from the myelinating phenotype to the growth supportive nonmyelinating phenotype
(Hall, 1999). This is associated with a decrease in the expression of the myelin-associated genes
with an increase in the expression of regeneration associated genes (RAG), which include
neurotrophic factors, such as the brain-derived neurotrophic factor (BDNF), neurotrophin, glial
cell derived neurotrophic factor (GDNF), truncated receptors and the p75 neurotrophic factor
receptor (Boyd and Gordon, 2003; Funakoshi et al., 1993; Höke et al., 2002; Ito et al., 1998;
Meyer et al., 1992; Naveilhan et al., 1997; Seniuk et al., 1992 ).
In contrast, the CNS neuron does not mount a regenerative response after axotomy. This
could be due to (1) the insufficient ability of CNS neurons to express RAGs (Fernandes et al.,
1999; Hiebert et al., 2000; Plunet et al., 2002), (2) the inhibitory proteins that expressed by
oligodendrocytes, such as Nogo-A, oligodendrocyte-myelin glycoprotein (OMgp), myelinassociated glycoprotein (MAG) (Atalay et al., 2007; Giger et al., 2008; McDonald et al., 2011),
as well as (3) the proliferation of astrocytes, the formation of the glial scar and its release of
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inhibitory molecules, especially chondroitin sulfate proteoglycans (CSPGs) (Holmberg et al.,
2008; Ito et al., 2009; Susarla et al., 2011; Toyooka et al., 2011).
The pattern of axonal injury results in different fates for the neuronal cell body
Following axotomy, CNS neurons undergo cell death or somatic atrophy. Axonal injury
due to direct transection is commonly followed by neuronal death. Dale et al (1995) reported that
only 30 - 40% of corticospinal motor neurons in layer V of the adult rat cerebral cortex survived
13 days after the intracortical transection at 200µm ventral to the layer V cortex. The number of
corticospinal neurons decreased 5 and 10 weeks after complete thoracic spinal cord transection at
T-6/T-7 level (Feringa et al., 1983). Similarly, the number of corticospinal and rubrospinal
neurons decreased at 10 or 20 weeks after complete thoracic spinal cord transection at T-9 level
(McBride et al., 1990). Apoptosis of the primary cortical motor neurons was observed at 1 week
after transection of the dorsal funiculus at T-9 level (Hains et al., 2003). Galindo-Romero and
colleagues (2011) observed significant retinal ganglion cell (RGC) loss at 5 days and 21 days
following optic nerve transection 0.5mm from the optic disc.
In contrast to neuronal death seen with transection, neuronal survival and atrophy has
been described following diffuse traumatic axonal injury in animal models. Povlishock and
colleagues demonstrated that the neuronal cell bodies affected by perisomatic axonal injury
sustained atrophy rather than cell death (Greer et al., 2011; Lifshitz et al., 2007; Singleton et al.,
2002). Specifically, in a rat midline fluid percussion injury model, a diffuse TBI model,
Singleton (2002) observed that diffuse axonal swellings occurred within the mediodorsal
neocortex, with the neocortical neurons sustaining traumatic axonal injury from 30 minutes to 48
hours post injury. These axotomized somata demonstrated the increased expression of eIF2α,
while ultrastructurally these somata showed reactive response, the dispersion and loss of rough
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endoplasmic reticulum, without evidence of overt organelle or cytoskeletal change, not
supporting a cell death cascade (Singleton et al., 2002). Utilizing the same animal model,
Lifshitz (2007) observed that the number of neurons in the ventral basal complex suffering
perisomatic axotomy, did not decrease significantly from 1 day through 28 days post injury,
suggesting no significant cell death following diffuse traumatic axonal injury (Lifshitz et al.,
2007). The nuclear volume of thalamic neurons of the ventral basal complex, however, decreased
at 1 day and 7 days post injury compared to sham animals, consistent with atrophy (Lifshitz et al.,
2007). By modifying this midline fluid percussion injury model to mice, Greer (2011) showed
evidence that the neurons in layer V of cerebral cortex demonstrated atrophy at 28 days after
diffuse TBI, without evidence of neuronal death, and over time the downstream axon showed a
significant elongation, suggesting a regenerative response.
The distance from the axonal lesion to the neuronal soma affects the neuronal response
In addition, the proximity of the axonal injury to their neuronal cell bodies of origin may
influence the neuronal cell body response. More cell death occurs when the axonal lesion is near
to the neuronal cell body of origin, with more neuronal sparing seen with more distal lesions
(Dale et al., 1995; Liu et al., 2003; Liu et al., 2004). For example, the number of surviving
corticospinal motor neurons in layer V of the adult rat cerebral cortex was 70% at 13 days after
the intracortical transection 400µm below the layer V cortex, and decreased to 30-40% during
the same period when the intracortical transection was 200µm below the layer V cortex (Dale et
al., 1995). After infusion of ciliary neurotrophic factor (CNTF), the number of surviving
corticospinal motor neurons increased to 2- fold compared to the number seen with vehicle
treatment following the axonal transection at the 200µm depth, while no recognizable CNTF mediated neuronal protection was observed when the intracortical transection was at the 400µm
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depth (Dale et al., 1995). These results suggest that the neuronal survival depends on the
retrograde axonal transport of neurotrophic factors to the neuronal cell body and/or other
neuronal signaling molecules. The more distant axotomy from the neuronal cell body, the more
continued retrograde axonal transport of the neurotrophic factors from the downstream target
tissue, and the more likely that the sustaining neuronal cell body will survive.
Similar findings were observed in spinal cord injury. Fifty seven percent cell loss of rat
rubrospinal neurons occurred at 2 weeks after the axonal transection at the brain stem level, in
contrast to the 7% cell loss during the same period after the axotomy at C2 level (Liu et al.,
2003). More swollen mitochondria appeared in rat rubrospinal neurons following axotomy at
brainstem than at C2 level, with more increased expression of nitric oxide (NO) synthase after
axotomy at brainstem than at C2 level, and no significant change after axotomy at T10 level, and
the mitochondrial Mn-superoxide dismutase was significantly reduced after axotomy at
brainstem in contrast to no alteration following C2 axotomy (Liu et al., 2004). These findings
suggest that the distance between the axonal lesion and the neuron soma is one of the
determinants of the response on the neuronal body and the neuronal fate, probably through the
NO-mediated toxicity and superoxide -mediated mitochondrial damage (Liu et al., 2004).
The signal transmission process from the axonal lesion to the neuron body
Since different neurons have different fates following different patterns/locations of
axotomy, as described above, it is meaningful to address how the axonal injury signal transfers to
the neuronal cell body. The current view regarding retrograde response of neuronal cell body to
axonal injury is based on physical transection model (Bonatz et al., 2000; Giehl and Tetzlaff
1996; Merline and Kalil 1990). The transection of CNS axons exposes the axonal cylinder to
different extracellular electrical and chemical environment, and activates a complex series of
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responses. The early phase is mediated by the electrical signal from the axonal lesion site back to
the soma (Mandolesi et al., 2004), the second phase is the alteration of biochemical signal,
followed by the third phase of modulating gene expression and protein translation.
The first signal from axotomy event is the electrophysiological response. In an in vitro
study, following the axotomy (~100µM from cell body) of neurons cultured from rodent visual
cortex, influx of calcium was initially observed at the lesion site, and then this increase of
calcium transferred along the axon toward the soma. This axotomy induced calcium increase was
associated with the activation of the voltage-gated calcium channels and Na+/Ca2+ exchange
(Mandolesi et al., 2004).
The second signal involves the interruption of the supply of trophic factors conveyed to
the cell body by retrograde axonal transport, which are essential for neuronal survival and
regeneration (Ben-Yaakow and Fainzilber, 2009; Shadiack et al., 2001).
Another system of signaling involves the retrograde transport of activated proteins
originating from the injury site (Ambron and Walters, 1996; Ben-Yaakow and Fainzilber, 2009;
Hanz et al., 2003; Perlson et al., 2004; Zhang and Ambron, 2000). De novo synthesis of importin
β at the axon lesion site was observed 30 minutes to 1 hour after lesioning by local translation of
axonal mRNA (Hanz et al., 2003). Then importin α and importin β formed a high-affinity
heterodimer and associated with the motor protein dynein 2 hours after lesion (Hanz et al., 2003).
Further, nuclear localization signal (NLS) – bearing signaling protein bond to the high-affinity
binding site on the α/β importin (Hanz et al., 2003). Then, NLS-binding complex was transferred
retrogradely toward the cell body at about 1h/mm, through the interaction of importin α with
dynein (Hanz et al., 2003; Hanz and Fainzilber, 2004). Any disruption of NLS complex slowed
the regeneration of injured sensory neurons (Hanz and Fainzilber, 2004). These findings
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implicated the connection between retrogradely transported NLS by importins in periphery and
the nuclear import of NLS by importins in cell bodies, and probably this is a potential retrograde
intrinsic mechanism to promote neuronal regeneration in CNS.
The activation of CREB-cAMP pathway in neuron cell body after axotomy
After receiving the retrograde transported injury signal, the neuronal cell body regulates
transcription factors and alters translation of related protein. It has been documented that cAMP
level was elevated in the DRG neurons following a conditioning lesion, in which the sciatic
nerve and the dorsal column were injured simultaneously, or the sciatic nerve was injured before
the dorsal column (Hannila and Filbin, 2008; Qiu et al., 2002). This cAMP elevation was
dependent on the activation of protein kinase A (PKA) (Qiu et al., 2002). Following cAMP
elevation, the transcription factor cAMP response element binding protein (CREB) was
activated, promoting neurite outgrowth and axon regeneration (Gao et al., 2004). Several cAMPregulated genes have been identified, such as arginase I, polyamines (Abe and Cavalli, 2008; Cai
et al., 2002; Gao et al., 2004) and interleukin-6 (IL-6; Cao et al., 2006).
The activation of c-Jun and the induction of ATF-3 in neuron cell body after axotomy, and
their relation to axon regeneration
In addition to the activation of CREB-cAMP pathway, the c-Jun N-terminal kinase (JNK)
pathway is also activated following axotomy (Kenney and Kocsis, 1998; Greer et al., 2011; Itoh
et al., 2011; Lindwall and Kanje, et al., 2005). Greer et al (2011) demonstrated that at 1 and 3
days following midline fluid percussion injury, phospho-c-Jun was expressed in atrophic neurons
within the layer V cortex that sustained traumatic axonal injury, and this expression persisted
through 28 day following injury. Similarly, activating transcription factor 3 (ATF-3), was also
upregulated in axotomized neurons in layer V cortex at 3 day and 7 day post-injury, although its
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expression was reduced at 14 day and 28 day post-injury (Greer et al., 2011). Concomitant with
these findings, reactive sprouting from the truncated axon was observed as early as 1 day postinjury, and long, thin axonal profiles originated from phospho-c-Jun positive neurons was
observed at 14 and 28 day post-injury (Greer et al., 2011). These results support the axonal
regeneration function of JNK pathway following axotomy (Broude et al., 1997; Raivich et al.,
2004; Raivich, 2008). Lindwall and Kanje (2005) observed in a rat sciatic nerve ligation model,
the retrograde axonal transport of JNK upstream kinases, including mitogen activated protein
kinase (MAPK) kinase kinases (MEKKs) MEKK1, MAPK kinases (MKK) MKK7 and pMKK4, mixed lineage kinase (MLK) 3, p-JNK, p-ATF2, and the scaffolding protein JNK
interacting protein (JIP) (Whitmarsh et al., 2001; Yasuda et al., 1999). On the contrary, the
retrograde transport of c-Jun and p-c-Jun was minimal (Cavalli et al., 2005; Lindwall and Kanje,
et al., 2005). Additionally, they revealed the anterograde axonal transport of Hsp27, a protein
upregulated after the activation of c-Jun and the induction of ATF3 in the nucleus, and
transported and coupled with p-c-Jun and ATF3 (Lindwall and Kanje, et al., 2005; Nakagomi et
al., 2003). These facts indicate that JNK signaling molecules are transported retrogradely toward
the neuronal cell body, where they activate the phosphorylation of c-Jun and the induction of
ATF3 (Lindwall and Kanje, et al., 2005). Interestingly, NLS motifs, as described before which
were transferred retrogradely toward the cell body via the coupling of importin α with dynein
(Hanz et al., 2003), were found located within the basic region of the DNA binding domain of
ATF proteins (Hai et al., 1989), suggesting that ATF3 could be induced after the reception of the
retrogradely transported NLS signal from the axon lesion site.
JNKs have 3 isoforms, JNK1, JNK2 and JNK3. It has been demonstrated that JNK2 and
JNK3 are necessary for neuritogenesis, JNK1 and JNK2 are related to neurite elongation and the
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phosphorylation of microtubule-associated protein MAP1B which plays function in axonal
regeneration, and JIP1 is associated with neurite initiation and extension (Barnat et al., 2010;
Bogovevitch 2006; Bouquet et al., 2004; Dajas-Bailador et al., 2008; Mack et al., 2000). These
JNKs functions are further supported by the fact that axonal outgrowth was reduced when c-Jun
phosphorylation was inhibited by the selective JNK inhibitors SP600125 and (D)-JNKI1
(Lindwall et al., 2004).
The phosphorylation of c-Jun is involved in axonal regeneration. Upregulation of
phospho-c-Jun was observed in the rat layer V cortex neuron after central fluid percussion brain
injury (Greer et al., 2011), the rat mammillaris neurons up to 150 days after the transection of the
medial forebrain bundle and mammillothalamic tract (Herdegen et al., 1993), bulbospinal and
rubrospinal neurons after cervical spinal hemisection (Vinit et al., 2011). In a sciatic nerve crush
injury model, when the expression of c-Jun was depleted in adult DRGs by siRNA technique, the
size of the growth cone of the regenerating axons reduced, suggesting the role of c-Jun in
regulating growth cone morphology (Saijilafu et al., 2011).
ATF-3 expression is also associated with axon regeneration. It has been demonstrated
that ATF-3 facilitated peripheral nerve regeneration by increasing the expression of growthassociated genes small proline-repeat protein 1A (SPRR1A) in the DRG neurons (Huebner et al.,
2009; Seijffers, et al., 2007). When pieces of peripheral nerve were transplanted into the
thalamus of adult rats, axonal regeneration was observed originating from the thalamic reticular
nucleus and medial geniculate nuclear that contained ATF-3 positive cells, which concomitantly
expressed c-Jun (Campbell et al., 2005). Again, Greer (2011) also observed ATF-3 expression in
axotomized neurons in layer V cortex at 1 - 7 day post-injury. These results indicate the initiation
of a somatic gene expression program promoting neuronal recovery and/or axon regeneration.
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In summary, the CNS neurons undergo cell loss due to primary transection of the axon,
or survive and /or undergo atrophic change following diffuse axonal injury induced by the stretch
at the acceleration/deceleration event. This divergent neuronal response could be due to different
electrical and biochemical signals transferred from the axon terminal retrogradely toward the cell
body of CNS neuron, which then initiates the synthesis and/or modification of corresponding
molecules and factors, determining whether the neuron should die or survive and promote axon
regeneration and/or repair. This response could be further influenced by the distance from the
axonal lesion to the neuronal soma (perisomatic versus remote from the cell body).

Visual dysfunction in TBI
As noted above, there are limitations in our understanding of the mechanisms involved in
axonal dieback in TAI, its anterograde/downstream degeneration and potential synaptic plasticity,
as well as the differential response of the CNS neuronal cell body to axonal injury. In addition to
these limitations, the majority of previous TAI studies have been conducted in neocortex,
thalamus, corpus callosum, internal capsule and brainstem, and focused on motor and memory
function, without sufficient consideration of the special sensory pathways involved in TBI, such
as the visual system.
This issue is of merit as visual dysfunction occurs frequently following TBI and can
include decreased visual acuity, loss of color perception and contrast sensitivity, visual field loss,
diplopia, blurred vision, photophobia, convergence insufficiency, saccade and disorientation
(Atkins et al., 2008; Barker et al., 1997; Hoyt, 2007). In a study on the incidence of combatrelated eye injuries, the Defense Veterans Brain Injury Center (DVBIC) reported that 80 percent
of the 3,900 troops sustaining TBI had visual problems (Zampieri, 2007). These could be due to
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traumatic optic nerve damage or the disturbance of the intracranial visual pathways associated
with TBI (Atkins et al., 2008). Traumatic optic nerve damage may be directly due to optic canal
fracture (Matsuzaki et al., 1982; Sarkies 2004) during TBI which results in optic nerve
compression/crush (Chen et al., 2004; Rumiantsev et al., 1981; Zhilin et al., 2011) or transection
(Sarkies 2004). Optic nerve may also be injured indirectly from compression and contusion in
closed head injury (Anderson et al., 1982; Sarkies, 2004). The intracanalicular optic nerve is
unmovable within the optic canals, making this segment susceptible to shearing and/or stretching
forces from the orbital and intracranial segments during rapid acceleration-deceleration
movements (Rubin, 2005). In addition to the optic nerve, the optic chiasm, the optic radiation,
the occipital cortex, as well as cranial nerves III, IV and VI may also be damaged during TBI
(Cockerham et al., 2009).

Diffuse traumatic axonal injury in the visual system
Several human and animal studies have demonstrated diffuse axonal injury within the
visual system after traumatic brain injury. With diffusion tensor imaging, Palmer et al (2010)
showed that fractional anisotropy (FA) decreased in the optic radiation in patients sustaining
severe TBI, consistent with axonal damage in that area. In a study on infants sustaining the
shaken baby syndrome, Gleckman et al (2000) observed axonal swellings in the optic nerve
caudal to the lamina cribrosa utilizing beta-amyloid precursor protein immunostaining. Foda and
Marmarou (1994) found diffuse axonal injury in the optic tract in a rat weight drop model.
Similarly, in a rat weight drop injury model, Ding et al (2001) observed diffuse axonal injury in
the optic chiasm, optic tract, lateral geniculate nuclei and superior colliculus with silver staining.
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Besides the occurrence of TAI within the visual system after TBI, several researchers
have utilized an optic nerve stretch model to generate diffuse axonal injury in the optic nerve
(Gennarelli et al., 1989; Maxwell et al., 1994; Maxwell and Graham, 1997; Sulaiman et al.,
2011; Saatman et al., 2003; Serbest et al., 2007). As early as 1989, Gennarelli and colleagues
stretched the optic nerve of albino guinea pigs, and observed beaded axons and terminal bulbs in
the optic nerve, as well as impaired axonal transport of HRP from the vitreous to the superior
colliculus. Saatman and colleagues (2003) modified this optic nerve stretch model in the albino
guinea pig to mice, and observed axonal swellings and bulbs in the optic nerve, as well as
impaired retrograde axonal transport from the superior colliculus to the retina.

Summary and Statement of the Problem
In sum, we have discussed TBI and TAI as a major contributor to TBI mortality and
morbidity. Previous work on TAI has provided critical insight into the initiating mechanisms
associated with TAI, involving alterations in axolemmal permeability, calcium dysregulation,
and the subsequent activation of the proteases calpain and caspase, which then alter the
cytoskeleton to ultimately impair axonal transport to result in organelle / protein accumulation,
with the formation of axonal swelling and disconnection. However, following axonal swelling
and disconnection, little is known in terms of the subsequent axonal dieback overtime post TAI,
as well as its ongoing anterograde/downstream changes or the retrograde response of neuronal
cell body to TAI. These issues are important from several perspectives in that such information is
critical to future studies targeting neuroprotection and repair. Further, in that the visual system
provides a highly organized projection system to follow these events, its choice for continued
investigation seems both reasonable and rational. Lastly, given the prevalence of visual
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dysfunction following TBI, and the evidence of TAI within the visual system in human and
animal studies, the current thesis attempts to address TAI within the optic nerve/visual pathway
following TBI, and its anterograde and retrograde change take on further significance.
In this dissertation (Chapter 3), using a mice central fluid percussion diffuse brain injury
model, we describe the development of TAI within the optic nerve, its disconnection and
associated axonal dieback both proximally and distally overtime post injury. We compare and
contrast the morphological differences between the proximal and distal disconnected axonal
segments. Specifically, we describe the regression and reorganization of the proximal swellings,
and the persistence of the distal disconnected and degeneration swellings. We also demonstrate
that this pathological TAI within the optic nerve is accompanied by transient and subtle
breakdown of the blood-brain-barrier with the formation of edema and YFP fluorescence
quenching in the early phases post injury.
In this communication (Chapter 4), we also address the fate of retinal ganglion cell layer
following TAI within the optic nerve from 2 to 90 days post injury. Utilizing multiple qualitative
and quantitative methods as well as ultrastructure analysis, we find no evidence of RGC loss
following TAI. Rather, we demonstrate RGC survival, together with the persistent expression of
phospho-c-Jun, which has been linked to neuronal survival and potential axonal repair in other
injury paradigms.
Further, in Appendix I (Chapter 5), we demonstrate a differential microglia/macrophage
response in the disconnected proximal and distal axonal segments. Specifically, we demonstrate
that activated microglia/macrophages closely envelop/encompass the distal disconnected,
degenerating axonal segments. In contrast, the microglia/macrophages appear less reactive in the
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proximal axonal segments, with their processes paralleling these axonal profiles undergoing
reorganization/repair.
Lastly, in Appendix II (Chapter 6), we demonstrate the resolution of edema in the
interstitial space within the optic nerve, and the recovery of intact YFP fluorescent axonal fibers
overtime in the region of previously demonstrating fluorescent loss (Chapter 3). This recovery of
the intact YFP fibers is consistent with the reversal of fluorescence quenching.
Collectively, the data provided in both Appendix I and II support the reparative processes
ongoing in the optic nerve at the site of injury as well as in its upstream/retrograde sites, while
supporting the persistence of downstream/anterograde scattered Wallerian degeneration.
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CHAPTER TWO
GENERAL MATERIALS AND METHODS

Breeding and genotyping of YFP-16 transgenic mice.
The Thy1-YFP-16 transgenic mice [B6.Cg-Tg(Thy1-YFP)16Jrs/J, stock number 003709]
were obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained as heterozygotes.
Inheritance of the YFP gene was identified from an ear punch taken at weaning (approximately
postnatal day 21). The ear tissue was mounted onto a glass slide and examined using a FITC
filter on an Olympus DP71 digital camera (Olympus, Center Valley, PA), where YFP-positive
axons could be easily identified.

Surgery and animal model of traumatic brain injury.
All protocols used in this study were approved by the Institutional Animal Care and Use
Committee (IACUC) of Virginia Commonwealth University. Adult male C57/BL6 mice and
Thy1-YFP-16 transgenic mice (20–25 g) were subjected to central fluid percussion TBI to
produce traumatic axonal injury in the optic nerve. The fluid percussion injury model was
modified from that previously described in detail by Dixon (1987). Briefly, animals were
anesthetized with 4% isoflurane in 100% O2, and maintained via nosecone with 2% isoflurane in
100% O2 during surgery, with the body temperature controlled at 37oC via a feedback-controlled
heating pad (Harvard Apparatus, Holliston, MA). A midline 3.0 mm circular craniotomy was
made over the sagittal suture halfway between the bregma and the lambda, taking care not to
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damage the underlying dura. A Luer-Loc syringe hub was cut away from a 20 gauge needle and
affixed to the craniotomy site. Dental acrylic was applied around the hub to enhance stability. As
the dental acrylic dried and the injury hub became stable, saline was applied to blunt any
exothermic reaction from the cured acrylic. The skin was then sutured over the hub, with
lidocaine and bacitracin ointment applied to the wound. The animal was allowed to recover for 1
hour in a warmed cage prior to injury. Before the induction of injury, each animal was again
anesthetized for 4 min (100% O2 and 4% isoflurane). The craniotomy site was exposed and the
injury hub was connected to the fluid percussion device. The animal was then injured at a
magnitude of 1.40±0.05 atmospheres. The pressure pulse was measured by a storage
oscilloscope (Tektronix 5111; Tektronix, Beaverton, OR). Injury preparation and induction were
completed prior to the animal’s recovery from anesthesia. The hub and dental acrylic were then
removed, and the incision was rapidly sutured. The duration of transient unconsciousness was
determined by measuring the time it took for the animal to recover the following reflexes: toe
pinch, tail pinch, corneal blink, pinna, and righting reflex. After recovery of the righting reflex,
the animals were placed in an incubator with a heating pad to maintain normothermia and
monitored during recovery. For animals receiving sham injury, all of the above steps were
followed with the exclusion of the injury pulse. All injured animals had righting reflex recovery
times of 4–5 min, compared with less than 2 min for sham-injured animals, indicating injuries of
comparable severity.

Animals Utilized for Specific Studies.
For the characterization of the diffuse traumatic axonal injury within the optic nerve
following TBI, YFP-16 and wild type (WT) mice were allowed to survive 5 min, 15 min, 1 hour,
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3 hour, 12 hour, 24 hour and 48 hour following injury (for each time point, 1 WT and 6 YFP-16
mice were utilized in the injured group, with 1 WT and 2 YFP-16 mice was used in the sham
group). For the study of the retinal ganglion cell response to diffuse traumatic axonal injury, as
well as the activation of microglia/macrophage in the optic nerve, YFP-16 mice were allowed to
survive 2 day, 7 day, 14 day, 28 day and 90 day following injury (for each time point, 9 YFP-16
mice were utilized in the injured group, with 6 YFP-16 mice were utilized in the sham group).

Animal perfusion
At the predetermined survival times, mice were intraperitoneally injected with an
overdose of sodium pentobarbital and then transcardially perfused with 100 ml heparinized
normal saline followed by 200 ml 4% paraformaldehyde in Millonig’s buffer (135.8mM Na
Phosphate monobasic/108.8mM NaOH). For electron microscopy, animals were perfused with
4% paraformaldehyde/0.2% glutaraldehyde or 2% paraformaldehyde/2.5% glutaraldehyde for
optimal processing.

Optic nerve preparation
After above perfusion and overnight incubation in the perfusion fixative solution, the
optic nerve, chiasm and optic tract, together with the brain were removed from the skull for
routine fluorescence and confocal analysis. The optic nerves were blocked to include the entire
optic nerve, the chiasm, the initial part of the optic tract, and related brain tissue, and post-fixed
in the same fixative solution overnight. Following post-fixation, this optic nerve block was
cryoprotected and then cut longitudinally into 10µm sections with a cryotome (Shandon
Scientific Ltd., Cheshire, U.K.). Serial sections revealing the entire length of the optic nerve
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(from the globe to the chiasm) were then collected in a serial order in Millonig’s buffer in 24
well culture plates (Falcon, Newark, DE), and stored at 4oC for further use.

Retinal whole-mount preparations
After 15 minutes fixation, the extraocular muscles were cut from the globe, the optic
nerve was transected immediately behind the globe, and the globe was dissected out from the
orbit. The cornea was punctured with an 18 gauge needle, cut into 4 quadrants, and torn to the
limbus using two sets of forceps. The lens was removed. The retina was separated from the
pigmented layer, and immersed in 4% paraformaldehyde in Millonig’s buffer for 4 hours. Then
the retina was washed with phosphate buffered saline (PBS) for 5 x 10 minutes. Then each retina
was cut into 4 quadrants, and mounted flat on a glass slide with Vectashield Hardset Mounting
Medium with DAPI (Vector Laboratories), and cover-slipped for image capture with a Leica
TCS-SP2 AOBS confocal microscope (Wetzlar, Germany).

Retinal cryostat section preparation
After the retina was separated from the pigmented layer as described above, it was fixed
in 4% paraformaldehyde in Millonig’s buffer overnight. After 5 x 10 minutes thorough wash in
PBS, the retina was immersed in 30% sucrose in PBS overnight. The pair of retinal cups from
the same animal was then embedded side to side and frozen to -20oC in optimal cutting
temperature (OCT) compound (Electron Microscopy Sciences, Cat No.62550-01, Hatfield, PA,
U.S.A.), and cut into 12µm sections with a cryotome. Serial sections were collected on
Superfrost®/Plus microscopic glass slides (Fisher Scientific, catalog no.12-550-15, U.S.A.), with
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4 serial sections of each eye on each slide (8 sections for 2 eyes), and stored at -20oC for further
use.

Single and double immunofluorescence labeling protocol
After optic nerve or retinal sections were selected, they were rinsed 3 x 10 minute in PBS
or Tris-buffered saline (TBS) (for antibodies targeting phosphorylated antigens), sections were
treated with blocking solution 10% normal goat serum (NGS) with 0.5% Triton X-100 and 2%
bovine serum albumin (BSA) in PBS (or TBS) for 2 hours. When employing primary antibodies
produced from a mouse host, endogenous mouse IgG was blocked by Mouse on Mouse Kit
(MOM™; Vector Laboratories; Burlingame, CA). The sections were then incubated in primary
antibodies in 10% NGS with 0.5% Triton X-100 and 2% BSA in PBS (or TBS) at 4°C overnight.
On the second day, the sections were rinsed in 1% NGS with 0.2% Triton X-100 and 1% BSA in
PBS (or TBS) 6 x 10 minutes, then incubated in the appropriate Alexa fluor-conjugated
secondary antibodies (Alexa 568, Alexa 594 or Alexa 633) in 1% NGS with 0.2% Triton X-100
and 1% BSA in PBS (or TBS) solution for 2 hours at room temperature. Then tissue sections
were rinsed in PBS (or TBS), mounted onto gelatin-coated glass slides, and cover slipped with
Vectashield Hardset Mounting Medium with DAPI (Vector Laboratories). Antibody
concentrations are listed in Table 1.
For double labeling, the same protocols were utilized, with the specific attention that
different primary antibodies were added at the same time for the overnight incubation, followed
by the reaction with secondary antibodies that were conjugated to different Alexa fluors with
binding specifically to different primary antibodies.
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Table 1. Antibodies for immunofluorescence labeling

1st
2nd
1st
1st
2nd
1st
2nd
1st
2nd
1st
2nd
1st
2nd
1st
2nd

Antibodies
Anti-β-APP (c-terminus)
Alexa 594-conjugated
goat anti-rabbit IgG
Texas-Red conjugated
goat anti-mouse IgG
Anti-GFP
Alexa 594-conjugated
goat anti-rabbit IgG
Anti-Digoxigenin
Alexa 594-conjugated
goat anti-mouse IgG
cleaved-caspase-3(Asp175)
Alexa 594-conjugated
goat anti-rabbit IgG
Anti-Brn3a
Alexa 568-conjugated
goat anti-mouse IgG
phospho-c-Jun (Ser63)
Alexa 633-conjugated
goat anti-rabbit IgG
Anti-Iba1
Alexa 568-conjugated
goat anti-rabbit IgG

Host
rabbit
goat

Vendor
Zymed, San Francisco, CA
Vector Laboratories, Burlingame,
CA
Molecular probes, Invitrogen

Dilution
1:1000
1:200

rabbit
goat

Chemicon, Temecula, CA
Vector Laboratories

1:8000
1:500

mouse
goat

Roche Applied Science, Germany
Invitrogen; Eugene, Oregon

1:250
1:250

rabbit
goat

Cell Signaling Technology
Molecular probes, Invitrogen

1:500
1:250

mouse
goat

Chemicon and Linco, Millipore
Molecular probes, Invitrogen

1:125
1:500

rabbit

1:100

goat

Cell Signaling Technology, Danvers,
MA
Molecular probes, Invitrogen

rabbit
goat

Wako Pure Chemical Industries, Ltd
Molecular probes, Invitrogen

1:1000
1:500

goat

1:200

1:200

Confocal Microscopy and Image Acquisition
Images of YFP positive retina and optic nerve were acquired with a Leica TCS-SP2
AOBS confocal microscope (Leica Microsystems, Wetzlar, Germany). Targeted optic nerves or
retina were imaged with a scan resolution of 1024 × 1024 pixels. DAPI fluorescence was excited
using a 405nm laser, and emission was detected over a range of 410-550 nm with the intensity at
25%. YFP fluorescence was excited using the 514 nm line of an argon laser, and emission was
detected over a range of 520-554 nm with the intensity at 50%. Texas-Red fluorescence was
excited using a 594 nm helium–neon laser, and emission was detected over a range of 605-700
nm with the intensity at 50%. Alexa 568 fluorescence was excited using a 594 nm helium–neon
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laser, and emission was detected over a range of 599-628 nm with the intensity at 100%. Alexa
594 fluorescence was excited using a 594 nm helium–neon laser, and emission was detected over
a range of 600-652 nm with the intensity at 100%. Alexa 633 fluorescence was excited using a
633 nm helium–neon laser, and emission was detected over a range of 640-685 nm with the
intensity at 100%. During scanning, the “Offset” of PMT (photon multiply tube) which adjusts
the background was set to show a few green spots, and the “Gain” of PMT which adjusts the
bright points was set to show a few blue spots using the color gradient to avoid pixel intensity
saturation. To minimize noise, the line averaging was always set at 4. A sequential scan was
performed to avoid the potential for crosstalk between the YFP fluorophore, DAPI and Alexa
dyes.

For the study of the spatial-temporal relationship between the axon and

macrophage/microglia, their three-dimensional reconstruction was obtained via the Volocity
Software package (Improvision, version 4.3.2, Perkin Elmer; Waltham, MA).

Electron microscopy
For electron microscopic (EM) analysis, two different perfusion protocols were employed
to achieve: (1) optimal ultrastructure detail, or (2) the optimal visualization of the YFP-positive
axons.
To achieve optimal ultrastructure detail, wild type mice or the YFP-16 transgenic mice
were first perfused with 100ml heparinized normal saline, followed by 200ml 2%
paraformaldehyde and 2.5% glutaraldehyde in Millonig’s buffer. After 15 minutes fixation, the
retina was removed as described above, and immersed in 2% paraformaldehyde and 2.5%
glutaraldehyde in Millonig’s buffer overnight, together with the brain and the optic nerve. Then

these fixation prepared retina and optic nerves were osmicated, dehydrated, and flat embedded in
epoxy resin (Embed-812; Electron Microscopy Sciences, Hatfield, PA) as detailed below.
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For the optimal EM analysis of the YFP positive axons, the YFP-16 transgenic mice were
first perfused with 100ml heparinized normal saline, followed by 200ml 4% paraformaldehyde
and 0.2% glutaraldehyde in Millonig’s buffer in order to maintain the structure of YFP
fluorescent protein and optimize immunoreactivity. Again, the brain and the optic nerves were
post-fixed and blocked as described above. Then the optic nerve sections were cut longitudinally
at 16µm with a vibratome (Leica VT1000 S; Leica Microsystems GmbH, Nussloch, Germany),
and then prepared for immunocytochemistry using a primary antibody rabbit anti-GFP (1:8000;
Chemicon) followed by the secondary antibody, biotinylated goat anti-rabbit IgG (1:1000;
Vector). Next, the tissue was incubated in avidin-biotin complex (1:200, Vectastain ABC
Standard Elite Kit; Vector Laboratories), and visualized by diaminobenzidene (DAB; SigmaAldrich, St. Louis, MO) for subsequent EM analysis.
Briefly, the above-prepared retina, optic nerves and the immunoreactive YFP-expressing
optic nerve sections were osmicated in 1% OsO4, dehydrated, embedded in epoxy resins,
mounted on plastic slides (Thomas Scientific Co., Swedesboro, NJ) and cover-slipped. After
resin curing, the plastic slides were examined via routine light microscopy to identify RGCs, or
the injured axonal segments within the optic nerve based on the patterns of distribution seen in
the YFP-expressing mice evaluated by confocal microscopy. Once identified, these sites were
excised, mounted on plastic studs, and thick sectioned to the RGC layer, or the depth of the
immunoreactive sites of interest using an ultramicrotome (Leica Ultracut R; Leica, Wien,
Austria). Serial 40nm sections were cut and mounted onto Formvar-coated single-slotted grids.
The grids were then stained with 5% uranyl acetate in 50% methanol for 2 minutes and 0.5% lead
citrate for 1 minute, and visualized using a JEM 1230 electron microscope (JEOL Ltd., Tokyo,
Japan).
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Quantification of YFP fluorescent axonal swellings and statistical analysis
At the 12, 24 and 48 hours post injury time points, quantitative analysis of any observed
axonal swelling detected by confocal imaging was conducted. The randomly selected YFP optic
nerve sections were analyzed via the placement of 12 serial grids (each grid = 200 µm x 200 µm)
along the optic nerve, six of which were placed proximally and labeled P1–P6 moving from the
initial locus of TAI (approximately 1 mm rostral to the chiasm) to the globe, and the other six
grids were located distally and labeled D1–D6 moving from the initial locus of TAI to the
chiasm(Figure 3.6). Each 200 µm x 200 µm grid was aligned over the center of the optic nerve.
For each individual grid, the number of axonal swellings per unit area, the total area of axonal
swellings per unit area, and the percentage of the total area of axonal swellings per unit area, as
well as the size of axonal swellings per unit area were measured using the Imaging Processing
(IP) Lab 3.7 image analysis system (Scanalytics, Inc., Fairfax, VA). Only those swellings over 5
µm in diameter were analyzed (Gao et al., 2010). Any swellings overlapping either the top, the
bottom, or the left line of the grid were included, while those overlapping the right grid line were
excluded from analysis. All results were presented as mean ± standard error of the mean (SEM).
Each dependent variable was analyzed separately by a split-plot analysis of variance [ANOVA; 3
(Time) x 12 (Location)]. To examine the specific effect of time for each dependent variable at
each of the locations, subsequent one-factor (time) ANOVAs and posthoc Fisher LSD tests were
conducted for each grid location. Statistical significance was set at p < 0.05 for all tests.

Quantification of RGC and statistical analysis
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To quantify the number of RGCs, the Brn3a immunofluorescently labeled retinal sections
were captured using routine epifluorescent microscopy. Specifically, Brn3a retinal section (4
sections per eye, with each slide containing 8 sections from both eyes) was digitally acquired at
20 x magnification moving from side to side of the retina covering its entire extent, parallel to its
curvature. Each retinal section was reconstructed using 7-9 images taken along the extent of the
retina (Figure 4.4 A). To quantify the number of RGCs, the central image of those acquired was
selected together with the other next adjacent image from both sides (Figure 4.4 A arrow). For
each selected image, the number of Brn3a positive RGCs was counted in a 0.05 mm2 grid
expanding along the image parallel to the alignment of the RGCs (Figure 4.4 B). This process of
acquisition and counting was repeated for each of the retinal sections on the slide for a total of 72
retinal images per animal (3 images/section x 8 sections/slide x 3 slides/animal = 72
images/animal). For each animal, the number of Brn3a positive RGCs was calculated by
summating the number of Brn3a positive RGCs from the 72 images, expressing them as mean ±
standard deviation. To test the difference of the number of Brn3a positive RGCs overtime post
injury, one way ANOVA was conducted. Statistical significance was set at p < 0.05 for all tests.
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CHAPTER THREE
TRAUMATIC AXONAL INJURY IN THE OPTIC NERVE: EVIDENCE FOR AXONAL
SWELLING, DISCONNECTION, DIEBACK, AND REORGANIZATION

Abstract
Traumatic axonal injury (TAI) is a major feature of traumatic brain injury (TBI) and is
associated with much of its morbidity. To date, significant insight has been gained into the
initiating pathogenesis of TAI. However, the nature of TAI within the injured brain precludes the
consistent evaluation of its specific anterograde and retrograde sequelae. To overcome this
limitation, we used the relatively organized optic nerve in a central fluid percussion injury (cFPI)
model. To improve the visualization of TAI, we utilized mice expressing yellow fluorescent
protein (YFP) in their visual pathways. Through this approach, we consistently generated TAI in
the optic nerve and qualitatively and quantitatively evaluated its progression over a 48-h period
in YFP axons via confocal microscopy and electron microscopy. In this model, delayed axonal
swelling with subsequent disconnection were the norm, together with the fact that once
disconnected, both the proximal and distal axonal segments revealed significant dieback, with
the proximal swellings showing regression and reorganization, while the distal swellings
persisted, although showing signs of impending degeneration. When antibodies targeting the Cterminus of amyloid precursor protein (APP), a routine marker of TAI were employed, they
mapped exclusively to the proximal axonal segments without distal targeting, regardless of the
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survival time. Concomitant with this evolving axonal pathology, focal YFP fluorescence
quenching occurred and mapped precisely to immunoreactive loci positive for Texas-Redconjugated-IgG, indicating that blood–brain barrier disruption and its attendant edema
contributed to this phenomenon. This was confirmed through the use of antibodies targeting
endogenous YFP, which demonstrated the retention of intact immunoreactive axons despite YFP
fluorescence quenching. Collectively, the results of this study within the injured optic nerve
provide unprecedented insight into the evolving pathobiology associated with TAI.

Key words: anterograde and retrograde axonal change; amyloid precursor protein; axonal
dieback; brain edema; traumatic brain injury; YFP mice

Introduction
Traumatic axonal injury (TAI) is a major feature of human traumatic brain injury (TBI)
(Povlishock and Katz 2005), and has been associated with much of its morbidity (Graham et al.,
2002). This has recently been reaffirmed by the use of modern imaging tools, including diffusion
tensor imaging, which consistently demonstrates the presence of axonal injury across the
spectrum of mild to severe TBI (Belanger et al., 2007; Kumar et al., 2010; Wang et al., 2008). In
human postmortem studies, as well as in experimental animal investigations, significant insight
has been gained into its initiating pathogenesis (Blumbergs et al., 1989; Buki et al., 2000;
Christman et al., 1994; Farkas and Povlishock, 2007; Kelley et al., 2006; Maxwell et al., 1997;
Pettus and Povlishock, 1996; Povlishock, 1992; Povlishock and Katz, 2005; Saatman et al.,
2003; Saatman et al., 2009), and its potential therapeutic management (Buki et al., 2003; DengBryant et al., 2008; Hall et al., 2010; Kilinc et al., 2007; Koizumi and Povlishock, 1998;
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Marmarou and Povlishock, 2006; Mbye et al., 2009; Maxwell et al., 2005; Oda et al., 2011;
Okonkwo et al., 1999; Saatman et al., 2010).

Despite this progress, however, a fully comprehensive appreciation of TAI has been
limited by both technical and animal modeling issues that have precluded the possibility of
experimentally analyzing the course of a single nerve fiber from its initial injury to its ultimate
axotomy. Further, although various antibodies have been widely embraced in both humans and
animals to target such evolving axonal pathology, it is unclear if these antibodies, many of which
target amyloid precursor proteins (APP; Blumbergs et al., 1995; Hortobagyi et al., 2007; Sherriff
et al., 1994a, 1994b; Stone et al., 2000), universally detect axonal change within the proximal
disconnected axonal segment versus the more distal, disconnected segment, or both. This issue is
of more than academic interest in that these antibodies are routinely used in human forensic
analysis (Gleckman et al., 1999; Reichard et al., 2005).
To better follow the proximal and distal progression of traumatically-induced axonal
injury, we assessed in the current study the relationship of known biological markers of axonal
injury in an animal central fluid percussion injury (cFPI) model that evokes TAI within the optic
nerve, whose axons manifest a relatively organized alignment. Further, to better follow the fate
of these damaged axonal segments and their relation to known immunocytochemical markers of
axonal injury, we utilized transgenic animals expressing yellow fluorescent protein (YFP), a
variant of green fluorescent protein (GFP), in the optic nerve. Through the use of qualitative and
quantitative imaging approaches examining the YFP expressing injured axons, we confirm and
significantly extend previous data supporting the delayed pathogenesis of TAI. Importantly, we
also provide unprecedented insight into this complex pathology, demonstrating post-TBI axonal
swelling and disconnection, with proximal and distal axonal dieback accompanied by the
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regression and reorganization of the proximal axonal swellings, and the degeneration and
delayed clearance of the distal swellings.

Methods
To visualize axonal damage within the optic nerve, we utilized C57/BL6 wild-type mice
and Thy1-YFP-16 transgenic mice which express YFP under the promoter Thy1 within over
80% of the optic nerve fibers (Feng et al., 2000). We posited that within such a YFP-positive
fiber population, any potential axonal change induced by the traumatic event could be easily and
consistently visualized via routine fluorescence and/or confocal microscopy.

Breeding and genotyping of YFP-16 transgenic mice
The Thy1-YFP-16 transgenic mice [B6.Cg-Tg(Thy1-YFP)16Jrs/J, stock number 003709]
were obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained as heterozygotes.
Inheritance of the YFP gene was identified from an ear punch taken at weaning (approximately
postnatal day 21). The ear tissue was mounted onto a glass slide and examined using a FITC
filter on an Olympus DP71 digital camera (Olympus, Center Valley, PA), where YFP-positive
axons could be easily identified.

Surgery and animal model of traumatic brain injury
All protocols used in this study were approved by the Institutional Animal Care and Use
Committee (IACUC) of Virginia Commonwealth University. Adult male C57/BL6 mice and
Thy1-YFP-16 transgenic mice (20–25g) were subjected to central fluid percussion TBI to
produce TAI in the optic nerve. The fluid percussion injury model was modified from that
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previously described in detail by Dixon (1987). Briefly, animals were anesthetized with 4%
isoflurane in 100% O2, and maintained via nosecone with 2% isoflurane in 100% O2 during
surgery, with the body temperature controlled at 37oC via a feedback-controlled heating pad
(Harvard Apparatus, Holliston, MA). A midline 3.0mm circular craniotomy was made over the
sagittal suture halfway between the bregma and the lambda, taking care not to damage the
underlying dura. A Luer-Loc syringe hub was cut away from a 20 gauge needle and affixed to
the craniotomy site. Dental acrylic was applied around the hub to enhance stability. As the dental
acrylic dried and the injury hub became stable, saline was applied to blunt any exothermic
reaction from the cured acrylic. The skin was then sutured over the hub, with lidocaine and
bacitracin ointment applied to the wound. The animal was allowed to recover for 1h in a warmed
cage prior to injury. Before the induction of injury, each animal was again anesthetized for 4min
(100% O2 and 4% isoflurane). The craniotomy site was exposed and the injury hub was
connected to the fluid percussion device. The animal was then injured at a magnitude of 1.40 ±
0.05 atmospheres. The pressure pulse was measured by a storage oscilloscope (Tektronix 5111;
Tektronix, Beaverton, OR). Injury preparation and induction were completed prior to the
animal’s recovery from anesthesia. The hub and dental acrylic were then removed, and the
incision was rapidly sutured. The duration of transient unconsciousness was determined by
measuring the time it took for the animal to recover the following reflexes: toe pinch, tail pinch,
corneal blink, pinna, and righting reflex. After recovery of the righting reflex, the animals were
placed in an incubator with a heating pad to maintain normothermia and monitored during
recovery. For animals receiving sham injury, all of the above steps were followed with the
exclusion of the injury pulse. All injured animals had righting reflex recovery times of 4 - 5min,
compared with less than 2min for sham-injured animals, indicating injuries of comparable
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severity. The animals were allowed to survive 5min, 15min, 1h, 3h, 12h, 24h, and 48h following
injury.

Optic nerve preparation
At the appropriate survival times, Thy1-YFP-16 transgenic mice and wild-type mice were
euthanized via an intraperitoneal overdose of sodium pentobarbital, and then transcardially
perfused with 100ml heparinized normal saline, followed by 200ml 4% paraformaldehyde in
Millonig’s buffer. After overnight incubation in the perfusion fixative solution, the optic nerve,
chiasm, and optic tract, together with the brain were removed from the skull for routine
fluorescence and confocal analysis. The optic nerves were blocked to include the entire optic
nerve, the chiasm, the initial part of the optic tract, and related brain tissue, and post-fixed in the
same solution overnight. Following post-fixation, this optic nerve block was cryoprotected and
then cut longitudinally into 10µm sections with a cryotome (Shandon Scientific Ltd., Cheshire,
U.K.). Serial sections revealing the entire length of the optic nerve (from the globe to the chiasm)
were then collected in a serial order. All sections were collected beginning at a randomly
generated starting point in Millonig’s buffer in 24-well culture plates (Falcon, Newark, DE).
Beginning at a random starting point, every fourth serial section was then prepared for the
visualization of the YFP. These sections were directly mounted on glass slides with ProLongGold antifade reagent (Invitrogen, Carlsbad, CA), and cover-slipped for image capture with a
Leica TCS-SP2 AOBS confocal microscope (Wetzlar, Germany) under the same setting. The
adjacent serial sections were used for immunohistochemical staining via antibodies targeting
APP. Next, the adjacent serial sections were prepared for the evaluation of potential blood–brain
barrier (BBB) disruption via antibodies targeting IgG. Lastly, the subsequent adjacent serial
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sections were used for determining axonal integrity via antibodies targeting the endogenous YFP
(see below).

Immunohistochemistry
To study the relationship between the YFP-linked axonal change and an established
biological marker of axonal pathology, antibodies targeting APP were used. YFP fluorescent
optic nerve sections were microwaved for antigen retrieval (Stone et al., 1999; Stone et al.,
2000), incubated with the primary antibody rabbit anti-C-terminus APP (1:1000; Zymed, San
Francisco, CA), washed, and then incubated in the secondary antibody Alexa 594-conjugated
goat anti-rabbit IgG (1:200, Vector Laboratories, Burlingame, CA). Then the sections were
washed and mounted for analysis via confocal microscopy.
Additionally, to determine if these axonal changes were related to blood-brain barrier
(BBB) disruption, with the formation of edema and its potential quenching of the YFP
fluorescence, we probed the adjacent optic nerve sections with the antibody Texas-Red
conjugated goat anti-mouse IgG (1:200; Invitrogen), targeting mouse serum proteins, and
mapping any potential changes in BBB status with any related loss of YFP fluorescence.
Lastly, to determine the potential for axonal preservation despite the loss of YFP
fluorescence due to YFP fluorescence quenching, we reacted the subsequent adjacent segments
with antibodies targeting the endogenous YFP. Briefly, after antigen retrieval in a microwave,
YFP-expressing optic nerve sections were incubated with a primary antibody rabbit anti-GFP
(1:8000; Chemicon, Temecula, CA). This was done because YFP and GFP share the same
structure (Shagin et al., 2004). Thus, antibodies to GFP also recognize the YFP antigen (Sprecher
and Desplan, 2008). Next, the sections were washed, followed by incubation in the secondary
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antibody Alexa 594-conjugated goat anti-rabbit IgG (1:500; Vector Laboratories) for confocal
microscopic analysis. In these immunocytochemical/confocal studies 5 injured mice were
evaluated per time point, with the evaluation of 1 sham injured control per time point.

Electron microscopy
For electron microscopic (EM) analysis, additional mice were employed to include 1
injured wild-type mouse, 1 injured YFP-expressing mouse, and their appropriate sham injured
controls per time point. In these animals, two different perfusion protocols were employed to
achieve: (1) optimal ultrastructure detail, or (2) the optimal visualization of the YFP-positive
axons. To achieve optimal ultrastructure detail, wild-type mice were first perfused with 100mL
heparinized normal saline, followed by 200ml 2% paraformaldehyde and 2.5% glutaraldehyde in
Millonig’s buffer. For EM analysis of the Thy1-YFP-16 transgenic mice, the animals were first
perfused with 100ml heparinized normal saline, followed by 200ml 4% paraformaldehyde and
0.2% glutaraldehyde in Millonig’s buffer in order to maintain the structure of YFP fluorescent
protein and optimize immunoreactivity. Again, the brain and the optic nerves were post-fixed
and blocked as described above. For routine EM study the whole optic nerve was osmicated,
dehydrated, and flat embedded in epoxy resin (Embed-812; Electron Microscopy Sciences,
Hatfield, PA) as detailed below. In contrast, for the YFP-expressing mice, the optic nerve
sections were cut longitudinally at 16µm with a vibratome (Leica VT1000 S; Leica
Microsystems GmbH, Nussloch, Germany), and then prepared for immunocytochemistry using a
primary antibody rabbit anti-GFP (1:8000; Chemicon) followed by the secondary antibody,
biotinylated goat anti-rabbit IgG (1:1000; Vector). Next, the tissue was incubated in avidin-biotin
complex (1:200, Vectastain ABC Standard Elite Kit; Vector Laboratories), and visualized by
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diaminobenzidene (DAB; Sigma-Aldrich, St. Louis, MO) for subsequent EM analysis.
Briefly, the above-prepared immunoreactive YFP-expressing sections were osmicated in
1% OsO4, dehydrated, embedded in epoxy resins, mounted on plastic slides (Thomas Scientific
Co., Swedesboro, NJ) and cover-slipped. After resin curing, the plastic slides were examined via
routine light microscopy to identify the injured axonal segments within the optic nerve based on
the patterns of distribution seen in the YFP-expressing mice previously evaluated by confocal
microscopy. Once identified, these sites were excised, mounted on plastic studs, and thick
sectioned to the depth of the immunoreactive sites of interest using an ultramicrotome (Leica
Ultracut R; Leica, Wien, Austria). Serial 40nm sections were cut and mounted onto Formvarcoated single-slotted grids. The grids were then stained with 5% uranyl acetate in 50% methanol
for 2 min and 0.5% lead citrate for 1 min, and visualized using a JEM 1230 electron microscope
(JEOL Ltd., Tokyo, Japan).

Confocal microscopic data analysis
At the 12-, 24-, and 48-h time points, quantitative analysis of any observed axonal
swelling detected by confocal imaging was conducted. The randomly selected YFP optic nerve
sections were analyzed via the placement of 12 serial grids (each grid = 200 µm x 200 µm) along
the optic nerve, six of which were placed proximally and labeled P1–P6 moving from the initial
locus of TAI (approximately 1 mm rostral to the chiasm) to the globe, and the other six of which
were located distally and labeled D1–D6 moving from the initial locus of TAI to the chiasm.
Each 200 µm x 200 µm grid was aligned over the center of the optic nerve. For each individual
grid, the number of axonal swellings per unit area, the total area of axonal swellings per unit
area, and the percentage of the total area of axonal swellings per unit area, as well as the size of
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axonal swellings per unit area were measured using the Imaging Processing (IP) Lab 3.7 image
analysis system (Scanalytics, Inc., Fairfax, VA). Only those swellings over 5 µm in diameter
were analyzed (Gao et al., 2010). Any swellings overlapping either the top, the bottom, or the
left line of the grid were included, while those overlapping the right grid line were excluded from
analysis. All results were presented as mean ± standard error of the mean (SEM). Each
dependent variable was analyzed separately by a split-plot analysis of variance [ANOVA; 3
(Time) x 12 (Location)]. To examine the specific effect of time for each dependent variable at
each of the locations, subsequent one-factor (time) ANOVAs and posthoc Fisher LSD tests were
conducted for each grid location. Statistical significance was set at p < 0.05 for all tests.

Results
Macroscopic changes in the mouse brain and optic nerve
Using this model system, which was modified from that previously used in rats (Dixon et
al., 1987), we consistently generated microscopic injury in the optic nerve (see below), without
overt damage to the brain tissue. As shown in Figure 3.1A, the injured brain revealed no
significant contusion, parenchymal hemorrhage, or overt damage of the optic nerve and/or the
globe. Macroscopic brain sectioning again revealed no damage within the brain parenchyma,
either in terms of intraparenchymal petechial hemorrhage or blood in the intraventricular space.

Qualitative fluorescent microscopic change within the optic nerve following TBI
Despite the lack of macroscopic damage in this model, axonal damage was evoked in a
scattered fashion throughout the brain parenchyma as well as the optic nerve of Thy1-YFP-16
transgenic mice following TBI. While not the focus of the current communication, within the
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brain parenchyma itself, scattered axonal damage could be identified within both the superficial
and deep layers of the neocortex, as well as the dorsolateral thalamus and subcortical white
matter. These findings are entirely consistent with those recently reported in the same mouse
injury model using a YFP-H mouse (Greer et al., 2011). Importantly, in the current study these
axonal changes occurred without any evidence of local petechial hemorrhage and/or any other
form of tissue disruption, consistent with a mild TBI. Within the optic nerve, the traumatic
axonal injury typically was induced approximately 1mm proximal to the chiasm. As will be
detailed below, within this locus, scattered reactive axonal change could be observed in YFPexpressing axons, while adjacent YFP axons maintained normal structural detail. These findings
stood in stark contrast to the sham-injured animals, wherein numerous linear/non-swollen YFPexpressing axonal profiles (Fig.3.1B) could be seen spanning the length of the optic nerve,
consistent with the initial characterization of the Thy1-YFP-16 transgenic mouse (Feng et al.,
2000).
Consistent with previous descriptions of traumatically induced axonal damage, the
injured YFP-expressing axons demonstrated a progression of reactive change over time. At 1h
post-TBI, the majority of axons manifested normal morphology, with only scattered axons
demonstrating punctuate, focal YFP-fluorescent axonal swellings (Fig. 3.1C), as well as some
evidence of initial axonal disconnection (Fig. 3.1D). These scattered punctuate swellings were
typically found at only one locus along the axon’s length, without any evidence of additional
proximal to distal involvement.
By 3h post-TBI, focal axonal disconnection was now prominent together with a
significant increase in the number and the size (8.32±0.69µm) of the YFP-expressing axonal
swellings, which now capped both the proximal and distal disconnected segments. Again, these
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damaged axons were interspersed among adjacent intact fibers (Fig. 3.1E). At this time point,
those proximal axonal swellings maintaining continuity with the retina (arrow in Fig. 3.1E)
appeared bulbous/spheroidal in shape. The distal axonal swellings on those axons projecting to
the chiasm were also spheroidal (arrowhead in Fig. 3.1E). As now both the proximal and distal
swellings were frequently separated, this suggested axonal retraction or dieback, an issue further
detailed below.
By 12h post-TBI, the above described YFP-expressing axonal swellings exhibited further
maturation (Fig. 3.2A), with axonal disconnection now predominating. The proximal axonal
swellings had expanded to an area of 28.26±2.00µm2, and now revealed a more truncated
configuration (Fig. 3.2C and 3.2E). In contrast, the distal axonal swellings continued to expand
(25.53±1.38µm2), yet maintained their more rounded/spheroidal shape (Fig. 3.2B and 3.2D).
From 24h to 48h post-TBI, the distal axonal swellings underwent further expansion
(42.78±5.88µm2 at 24h post-TBI, and 50.84±2.48µm2 at 48h post-TBI), with their distribution
shifted more distally toward the chiasm. Similarly, the proximal axonal swellings now
redistributed from the initial site of injury to the more proximal segments of the optic nerve
approaching the globe. In contrast to the distal segments, however, these proximal truncated
segments showed continued evidence of shrinkage and resorption.
While these axonal findings at 12, 24, and 48h post-TBI were scattered, routine confocal
analysis revealed that these reactive axonal changes and dieback were accompanied by an
apparent focal loss of fluorescence in the region between the detached proximal and distal axonal
segments. At first, this was interpreted to reflect total fiber loss in this now nonfluorescent
domain. However, as will be explicated below, this apparent fluorescent fiber loss was not the
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result of actual fiber dissolution. Rather it was the result of local fluorescence quenching, a
sequelae of local BBB disruption discussed below.

Electron microscopic evaluation of the traumatic axonal damage
EM analysis confirmed and supplemented the above described fluorescence analysis. Via
EM analysis of the wild type mice, we observed as early as 5 to 15 min post-TBI, scattered axons
located approximately 1mm rostral to the optic chiasm demonstrating initial axonal swelling,
associated with an accumulation of mitochondria (M in Fig. 3.3). Despite these local reactive
changes, adjacent axons remained intact and displayed normal ultrastructural detail, all of which
was consistent with previous descriptions of TAI. In these same regions, edematous-like change
could also be identified via the expansion of the interstitial space (asterisk in Fig. 3.3).
Additionally, by 1h post-TBI, there was local dissolution of some damaged axons, consistent
with the process of disconnection and separation (arrowhead in Fig. 3.3).
By 3h post-TBI, axonal detachment was common in the Thy1-YFP-16 mice, with both
the proximal and distal axonal swellings now easily recognized. As observed via confocal
microscopy above, both proximal and distal swellings were spheroidal, with obvious separation
between the proximal and distal swellings. Although it proved difficult to follow the course of
one individual separated axon via electron microscopy, examination of numerous serial sections
revealed that the proximal and distal swellings were separated by highly vacuolated and
organelle-devoid axonal cylinders, suggesting that they were the residual axonal segments that
once joined both the proximal and distal swellings. The proximal swelling appeared reminiscent
of previous descriptions of TAI in that the swelling itself contained numerous profiles of smooth
endoplasmic reticulum and vesicles which were interspersed with intact mitochondria and
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multiple vesicular profiles embedded in an electron-lucent axoplasm (Povlishock et al., 1983).
This proximal organelle cap typically encompassed a disorganized cytoskeletal core containing
misaligned neurofilaments and microtubules. The distal swellings also showed organelle
accumulation and a disorganized cytoskeletal core (Fig. 3.4). However, unlike the proximal
segments, these swellings were typically electron dense, and they contained numerous dilated
mitochondria with disorganized cristae (M in Fig. 3.4), all of which appeared consistent with an
ongoing degenerative process.
By 24h post-TBI of the Thy1-YFP-16 mice, the distal swellings enlarged further, once
again containing numerous mitochondria with disordered cristae, as well as occasional
autophagic vacuoles and lysosomal debris (Fig. 3.5C and D). In contrast to the distal swellings,
the proximal axonal swellings, similarly to those observed via confocal fluorescence microscopy,
were now truncated (Fig. 3.5A and B). Typically, these truncated segments were encompassed
by an intact myelin sheath, and contained numerous organelles, all of which appeared intact (Fig.
3.5B). Specifically, these truncated appendages contained numerous mitochondria, profiles of
smooth endoplasmic reticulum and vesicles, as well as cytoskeletal constituents, all of which
revealed normal morphological detail. In contrast to the distal swellings, not only did these
proximal swellings reveal intact mitochondria, but importantly, these organelles were found in an
electron-lucent environment, with no evidence of increased electron density.

Quantitative analysis of the progressive axonal swellings and dieback in the proximal and
distal segments
As noted, the quantitative analysis conducted in the current investigation employed
confocal microscopy to assess the number of axonal swellings per unit area, the total area of
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axonal swellings per unit area, the percentage of the total area of axonal swellings per unit area,
as well as the size of axonal swellings per unit area. As noted, these measures were examined
along the proximal to distal extent of the optic nerve, with a grid analysis (Fig. 3.6) that moved
both proximally and distally from the point of injury initiation.
While examining the total number of axonal swellings within each grid, a split-plot
ANOVA on these data yielded a significant main effect of location (F11, 66 = 81.31, p<0.001), and
a Time x Location interaction (F22, 66 = 22.44, p<0.001). Figure 3.7 displays a line graph (Fig.
3.7A) and a bar graph (Fig. 3.7B) of the same data set, along with the results of the Fisher LSD
tests that examined significant group differences at each axonal location. In the proximal portion
of the optic nerve, the peak number of axonal swellings per unit area revealed significant
redistribution from 200µm – 400µm (grid P2) at 12 h post-TBI (97.44±7.61), to 400µm – 600µm
(grid P3) at 24 h post-TBI (53.22±9.56), and approaching 600µm – 800µm (grid P4) at 48h postTBI (46.55±4.05). These data suggested a dieback of the proximal disconnected axons over time.
Similarly, axonal swellings in the distal segment moved in the opposite direction toward the
chiasm. Specifically, here the peak number of axonal swellings per unit area moved from 200µm
– 400µm (grid D2) at 12 h post-TBI (87.56±13.36), to 400µm – 600µm (grid D3) at 24h postTBI (87.11±8.78), and approaching 600µm – 800µm (grid D4) at 48 h post-TBI (103.78±1.73).
These quantitative findings confirmed those qualitative impressions of proximal swelling and
regression as well as distal expansion and retention, all of which were associated with dieback.
Comparable to the data discussed in terms of the number of axonal swellings, a similar
relationship was found in the total area of the axonal swellings per unit area over time along the
length of the optic nerve. As shown in Figure 3.8, a split-plot ANOVA on these data again
revealed a significant main effect of location (F11, 66 = 68.85, p<0.001), and a Time x Location
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interaction (F22, 66 = 19.27, p<0.001). In the proximal segment, the peak total area of axonal
swellings was redistributed from 200µm – 400µm proximal to the lesion (grid P2) at 12h postTBI (2203.67±216.93µm2), to 400µm – 600µm proximal to the lesion (grid P3) at 24h post-TBI
(1502.28±42.09µm2), and further to 600µm –800µm proximal to the lesion (grid P4) at 48h postTBI (1006.01±137.07µm2). In the distal segment, the peak total area of axonal swellings
migrated from 200µm – 400µm distal to the lesion (grid D2) at 12h post-TBI
(2271.54±451.63µm2), to 400µm – 600µm distal to the lesion (grid D3) at 24h post-TBI
(3689.21±294.12µm2), and further to 600µm – 800µm distal to the lesion (grid D4) at 48h postTBI (5267.26±209.76µm2). This again demonstrated progressive axonal dieback in both the
proximal and distal directions along the optic nerve post-TBI.
Similarly, the analysis on the percentage of the total area of axonal swellings per unit area
revealed a statistically significant relationship comparable to that described above over time
along the length of the optic nerve (data not shown). In contrast, the analysis of the size of axonal
swellings per unit area did not reveal robust significant changes over time along the length of the
optic nerve (data not shown).

Relationship between the above-described YFP-linked changes and established markers of
TAI (APP)
To compare the above results of progressive proximal and distal axonal swellings
obtained from the YFP-16 transgenic mice to the previous data gained from the use of biological
markers of axonal pathology, including those targeting APP, a dual fluorescence approach was
employed. At all time points post-TBI, the use of antibodies to APP alone revealed
immunoreactive axonal swellings consistent with previous descriptions (Fig. 3.9). However,
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when these same nerve segments were examined via confocal microscopy to visualize both the
endogenous YFP as well as the antibodies to the C-terminus of APP, an unanticipated response
was seen. Specifically, in this approach, we noted that the antibodies to the C-terminus of APP
mapped exclusively to proximal swellings, with no evidence of distal immunoreactivity, despite
the presence of numerous large and well-formed distal YFP-positive swellings (Fig. 3.9).

Evidence for blood–brain barrier disruption and the retention of axons in the region of YFP
fluorescence quenching
As noted previously, the delayed regional loss of YFP fluorescence observed in the
current study was potentially related to fluorescence quenching and not to the over-loss of fiber
coursing through this region. To assess this potential and its impact upon our data analysis, we
probed the injured YFP optic nerve sections with antibodies to assess the BBB integrity
(antibodies to endogenous IgG), as well as antibodies targeting the retention of potentially YFP
fluorescence-quenched axons (the antibody to GFP recognizes the endogenous YFP; Sprecher
and Desplan, 2008). As early as 1h post-TBI, Texas-Red fluorescent IgG mapped to the region of
YFP fluorescent loss in the damaged optic nerve (Fig. 3.10A, B, and C), with the caveat that this
IgG penetrance was not seen in sham YFP expressing animals. The zone of IgG Texas-Red
fluorescence expanded further at 3h post-TBI (Fig. 3.10D, E, and F), and again mapped to the
now expanded locus of YFP fluorescence loss. This extravasation of IgG was interpreted to
reflect a focal perturbation of the BBB, with the passage of serum proteins into the interstitial
space. Further, it was assumed that this protein passage most likely involved the concomitant
movement of water, with the formation of edema, all of which were also consistent with our EM
observations of edematous-like change occurring in the expanding interstitium (Fig. 3.3). It is
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important to note that this barrier disruption, associated with IgG passage into the optic nerve,
was not linked to the presence of either overt or petechial hemorrhage, suggesting a more subtle
form of BBB perturbation.
Despite the breakdown of the BBB and the loss of YFP fluorescence, we also observed
the persistence of intact/unaltered axons, as well as detached and fragmented axons, in these
same regions via the use of antibodies targeting endogenous YFP. Specifically, as shown in
Figure 3.11, through the anti-GFP antibody’s positive immunoreactive staining of the
endogenous YFP, the optic nerve at 24h post-TBI revealed the existence of unaltered axons
coursing through the locus of fluorescence quenching, together with scattered damaged axonal
profiles again consistent with TAI.

Discussion
This study illustrates that a model of traumatic brain injury is capable of evoking
traumatic axonal change within the optic nerve that can be evaluated in a consistent fashion. The
current study’s use of YFP-expressing mice provides an unprecedented view into the
pathogenesis of traumatic induced axonal injury, allowing for the precise identification of the
initiation of axonal injury and the subsequent progression of axonal swelling and disconnection,
as well as the ongoing proximal and distal axonal response. To date, others have studied
traumatic axonal injury using optic nerve stretch (Maxwell et al., 1990; Maxwell and Graham,
1997; Mohammed Sulaiman et al., 2011; Saatman et al., 2003; Serbest et al., 2007), and these
studies have provided important information on the progressive changes associated with
traumatically-induced axonal injury. While one could argue that the reactive changes seen within
the optic nerve following cFPI mirror those observed with the optic nerve stretch model,
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differences do exist. Although both injury models involve predominantly the prechiasmatic
region, cFPI, in contrast to optic nerve stretch (Gennarelli, et al., 1989), involves less prominent
axonal damage over the length of the optic nerve. Further, following cFPI, blood–brain barrier
disruption is seen within the optic nerve. This appears consistent with the brain parenchymal
barrier disruption seen following fluid-percussion brain injury that has been linked to
concomitant brain deformation and compression (Povlishock et al., 1978). Such differences
between the optic nerve injury induced by cFPI versus optic nerve stretch suggest that unlike
optic nerve stretch models, cFPI involves a stretch as well as a compression/deformation
component that participates in the subsequent pathological response. Irrespective of the causative
factors and their specific relationship to the pathobiology of TBI, the current animal model offers
another important characteristic that further distinguishes it from the optic nerve stretch model.
Specifically, unlike optic nerve stretch, cFPI also evokes TAI throughout the related brain
parenchyma, which is entirely consistent with our recent finding of TAI within the neocortex,
hippocampus, and thalamus of comparably injured YFP-H mice (Greer et al., 2011). This is of
more than academic interest in that we envision that the currently described optic nerve injury
model via its routine quantitative assessment of axonal damage will allow for rapid preclinical
therapeutic screening using either intravenous, intraperitoneal, or intrathecal routes of therapy
administration. The perceived benefit of this current cFPI-induced optic nerve injury model
resides in the fact that if any therapy is judged to be protective within the optic nerve, such
protection could then be easily screened in the brain parenchyma of these same animals, thereby
providing more compelling evidence of generalized therapeutic efficacy.
In the current investigation using a model of brain and optic nerve injury, we
demonstrated within the optic nerve, the involvement of multiple axons typically found in
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relation to other unaltered axons. Consistent with previous descriptions of the pathogenesis of
TAI, our studies confirmed that this optic nerve involvement did not involve physical transection
of the axon or the concomitant involvement of local destructive vascular lesions (Maxwell et al.,
1997; Povlishock et al., 1983; Povlishock and Kontos, 1985). Rather, the injury evoked in YFPexpressing axons was scattered swellings that underwent lobulation, leading to disconnection
over a 1 to 3h post-TBI period. Particularly significant in the current communication was the
parallel finding of the relatively rapid dieback of both the proximal and distal disconnected
segments, together with the rapid regression of the proximal swollen axonal segment, and the
persistence of the degenerating distal swelling. To our knowledge, these findings have not been
previously described in either the experimental TBI animal or human forensic literature. As seen
in the data provided, relatively significant dieback occurred in both the proximal and distal
segments within 48h following injury, wherein the injured segments moved approximately 0.4–
0.8mm in both the proximal and distal directions. While such dieback has not been previously
described in the context of TBI, spatially and temporally similar dieback has been described
following spinal cord injury (Horn et al., 2008; Kerschensteiner et al., 2005; Oudega et al., 1999),
and laser induced in vitro axonal damage (Hellman et al., 2010). With spinal cord injury such
dieback has been linked to macrophage infiltration and possible substrate modification (Busch et
al., 2009; Horn et al., 2008), while in vitro studies suggest that calcium dysregulation plays an
important role (Hellman et al., 2010). Given the differences between TBI and in vivo spinal cord
injury and in vitro laser injury, the actual mechanisms involved in this dieback remain unclear,
and perhaps may involve a combination of all the above factors. In relation to this process of
axonal dieback, it is also of note that the singular distal swellings observed in the current study
are at variance with the Wallerian changes described following physical transection of the optic
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nerve, wherein Wallerian degeneration was associated with relatively dramatic axonal beading
along the continuous axonal segment distal to the transection (Beirowski et al., 2010). This
difference is most likely consistent with the nature of TAI, which does not evoke the dramatic
local destructive change typically associated with the studies of Wallerian degeneration evoked
by optic nerve transection (Beirowski et al., 2010), and/or the fiber damage seen with optic nerve
ligation or crush (Knöferle et al., 2010). Although it is difficult to directly extrapolate from a
static image the actual progression of a dynamic process, our parallel EM analysis proved useful
in assessing the fate of the proximal and distal swellings. As noted, the distal swellings routinely
demonstrated increased electron density, together with significant mitochondrial disruption, all
of which are consistent with their degeneration and subsequent dieback.
In concert with the above observations focusing on the distal swellings, our evaluation of
the proximal axonal swellings also provided significant, previously unreported insight into the
progression of TAI. Our quantitative and qualitative studies confirmed the dieback of the
proximal axonal swellings that moved proximally over time. As noted, such injured axons were
seen adjacent to other intact fibers, although this relationship was somewhat obscured by the
presence of local tissue edema and fluorescence quenching, an issue which will be discussed
below. While the proximal segment, like its distal stump, revealed dramatic dieback, it also
manifested a previously unappreciated response in which it underwent a relatively rapid
transition from an enlarged and swollen to a thinned and truncated appendage. Parallel
ultrastructural studies substantiated this finding and suggested that the dieback of the axonal
swelling and its formation of the truncated appendage were not related to overt degeneration, but
rather some form of axonal reorganization. In fact, this dynamic reorganization appeared
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consistent with the conversion of anterograde to retrograde axonal transport, which has been
suggested in other experimental studies (Martz et al., 1989; Sahenk and Lasek, 1988).
In concert with the above observations, another unanticipated finding centered on the
observation that antibodies targeting C-terminus APP mapped exclusively to the proximal axonal
segments, with virtually no evidence of distal swelling immunoreactivity at all the delayed time
points assessed. Antibodies to APP have been widely used in animal studies and human forensic
analysis (Hortobagyi et al., 2007; Sherriff et al., 1994a, 1994b; Stone et al., 2000), yet there has
been no widespread appreciation of what component of the injured axon is delineated by APP.
Further complicating this issue is also the fact that there has been no consideration of the
potential that different antibodies targeting different APP epitopes may yield different responses.
Our antibodies which target APP’s C-terminus consistently mapped to the proximal swelling,
without targeting to the distal swelling. In contrast, in studies of Wallerian degeneration within
the optic nerve, using antibodies targeting the N-terminus of APP, Beirowski and colleagues
(2010) demonstrated APP targeting of the distal swelling, although in these studies there was no
attempt to evaluate the immunoreactivity of the proximal axonal segment. The difference
between our study and that of Beirowski and colleagues most likely reflects epitope specificity,
with the caveat that the degenerative change ongoing in the distal degenerating segment may
undergo proteolytic cleavage of the C-terminus with the exposure of the N-terminus, an issue
which will obviously require further evaluation. This observation also takes on increased
importance in the context of human forensic studies, wherein the use of antibodies to the Nterminus is the norm, raising the issue as to whether the use of such antibodies may lead to either
an over- or under-appreciation of the overall burden of axonal injury both in studies of adult
brain injury and child abuse.
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Although we have emphasized the scattered nature of axonal change occurring within the
optic nerve, we have also observed that this phenomenon was negatively influenced by the
presence of local CNS BBB disruption and edema, which correlated with local quenching of the
endogenous YFP fluorescence. Such non-hemorrhagic BBB disruption is a well-recognized
feature of mild TBI, and our lab has previously identified comparable barrier disruption and
protein extravasation within the brainstem and neocortex following TBI (Kelley et al., 2007;
Povlishock et al., 1978). The linkage of BBB disruption to fluorescent quenching is supported by
the observation that all zones of local fluorescence loss mapped precisely to concomitant
alterations in BBB status, as assessed by the passage of the endogenous immunoglobulin IgG.
The suggestion here is that the parallel movement of water with the IgG participated in the
fluorescent quenching. While this phenomenon has not been described in the context of
fluorescently-expressing transgenic animals, it has been demonstrated that water and solvent
properties of water can result in fluorescence quenching by multiple mechanisms such as
hydrogen-bond interactions (Oshima et al., 2006), photoionization (Sadkowski and Fleming,
1980), the transition to a close-lying energy level (Tobita et al., 2001), intersystem crossing
(Seliskar and Brand, 1971), and specific solute–solvent interactions (Ebbesen and Ghiron, 1989).
Since optic nerve edema most likely involves significant water generation (Donkin and Vink,
2010), it is not unreasonable to assume that this water can participate in fluorescence quenching
via either one or several of the above-described mechanisms. The correctness of this assumption
is further supported by our parallel investigations using antibodies to the endogenous YFP,
which consistently labeled fibers independent of their YFP fluorescence, via our reliance on a
chromogen-based approach. This strategy confirmed that the loss of fluorescence was most
likely due to quenching, and not associated with actual fiber loss.

65

In summary, this study reveals TBI-induced TAI within the optic nerve. Further, these
observations within the optic nerve provide unique insight into the pathobiology associated with
TAI, particularly in terms of axonal swelling, disconnection, and proximal and distal dieback
changes not well appreciated in the highly complex brain environment. We also demonstrate that
this optic nerve approach provides via its regional specificity, the opportunity for rigorous
quantification. This provides the potential for multiple future applications utilizing the rigorous
assessment to evaluate various therapeutic interventions in attenuating axonal damage, while also
permitting the evaluation of anterograde downstream neuronal and/or synaptic plasticity, and/or
the assessment of retrograde upstream neuronal injury.
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Figure 3.1 A macroscopic view of the injured brain and the optic nerve together with the
microscopic evidence of axonal damage in the optic nerve of Thy1-YFP-16 mice. Note that upon
macroscopic examination, no significant contusion, mass lesion or hemorrhage can be identified
within either the brain or the optic nerve following TBI (A). Via confocal microscopy, the optic
nerve of the sham injured mice reveals a robust distribution of YFP positive axons maintaining
continuity with no evidence of axonal swelling (B). At 1 hour post TBI, the majority of YFP
positive axons manifest normal morphology, with only scattered, punctate axonal swelling
(arrow in C) and isolated axonal disconnection (grid in D). At 3 hours post TBI, note the increase
in both the number and the size of axonal swellings in both the proximal (arrow in E) and distal
segments (arrow heads in E). Also note that the disconnection of many damaged axons occurs
interspersed among adjacent intact fibers. In this image, the chiasm is to the left and the globe
lies to the right. All scale bars, 20μm.
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Figure 3.2 Confocal microscopic evidence of axonal swellings within the optic nerve of Thy1YFP-16 mice at 12 hours post TBI. Note that the axonal swellings now manifest further
maturation (A). Additionally note that the distal axonal swellings expand to form spheroids (B
and D), while the proximal axonal swellings now assume a more truncated form (C and E). Scale
bar, 200µm (A), 20μm (B, C, D and E).
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Figure 3.3 Electron microscopic evidence of the progression of axonal damage in the optic nerve
of wild type mice from 5 minutes to 1 hour post TBI. Note that at 5 minutes and 15 minutes post
TBI the initial axonal swellings are associated with accumulation of mitochondria, some of
which are swollen (M). Also note the related expansion of the extracellular space consistent with
the presence of edema (asterisk). Lastly, note that at 1hour post TBI damaged axons reveal local
dissolution (arrow head) consistent with the process of disconnection which is present in the
optic nerve of Thy1-YFP-16 mice. All scale bars, 1μm.
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Figure 3.4 Electron microscopic evidence of axonal swelling in the optic nerve of Thy1-YFP-16
mice at 3 hours post TBI. At this time point the distal axonal swellings display continued
maturation, with the accumulation of numerous vesicles and organelles which overlie a
disorganized cytoskeletal core (A). Note that in the enlarged image (B), the dilated mitochondria
exhibit disorganized cristae (M). Also note that in contrast to the swollen damaged axon, the
adjacent axon remains intact (arrow in A). Scale bar, 2μm (A), 1μm (B).
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Figure 3.5 Electron microscopic evidence of progressive axonal swelling in the optic nerve of
Thy1-YFP-16 mice at 24 hours post TBI. Now the proximal axonal swelling is more truncated
(A and B), with numerous vesicles and smooth endoplasmic reticulum accumulating in the
swollen axonal segment (B), while the related mitochondria remain intact (B). In contrast, the
distal axonal swelling continues to expand and becomes increasingly rounded (C). Note the
swollen mitochondria with disordered cristae (D) accumulating within the swollen bulb (C and
D). Also note the presence of isolated continuous non-axotomized fibers coursing adjacent to the
swollen axons at this time point (C and D arrow). All scale bars, 1µm.
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Figure 3.6 The location of 12 grids along the YFP expressing optic nerve for quantitative
assessment. In this study, each grid encompasses 200μm x 200μm. From the initial locus of TAI,
grids P1 to P6 are placed along the proximal segment approaching the globe, while grids D1 to
D6 are located in the distal segment approaching the chiasm. Scale bar: 200μm.
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Figure 3.7 A plot of the number of axonal swellings per unit area and their distribution along the
optic nerve over time. In both the line (A) and bar (B) graph, significant difference exists
between the number of axonal swellings each time point at the related region (p<0.05). The line
graph (A) best illustrates the change of axonal swelling distribution along the optic nerve over
time (blue-12 hour, red-24 hour and green-48 hour). Note that the peak number of proximal
axonal swellings moves from P2 to P3 and to P4 from 12 hours to 24 hours and to 48 hours post
TBI respectively. The peak number of distal axonal swellings also shows significant
redistribution from D2 to D3 and further to D4 from 12 hours to 24 hours and further to 48 hours
post TBI respectively. This is consistent with progressive axonal dieback both proximally and
distally over time post TBI. The bar graph (B) shows, in more detail, the statistical difference at
each location. Specifically, in those segments 200μm-600μm proximal to the initial focus of
injury (P2 and P3), the number of axonal swellings at 12 hours post TBI is significantly higher
than those of 24 hours and 48 hours post TBI. These confirm the qualitative impression of the
regression of proximal axonal swellings. In contrast, at 600μm-1200μm distal to the initial focus
of injury (D4, D5 and D6), the number of axonal swellings at 24 hours post TBI is higher than
that of 12 hours post TBI, while at 48 hours post TBI the number is again significantly higher
than those of 12 hours and 24 hours post TBI. These confirm the qualitative impression of the
retention of distal axonal swellings (* p<0.05, ** p<0.01, *** p<0.001).
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Figure 3.8 A plot of the total area of axonal swellings per unit area and their distribution along
the optic nerve over time. Here again we display both in line (A) and bar (B) graph formats the
total area of axonal swellings per unit area, which equals the sum of the area of each swellings in
each individual grid. The line graph (A) best illustrates the change of the total axonal swelling
area and its distribution along the optic nerve over time (blue-12 hour, red-24 hour and green-48
hour). Note that the peak of total area of proximal axonal swellings moves from P2 at 12 hours,
to P3 at 24 hours and further to P4 at 48 hours post TBI. The peak of total area of distal axonal
swellings shows significant redistribution from D2 at 12 hours, to D3 at 24 hours and further to
D4 at 48 hours post TBI. This again demonstrates progressive axonal dieback both proximally
and distally post TBI. The bar graph (B) reveals in more detail the statistical deference at each
individual location. Specifically, in those segments 200μm-600μm proximal to the initial focus
of injury (P2 and P3), the total area of axonal swellings at 12 hours post TBI is significantly
higher than those of 24 hours and 48 hours post TBI. These confirm the qualitative impression of
the regression of proximal axonal swellings. In contrast, at 400μm-800μm distal to the initial
focus of injury (D3 and D4), the total area of axonal swellings at 24 hours post TBI is higher
than that of 12 hours post TBI. At 400μm-1200μm distal to the initial focus of injury (D3, D4,
D5 and D6), the total area of axonal swellings at 48 hours post TBI is higher than that of 12
hours post TBI. These again suggest the retention of distal axonal swellings over time (*p<0.05,
**p<0.01, ***p<0.001).
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Figure 3.9 The relationship between the YFP-linked axonal changes and the APP
immunofluorescent staining via confocal microscopy. As noted above, axonal swellings can be
readily visualized by their YFP fluorescence at both the proximal and the distal optic nerve
segments at 12 hours post TBI. Note that at this time point the APP immunoreactivity is found
exclusively in the proximal segments, where it co-localizes with the YFP fluorescence (yellow in
the merged image). In contrast, in the distal segment, there is no APP immunoreactivity despite
the presence of numerous YFP positive axonal swellings. Here the chiasm is to the left and the
globe is to the right. Scale bar, 200µm.
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Figure 3.10 Texas-Red-conjugated-IgG maps to the region of YFP fluorescence quenching in
the optic nerve of Thy1-YFP-16 mice. Note that at 1 hour post TBI, the region of fluorescent loss
(A) directly correlates with the IgG immunoreactivity (B and C). Further, note the locus of YFP
fluorescent loss is expanded at 3 hours post TBI (D), which also corresponds to the Texas-Redconjugated IgG localization (E and F). Scale bar, 500µm.
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Figure 3.11 The retention of YFP expressing axons in the region of fluorescence quenching.
With confocal microscopy, at 24 hours post TBI, the YFP fluorescently-quenched axons can now
be visualized by antibodies targeting GFP (arrows) in a distal optic nerve segment. This suggests
that despite axonal YFP fluorescence quenching, intact axons are retained in the same field.
Scale bar, 50µm.
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CHAPTER FOUR
DIFFUSE AXONAL INJURY IN THE OPTIC NERVE IS NOT ASSOCIATED WITH
RETINAL GANGLION CELL LOSS

Abstract
Much of the morbidity following traumatic brain injury (TBI) is associated with traumatic
axonal injury (TAI). Although most TAI studies focus on the callosal white matter, visual system
involvement has been increasingly identified. To assess visual system TAI and probe various
therapeutic approaches we developed a mouse model of optic nerve TAI. However, in this model it is
unknown if TAI causes retinal ganglion cell (RGC) death, an issue of importance to therapeutic
intervention. YFP-16 transgenic mice were subjected to mild TBI and followed from 2 days to 3
months. RGC death was evaluated qualitatively by TUNEL and cleaved caspase-3 immunostaining.
RGC survival was quantified by counting Brn3a immunoreactivity and phospho-C-Jun
immunolabeling. YFP positive cells in the RGC layer revealed no loss from 2 days to 28 days postTBI. No TUNEL+ or cleaved caspase-3 immunoreactive RGCs were observed from 2 days to 3
months post-TBI. Brn3a immunoreactive RGC quantification revealed no significant RGC loss with
concomitant phospho-c-Jun expression elevated up to 3 months post-TBI. Parallel EM analysis
revealed no evidence of RGC death. These findings confirm many of the unique features of TAI, and
suggest that this model offers advantages for future studies focusing on visual system TAI, its
therapeutic management and its potential reorganization and repair.

Key words: traumatic brain injury; traumatic axonal injury; visual system; YFP-16 transgenic
mice; retinal ganglion cell survival
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Introduction
Traumatic brain injury (TBI) is a major national and global health problem which can
lead to death and serious neurological dysfunction. Much of the mortality and morbidity of TBI
is associated with diffuse traumatic axonal injury (TAI) (Christman et al., 1994; Li and Feng,
2009; Li et al., 2010; Zemlan et al., 1999). Although previous studies of TAI have focused on the
callosal and rostral subcortical white matter, there is increased recognition that the visual system
white matter is equally sensitive to injury (Ding et al., 2001; Foda and Marmarou, 1994;
Gleckman et al., 2000; Palmer et al., 2010). This is reflected in both the military and civilian
populations. In a study on the incidence of combat-related eye injuries, the Defense Veterans
Brain Injury Center (DVBIC) reported that 80 percent of over 3,900 troops sustaining TBI had
some form of visual problem (Zampieri, 2007).
To date, few have addressed this issue in either animal models or humans to gain better
insight into the pathobiology of this visual damage and/or its potential treatment. To address this
issue, we have recently characterized a model of diffuse traumatic axonal injury in the mouse
visual system wherein we found diffuse/scattered axonal swellings, together with their
disconnection, dieback and reorganization overtime (Wang et al., 2011).
Given the TAI observed in this system, an obvious question relevant to any future
investigations including potential therapeutic intervention centers on the fate of the cell bodies of
origin of these diffusely damaged optic nerve axons. Historically, it has been reported that
virtually any form of damage to optic nerve results in dramatic retinal ganglion cell (RGC) loss.
Complete intraorbital optic nerve transection has been shown to result in the loss of the majority
of RGCs within 2 weeks (Berkelaar et al., 1994; Kielczewski et al., 2005; Peinado-Ramon et al.,
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1996). With rat optic nerve crush, Dibas (2010) reported that the number of RGCs labeled
retrogradely from superior colliculus, decreased by 47% at 7 days post injury, reaching a 76%
loss at 2 weeks post injury. In a guinea-pig optic nerve stretch model, a model assumed to
replicate the important features of TAI, Mohammed Sulaiman (2011) observed a continued loss
of RGCs beginning at 1 week and further increasing over the next 12 weeks, with only 60% of
RGCs remaining at 12 weeks post TAI. Further they recognized that this cell loss was associated
with RGC apoptosis at 2, 3, 8 and 12 weeks, with the peak number of apoptic RGCs occurring at
3 weeks post injury. In a mouse optic nerve stretch model, Saatman (2003) reported that the
number of RGCs, retrogradely labeled by Fluorogold injected into the superior colliculus,
dramatically decreased by over 50% by 1 day and at 2 weeks after stretch injury, in contrast to
the sham animals.
Based upon these studies, it would seem that retinal ganglion cell death would be the
foregone conclusion of diffuse axonal injury in the optic nerve. However, our previous work in
the diffusely injured optic nerve suggested otherwise (Wang et al., 2011). Specifically, in this
TAI model system we demonstrated that once disconnected, the proximal axonal segment
underwent a relatively rapid transition from an enlarged and swollen axonal segment to a thinned
and truncated appendage. Further this transition was not related to degeneration, but rather
axonal reorganization and repair (Wang et al., 2011). Collectively, these observations in the
proximal axotomized segment are entirely consistent with an intact axon maintaining continuity
with viable RGCs that are capable of continued protein synthesis and organelle stability.
Support for the premise of RGC survival also follows from the work of Povlishock and
colleagues who evaluated in the neocortex those neuronal cell bodies linked to diffuse axonal
injury (Greer et al., 2011; Lifshitz et al., 2007; Singleton et al., 2002). Specifically, using
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multiple experimental approaches, they demonstrated that TAI did not result in either neocortical
or thalamic neuronal death. Rather it triggered atrophic change. In these studies, it was assumed
that the subtle axonal changes precipitated by TAI, did not trigger the massive ionic influx and
dysregulation associated with axonal transection or crushing, thereby protecting the neuronal cell
body, a premise that may also carry forward to the diffusely injured optic nerve.
Because of the importance of these issues to our understanding of the pathobiology and
treatment of TAI in the visual system and because of the predominance of the literature
suggesting that RGC loss is the inevitable consequence of any form of optic nerve damage, the
current study comprehensively evaluated the response of RGCs to diffuse TAI. Specifically,
using multiple markers of neuronal cell death together with rigorous qualitative and quantitative
assessments of RGC integrity, we demonstrate that diffuse traumatic axonal injury within the
optic nerve is not associated with significant ganglionic cell death.

Material and methods
To study the cell death or survival of RGCs following diffuse traumatic axonal damage
within the optic nerve, we utilized Thy1-YFP-16 transgenic mice which express YFP under the
promoter Thy1 within the retina and the optic nerve fibers (Feng et al., 2000). This strategy, as
previously described (Wang et al., 2011), was employed to directly visualize the YFP cells in the
RGC layer under routine fluorescent and/or confocal microscope, with the endogenous
expression of YFP (Feng et al., 2000).

Animal Surgery and Perfusion
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All protocols used in this study were approved by the Institutional Animal Care and Use
Committee (IACUC) of Virginia Commonwealth University. Thy1-YFP-16 transgenic mice were
obtained from the Jackson Laboratory (Bar Harbor, ME), and were breed, genotyped and
maintained as heterozygotes as described previously (Wang et al., 2011). Adult 2 month old
Thy1-YFP-16 mice (20–25g) were subjected to mild central fluid percussion injury (1.40±0.05
atmospheres) as previously described (Wang et al., 2011, Dixon et al., 1987). The fluid pressure
pulse in this model resulted in a brief deformation of the brain and induced diffuse traumatic
axonal injury in the optic nerve approximately 1mm proximal to the chiasm (Wang et al., 2011).
Sham-injured animals received the same surgeries, with the absence of the injury. Animals were
allowed to survive for either 2 days, 7 days, 14 days, 28 days or 90 days following injury. At the
appropriate survival times, animals were euthanized via an intraperitoneal overdose of sodium
pentobarbital, and then transcardially perfused with 100ml heparinized normal saline, followed
by 200ml 4% paraformaldehyde in Millonig’s buffer. For electron microscopy (EM) analysis,
animals were perfused with 200ml 2% paraformaldehyde and 2.5% glutaraldehyde in Millonig’s
buffer. At each time point, 9 animals were injured, of which 2 animals were prepared for retinal
whole mount observation to allow for a qualitative assessment of any potential loss of YFPexpressing cells in the RGC layer. Five mice were prepared for serial sectioning on a cryostat to
permit immunocytochemical processing for markers of cell death while also allowing for the
quantitative assessment of any potential RGC loss. Lastly, 2 animals were prepared for EM
analysis to identify any potential neuronal damage or loss in the RGC layer. These injured
animals which were evaluated at all time points, were prepared together with 6 sham injured
mice per time point (1 for retinal whole mount observation, 3 for qualitative
immunocytochemistry and quantitative assessment, and another 2 for EM).
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Retinal whole-mount preparation
Following transcardial perfusion, the extraocular muscles were cut from the globe, the
optic nerve was transected immediately behind the globe, and the eye was dissected from the
orbit. The cornea was punctured with an 18 gauge needle, cut into 4 quadrants, and opened to the
limbus using two sets of forceps. The lens was removed and the retina was then separated from
the pigmented layer, and immersed in 4% paraformaldehyde in Millonig’s buffer for 4 hours.
Next, the retina was washed thoroughly with phosphate buffered saline (PBS) 5 x 10 minutes.
The retina was then cut into four quadrants, and mounted flat on a glass slide with Vectashield
Hardset Mounting Medium with DAPI (Vector Laboratories), and cover-slipped for image
capture with a Leica TCS-SP2 AOBS confocal microscope (Wetzlar, Germany).

Retinal cryostat section preparation
After the retina was separated from the pigmented layer as described above, fixation was
continued in 4% paraformaldehyde in Millonig’s buffer overnight. After washing in PBS 5 x 10
minutes, the retina was immersed in 30% sucrose in PBS overnight. The pair of retinal cups from
the same animal was then embedded side to side and frozen to -20oC in optimal cutting
temperature (OCT) compound (Electron Microscopy Sciences, Cat No.62550-01, Hatfield, PA,
U.S.A.). Twelve micrometer sections were then cut with a cryotome (Shandon Scientific Ltd.,
Cheshire, U.K.). Serial sections were collected on Superfrost®/Plus microscopic glass slides
(Fisher Scientific, catalog no.12-550-15, U.S.A.), with four serial sections of each eye on each
slide for a total of 8 sections on each slide, and stored at -20oC for further use.
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Immunohistochemistry
TUNEL immunohistochemistry
To detect nuclear fragmentation within RGCs, frozen retinal sections (3 random slides
from each injured and sham injured animal) were processed at the designated 2 days, 7 days, 14
days, 28 days and 90 days time points, using a terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) kit (ApoTag In Situ Apoptosis Detection Kit; S7101, S7160 and S7165,
Millipore), using modification of the manufacturer’s protocol. Frozen retinal sections were
obtained and warmed to room temperature for 30 minutes. They were then rinsed 2 x 5 minutes
in PBS, and post fixed in precooled ethanol: acetic acid (2:1) solution for 5 minutes at -20oC in a
humidified chamber. After washing 2 x 5 minutes in PBS, the sections were incubated in
50μg/ml proteinase K (Invitrogen, Cat No. 25530-015) in PBS for 30 minutes at room
temperature. Once again, sections were washed 2 x 5 minutes in PBS, and incubated in the
proprietary equilibration buffer for 30 minutes at room temperature. After clearing the
equilibration

buffer,

the

sections

were

incubated

with

working

strength

terminal

deoxynucleotidyl transferase (TdT) enzyme in a humidified chamber for 1.5 hours at 37°C. The
slides were then rinsed by the proprietary stop/wash buffer 2 x 10 minutes at room temperature,
and washed in PBS 3 x 5 minutes. The sections were then incubated in the mouse antiDigoxigenin (1:250, Roche, Cat. No. 11333062910) at 4oC in a humidified chamber overnight.
After rinse in PBS 4 x 5 minutes, the sections were incubated with secondary antibody Alexa
fluor 594-conjugated goat anti-mouse IgG (1:250, Invitrogen) for 1 hour at room temperature.
Then the slides were washed 4 x 2 minutes in PBS, cover-slipped with Vectashield Hardset
Mounting Medium with DAPI (Vector Laboratories) for confocal microscopic analysis with a
Leica TCS-SP2 AOBS confocal microscope (Wetzlar, Germany). To generate positive control,
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sham-injured retinal sections pretreated with deoxyribonuclease (DNAase, 1,000U/ml) at room
temperature for 10 minutes were used. To generate a negative control, the TdT enzyme treatment
was deleted.

Cleaved-caspase-3 immunohistochemistry
To detect apoptosis within RGCs, frozen retinal slides adjacent to those prepared for
TUNEL staining (3 slides per animal), were selected for cleaved-caspase-3 immunofluorescent
staining. Sections were warmed to room temperature for 30 minutes, and then rinsed 3 x 10
minutes in PBS. Following pretreatment with 10% normal goat serum (NGS) with 2% bovine
serum albumin (BSA) and 0.5% Triton X in PBS at room temperature for 2 hours, they were
incubated overnight at 4oC with the primary antibody rabbit anti-cleaved-caspase-3(Asp175)
(1:500, Cell Signaling Technology, Cat. no. 9661), in 10% NGS with 2% BSA and 0.5% Triton
X in PBS. The sections were washed 6 x 10 minutes with 1% NGS with 1% BSA and 0.2%
Triton X in PBS at room temperature, followed by incubation with the secondary antibody Alexa
fluor 594-conjugated goat anti-rabbit IgG (1:250, Molecular probes, Invitrogen) in 1% NGS with
1% BSA and 0.2% Triton X in PBS for 2 hours at room temperature. Then the sections were
washed 4 x 5 minutes in PBS and 2 x 5 minutes in 0.1M sodium phosphate buffer, and coverslipped with Vectashield Hardset Mounting Medium with DAPI (Vector Laboratories) for
confocal microscopic analysis.

Brn3a immunohistochemistry
Besides the qualitative studies of the RGCs detailed above (TUNEL and caspase-3
immunostaining), quantitative evaluation of the number of RGC was performed using the anti-
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Brn3a antibody immunohistochemistry, which has been shown to specifically detect rodent
RGCs (Galindo-Romero et al., 2011; Nadal-Nicolas et al., 2009). This approach provided
advantages over routine YFP analysis in that unlike the YFP which can be found in RGCs as
well as amacrine cells (Feng et al., 2000), Brn3a is confined solely to RGCs (Xiang et al., 1995).
For Brn3a immunostaining, three slides from equivalent eccentricity from the optic nerve head,
and adjacent to those utilized for TUNEL and Caspase-3 immunostaining were employed. These
slides were warmed to room temperature for 30 minutes. Then the sections were rinsed 3 x 10
minutes in PBS, and pretreated with 10% NGS with 2% BSA and 0.5% Triton X in PBS at room
temperature for 2 hours. Endogenous mouse IgG was blocked by anti-mouse Ig Reagent derived
from a mouse host (Mouse on Mouse Kit, MOM™; Vector Laboratories; Burlingame, CA).
Then the sections were washed 3 x 10 minutes in 10% NGS with 2% BSA and 0.5% Triton X in
PBS, and then incubated overnight at 4oC with the primary antibody mouse anti-Brn3a
monoclonal antibody (1:125, Millipore, MAB1585) in 10% NGS with 2% BSA and 0.5% Triton
X in PBS. Then the sections were washed 6 x 10 minutes with 1% NGS with 1% BSA and 0.2%
Triton X in PBS at room temperature, followed by incubation with the secondary antibody Alexa
fluor 568-conjugated goat anti-mouse IgG (1:500, Molecular probes, Invitrogen) in 1% NGS
with 1% BSA and 0.2% Triton X in PBS for 2 hours at room temperature. Then the sections
were washed 4 x 5 minutes in PBS and 2 x 5 minutes in 0.1M sodium phosphate buffer, and
cover-slipped with Vectashield Hardset Mounting Medium with DAPI (Vector Laboratories) for
epifluorescent microscopic analysis. A Nikon Eclipse 800 microscope (Tokyo, Japan) fitted with
an Olympus DP71 digital camera (Olympus, Center Valley, PA) was utilized with the
appropriate excitation/emission filters.
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Phosphorylated c-Jun immunohistochemistry
In addition to assessing markers of neuronal death (TUNEL and caspase 3) as well as
survival (Brn3a), we also employed other antibodies linked to potential neuronal survival and
repair. Specifically, based on our recent experience with neocortical axonal injury (Greer et al.,
2011), we employed antibodies to phospho-c-Jun. Three slides containing eight frozen retinal
sections, adjacent to slides used for TUNEL, cleaved-caspase-3 staining and Brn3a staining,
were chosen from each animal for immunostaining with the primary antibody polyclonal rabbit
anti-phospho-c-Jun (Ser63) (1:100; Cat. no. 9261, Cell Signaling; Danvers, MA), followed by
the secondary antibody Alexa fluor 633 or Alexa fluor 594-conjugated goat anti-rabbit IgG
(1:200, Molecular probes, Invitrogen). The same protocol for Brn3a immunostaining was utilized,
except for the replacement of PBS by Tris-buffered saline (TBS). Further, adjacent slides were
chosen for Brn3a and phospho-c-Jun double labeling and the observation under confocal
microscopy.

Electron microscopy
For electron microscopic (EM) analysis, additional mice were employed to include 2
injured YFP-16 mice, and their appropriate sham injured controls per time point. To achieve
optimal ultrastructure detail, YFP-16 mice were first perfused with 100ml heparinized normal
saline, followed by 200ml 2% paraformaldehyde and 2.5% glutaraldehyde in Millonig’s buffer.
After 15 minutes fixation, the retina was removed as described above, and immersed in 2%
paraformaldehyde and 2.5% glutaraldehyde in Millonig’s buffer overnight, together with the
brain and the optic nerve. Then the fixation prepared retina was osmicated in 2% OsO4 in 0.1M
sodium phosphate buffer, dehydrated in alcohol with 1% uranyl acetate, embedded in epoxy
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resin (Embed-812; Electron Microscopy Sciences, Hatfield, PA), mounted on plastic slides
(Thomas Scientific Co., Swedesboro, NJ) and cover-slipped. After resin curing, the plastic slides
were examined via routine light microscopy to identify RGCs, using a Nikon Eclipse E800
microscope fitted with an Olympus DP71 digital camera (Olympus, Center Valley, PA). Once
identified, these sites were excised, mounted on plastic studs, and thick sectioned to the RGC
layer using an ultramicrotome (Leica Ultracut R; Leica, Wien, Austria). Serial 40nm sections
were cut and mounted onto Formvar-coated single-slotted grids. The grids were then stained with
5% uranyl acetate in 50% methanol for 2 minutes and 0.5% lead citrate for 1 minute, and
visualized using a JEM 1230 electron microscope (JEOL Ltd., Tokyo, Japan).

Quantification of RGC and statistical analysis
To quantify the number of RGCs, the Brn3a immunofluorescently labeled retinal sections
were captured using routine epifluorescent microscopy. Specifically, Brn3a retinal section (4
sections per eye, with each slide containing 8 sections from both eyes) was digitally acquired at
20 x magnification moving from side to side of the retina covering its entire extent, parallel to its
curvature. Each retinal section was reconstructed using 7-9 images taken along the extent of the
retina (Figure 4.4 A). To quantify the number of RGCs, the central image of those acquired was
selected together with the other next adjacent image from both sides (Figure 4.4 A arrow). For
each selected image, the number of Brn3a positive RGCs was counted in a 0.05 mm2 (0.435 mm
x 0.115 mm) grid expanding along the image parallel to the alignment of the RGCs (Figure 4.4
B). This process of acquisition and counting was repeated for each of the retinal sections on the
slide for a total of 72 retinal images per animal (3 images/section x 8 sections/slide x 3
slides/animal = 72 images/animal). For each animal, the number of Brn3a positive RGCs was
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calculated by summating the number of Brn3a positive RGCs from the 72 images, expressing
them as mean ± standard deviation. To test the difference of the number of Brn3a positive RGCs
overtime post injury, one way ANOVA was conducted.

Results
Whole mount retina YFP assessment following TAI in the optic nerve
The YFP expressing retinal whole mounts were well preserved, with RGC axons
converging toward the optic disc, without any evidence of axonal swelling. In the injured
animals, the YFP positive cells in the RGC layer from both the center of the retina and its more
peripheral regions, did not reveal overt loss or change in fluorescent intensity from 2 days, 7
days to 14 days and 28 days post TBI compared to the retina harvested from the 2 days sham
animal (Figure 4.1).

TUNEL and caspase 3 assessment in the RGC layer following TAI in the optic nerve
To assess the potential for any axonal damage-induced death of RGCs, the TUNEL
method was utilized to identify nuclear fragmentation within the RGC layer as a consequence of
axonal injury. Positive control retinal sections from DNAase treated YFP retinal sections
demonstrated positive staining in the nuclei of cells at the different layers of the retina (Figure
4.2). In retina from sham-injured animals, no TUNEL positive cells were observed in the RGC
layer (data not shown). Importantly, no TUNEL positive cells were observed within the RGC
layer at any time point from 2 days to 90 days assessed post injury (Figure 4.2).
Besides TUNEL analysis, we also assessed the potential for RGC apoptosis induced by
diffuse traumatic axonal injury of the optic nerve. Specifically, cleaved caspase-3
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immunostaining approach was utilized to identify apoptosis in the RGC layer from 2 days to 90
days after axonal damage. Positive control retinal sections from P2 mice pups demonstrated
positive staining of the cleaved caspase-3 (Figure 4.3). In retina from sham-injured animals, no
positive staining of the cleaved caspase-3 was observed in the RGC layer (data not shown).
Importantly, no cleaved caspase-3 immunoreactive cells were observed within the RGC layer
from 2 days to 90 days post-TBI (Figure 4.3).

Quantitative analysis of the RGCs following TAI in the optic nerve
Besides the use of TUNEL and caspase-3 immunostaining to detect RGC death,
quantitative analyses utilizing Brn3a immunostaining were performed to evaluate the number of
RGCs overtime following TAI. This approach revealed a subtle time dependent decrease of
RGCs in the injured animals from 7 days to 28 days post injury (Figure 4.4 C). Of note, however,
was the finding of a comparable time dependent decrease of RGCs in the sham animal at 7 days
to 28 days post sham injury, which was obviously not related to traumatic axonal injury.
Compared to sham injured animals, there was no significant decrease in the number of RGCs at
each time point post injury. At 7 days post injury, 2620.6±102.3 (mean ±standard deviation)
RGCs survived compared to 2610.7±103.5 in the sham group. At 14 days post injury,
2358.8±148.1 RGCs survived compared to 2509.5±65.8 in the sham group. Further at 28 days
post injury, 2378.8±93.2 RGCs survived compared to 2465.5±65.8 in the sham group. Despite
the subtle loss of RGCs overtime, majority of RGCs survived at each time point post injury,
consistent with the TUNEL and caspase-3 immunostaining which did not support dramatic RGC
death following diffuse traumatic axonal injury of the optic nerve.
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Persistent expression of phospho-c-Jun overtime following TAI in the optic nerve
As noted above, as no overt RGC loss could be identified post injury, we also employed
antibodies to phospho-c-Jun, which has been linked to neocortical neuronal survival and axonal
regeneration following diffuse traumatic axonal injury (Greer et al., 2011). In the current study,
the expression of phospho-c-Jun was found specifically within the RGCs, based upon its
colocalization with Brn3a (Figure 4.5). In this domain, the phospho-c-Jun positive RGCs were
interspersed by other RGCs lacking phospho-c-Jun expression. Further, the expression of
phospho-c-Jun by RGCs persisted from 2 days to 90 days post-TBI (Figure 4.6). Collaboratively,
this persistent expression of phospho-c-Jun is consistent with RGC survival overtime.

Qualitative ultrastructural analysis of RGC following TAI in the optic nerve
Parallel ultrastructural analysis of cells within the RGC layer undertaken from 7 days to
28 days post injury also confirmed the absence of overt cell death. Throughout the period of 7
days, 14 days and 28 days no apoptotic or necrotic RGC profiles were seen (Figure 4.7).
Additionally, no evidence of chromatin clumping, nuclear eccentricity or increased neuronal
electron density was found, again consistent with neuronal preservation. Although occasional
mitochondrial dilation was observed, this dilation did not progress over time, suggesting that this
was a fixation artifact. Of note, the cell body appeared smaller at 28 days post injury, suggesting
atrophic change overtime (Figure 4.7).

DISCUSSION
In the current communication, both qualitative (TUNEL and caspase-3 immunostaining)
and quantitative (Brn3a immunostaining) studies demonstrated no evidence of significant RGCs
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death following diffuse traumatic axonal injury in the optic nerve. The parallel finding from 2
days to 90 days post injury of phospho-c-Jun expression, an established marker of neuronal
survival and potential axonal repair, further argued for RGC survival rather than death. Lastly,
our parallel ultrastructural analysis did not reveal RGC death, again consistent with RGC
survival.
As presented the findings of the current study, stand in contrast to numerous studies
reporting that virtually any damage to optic nerve results in dramatic RGC loss (Berkelaar et al.,
1994; Dibas et al., 2010; Kielczewski et al., 2005; Sulaiman et al., 2011; Peinado-Ramon et al.,
1996; Saatman et al., 2003). The reason for this different response to TAI in comparison to other
models of optic nerve injury is not entirely clear, however, it most likely resides in the diffuse
nature of the injury, together with major differences in the pathogenesis of axonal injury
following diffuse traumatic injury vs. crush/transection.
As noted, the survival of RGCs following diffuse axonal injury in the optic nerve varies
from the dramatic RGC loss routinely described following the optic nerve transection and crush
injury. The major difference between these model systems is that optic nerve transection and
crush constitute a primary axonal injury, while TAI involves secondary/delayed processes
leading to disconnection over a period of several hours (Büki and Povlishock, 2006). Primary
axonal injury (transection) directly disrupts the axolemma, immediately exposing the injured
axonal cylinder to the extracellular environment, resulting in sodium and calcium influx and the
activation of proteases which then could cause further axonal damage progressing to neuronal
death (Emery et al., 1991; Leybaert and de Hemptinne, 1996; Lucas et al., 1990; Rosenberg et
al., 2001; Strautman et al., 1990). RGC death has also been observed following optic nerve
transection or crush, due to the activation of the superoxide anion-initiated apoptotic signaling
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pathway (Catrinescu et al., 2012), caspase-3 induced apoptotic signaling pathway (Agudo et al.,
2008), and TNF-α pathway (Lukas et al., 2009). Unlike optic nerve transection/crush injury, the
central fluid percussion brain injury used in the current study induces acute transit accelerationdeceleration and compression-decompression of the optic nerve, resulting in diffuse traumatic
axonal injury. This injury induces subtle, progressive changes in the axonal cylinder, as reported
in our previous publications in the optic nerve as well as other fiber systems (Buki and
Povlishock, 2006; Wang et al., 2011). Conceivably, these more subtle and progressive axonal
changes do not lead to the massive ionic disruption associated with transection thereby
supporting RGC survival.
Besides the differences between optic nerve TAI and transection/crush injury, the
survival of RGCs following diffuse traumatic axonal injury of the optic nerve, also differs from
the RGCs response to optic nerve stretch injury, which also typically evokes RGC death,
involving necrotic and/or apoptotic pathways (Sulaiman et al., 2011; Saatman et al., 2003). The
underling mechanisms for this RGC response most likely originates from the mechanical stretch
injury itself, during which the globe and optic nerve are stretched by a sling placed behind the
globe (Gennarelli et al., 1989; Maxwell et al., 1994; Maxwell and Graham 1997; Sulaiman et al.,
2011; Saatman et al., 2003; Serbest et al., 2007). In this model, the force of stretch is applied
directly to the globe, and then transferred from the globe to the optic nerve. This approach most
likely injures both RGCs and the axons within the optic nerve via the mechanical forces acting
on the retina, its intrinsic vasculature and downstream fibers. In contrast, with the central fluid
percussion injury used in this study, the fluid injury pulse impacts the dorsal cortex, causing its
elastic deformation along a rostral caudal path to reach the brainstem (Dixon et al., 1987; Wang
et al., 2011). This deformation compresses the optic nerve transiently, stretching it, inducing the

93

diffuse traumatic axonal injury approximately 1 mm proximal to the chiasm (Wang et al., 2011).
Importantly, in this model, the globe itself is shielded from the injury pulse, most likely sparing
the retina while generating DAI in a more remote segment of the optic nerve than that previously
assessed by others.
In this regard, the majority of optic nerve transection or crush lesions have been
performed in the intraorbital segment of the optic nerve, which directly approximates the RGCs
(Alarcón-Martínez et al., 2010; Dibas et al., 2010; Hu et al., 2012). Similarly with optic nerve
stretch, the utilized sling triggers axonal damage in the proximal optic nerve segment, with the
caveat that the proximity of the axonal injury to the RGC of origin may also be a confounding
factor in the fate of the RGC cell body. Previous studies evaluating the survival of rubrospinal
neurons following axonal transection at the brain stem vs. the C2 level (Liu et al., 2004; Liu et
al., 2003), and the survival of the corticospinal motor neuron after the intracortical axonal
transection at different depth below layer V cortex (Dale et al., 1995), have shown that more
neuronal sparing occurs as the distance between the neuronal somata and the downstream lesion
increases, with proportionally more neuronal death occurs when the primary axonal lesion occurs
adjacent to the neuronal cell body of origin (Dale et al., 1995; Liu et al., 2004; Liu et al., 2003).
These results are consistent with our observations in more RGCs surviving TAI in the remote
intracranial segment of the optic nerve, compared to less RGCs surviving transection/crush or
stretch of the more proximal segment of the optic nerve.
While the above described differences in animal modeling as well as our failure to
demonstrate evidence of cell loss/death support our conclusions, further direct confirmation of
RGC survival can be found in our additional immunocytochemical studies utilizing phospho-cJun. Previous studies have demonstrated that the activation of the c-Jun pathway is associated
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with scattered RGC survival, axonal sprouting and regeneration in various models of optic nerve
injury in fish and rodents (Fitzgerald et al., 2010; Fitzgerald et al., 2009; Herdegen et al., 1993;
Hüll and Bähr, 1994; Lu et al., 2003; Robinson 1994 and 1995). Further our RGCs expression of
phospho-c-Jun is consistent with its expression in the neocortical neurons sustaining TAI which
also do not die (Greer et al., 2011). Importantly, ATF-3, another transcription factor associated
with axonal regeneration, is activated in the neocortical neurons following TAI (Greer et al.,
2011).
One unexpected finding in the current communication is the subtle decrease of RGC
number in the sham and injured animals overtime as detected through the use of antibodies to
Brn3a. Importantly, however no difference existed between the number of RGC in the sham and
injured animals at each time point. Accordingly we cannot conclude that the subtle RGC loss in
the injured group was due to traumatic axonal injury. Rather other factors were at work most
likely. Recently, Comley and colleagues (2011) demonstrated that the YFP fluorescent protein
expressed in the thy1-YFP mice was not biologically inactive. In fact, it upregulated multiple
genes and proteins associated with various cell stress responses, such as apoptosis signaling,
DNA damage and repair, inflammation as well as oxidative or metabolic stress (Comley et al.,
2011). The high neuronal expression of YFP in YFP-16 transgenic mouse also subtly increased
the incidence of the neuronal morphological abnormality and altered the time-course of dyingback pathology (Comley et al., 2011). Thus, these adverse effects of YFP fluorescent protein
within the neuron could explain the subtle decrease of RGC currently described in both the sham
and injured animal populations.
While the current communication in the visual system significantly extends our
understanding of TAI and its implication for concomitant retinal change, it also offers many
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other potential applications and benefits. The preservation of the RGCs and their proximal
axonal appendages in a relatively intact optic nerve offer an unprecedented opportunity for
evaluating possible regeneration and repair. Further, the fact that the optic nerve itself is
accessible to both blood-born and CSF applied therapeutic approaches, this model should prove
invaluable in multiple drug screening approaches. Accordingly, in light of the current finding on
the preservation of the RGCs in response to TAI, our model system takes on increased utility and
importance.
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Figure 4.1 No overt loss of YFP positive cells in the retinal ganglion cell (RGC) layer overtime
post injury. These retinal whole mounts demonstrate comparable YFP distribution in the sham as
well as the injured animals at all time points post TBI. The axons in the retina maintain intact,
without any axonal swellings. Compared to the retina of the 2 day sham animal, the center and
the middle region of the retina reveal no overt loss of YFP positive cells in the retinal ganglion
cell (RGC) layer (the same layer of RGC axons) at 2, 7, 14 and 28 days post injury. Scale bar:
100μm.
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Figure 4.2 This figure reveals negative TUNEL staining of retinal ganglion cells from 2 days to
90 days post TBI, in contrast to the positive control section treated by DNAase, which shows
positive TUNEL staining within different layers of the retina. Scale bar: 50 µm.
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Figure 4.3 This figure demonstrates the absence of the cleaved caspase-3 expression in the
retinal ganglion cell layer from 2 days to 90 days post injury. This finding contrasts to the
positive control retinal section from a P2 pup, which shows positive expression of the cleaved
caspase-3 in different layers of the retina. Scale bar: 100 µm.
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Figure 4.4 This figure shows quantitative analysis of the retinal ganglion cell (RGC) number
following TAI. Figure A illustrates the images taken from side to side of the retinal section
immunostained with antibodies to Brn3a. Figure B shows the placement of a grid (0.435mm x
0.115mm = 0.05mm2) expanding along the image parallel to the alignment of the RGCs, and
covering all the RGCs that were counted. Figure C shows the quantitative assessments that
reveal a subtle time dependent decrease of RGCs in both sham and injured animals from 7 days
to 14 days and 28 days post injury. Note that, however, at each specific time point, the number of
RGC shows no difference between the sham and the injured groups. Scale bar: 500 µm in A;
200μm in B.
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Figure 4.5 Note that an expression of phospho-c-Jun is found specifically within the retinal
ganglion cell (RGC) layer, and colocalize with Brn3a positive RGCs (arrows). Also note that the
phospho-c-Jun positive RGCs (purple) are scattered among adjacent phospho-c-Jun negative
RGCs. Scale bar: 50μm.
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Figure 4.6 This figure reveals YFP positive retinal ganglion cell (RGC) layer with concomitant
labeling with antibodies to phospho-c-Jun, a known regulator of neuronal repair and regeneration
from 2 days to 90 days post injury. Note that, the phospho-c-Jun positive RGCs are scattered by
other phospho-c-Jun negative RGCs. Also note that no phospho-c-Jun expression is seen in the
RGCs from the sham animals. Scale bar: 50μm.
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Figure 4.7 These electron micrographs illustrate retinal ganglion cell ultrastructure at 7 days, 14
days and 28 days post injury. Note that at all time points the RGCs reveal normal ultrastructural
detail, characteristic of the healthy neurons from the retinal ganglion cell. The only caveat here is
that the RGCs visualized at 28 days post injury appear smaller, perhaps suggestive of atrophy.
Scale bar, 2μm.
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CHAPTER FIVE: APPENDIX I
DISTAL TRAUMATIC AXONAL DEGENERATION AND THE PROXIMAL AXONAL
REORGANIZATION WITHIN THE INJURED OPTIC NERVE ARE ASSOCIATED WITH THE
DIFFERENTIAL ACTIVATION OF MICROGLIA/MACROPHAGES

Introduction

Traumatic axonal injury (TAI) is a major feature of human traumatic brain injury (TBI)
(Povlishock and Katz 2005), and has been associated with much of its morbidity (Graham et al.,
2002). To date, significant insight has been gained into the initiating pathogenesis of TAI.
However, the precise anterograde and retrograde sequelae of TAI have not been well
characterized. Specifically once the axon disconnects, the continued changes in the proximal and
the distal disconnected axonal segments, have not been comprehensively appreciated, nor have
their causative mechanisms been fully probed.
Previously, axonal dieback, a phenomenon whereby axons retract from the initial site of
injury, has been reported in spinal cord injury (SCI). For example, axonal dieback was observed
in the rat and mice corticospinal tracts (CST) after thoracic spinal cord transection (Seif et al.,
2007, Yoshimura et al., 2011). In addition to the initial mechanical separation, continued SCI
axonal dieback has, in part, been linked to local macrophage activation (Busch et al., 2009;
Busch et al., 2010; Horn et al., 2008), concomitant oligodendrocyte and microglia/macrophage
death (Stirling et al., 2004) as well as myelin degeneration (McPhail et al., 2004). Of note,
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distinct macrophage subsets, proinflammatory type (M1) and anti-inflammatory type (M2), have
been described to be differentially activated following SCI (Kigerl et al., 2009).
Activation of microglia/macrophages has also been observed in relation to trauma
induced axotomy following traumatic brain injury. Specifically, using a mouse midline closed
skull injury model, which induces axonal injury in the corpus callosum, the activation of
different subpopulations of microglia has been described in both the acute and chronic phases of
injury (1 day – 28 days post injury) (Venkatesan et al., 2010). In such injuries, some activated
microglia engulf injured axonal segments, consistent with the role of myelin phagocytosis during
CNS inflammation (Reichert and Rotshenker, 1999, Venkatesan et al., 2010, Walther et al.,
2000). At the same time, other activated microglia express nerve growth factors (Venkatesan et
al., 2010), which can promote neuronal repair, axon sprouting and oligodendrocyte proliferation
(Kromer, 1987, Althaus et al., 1992, Sofroniew et al., 2001, Frielingsdorf et al., 2007). Thus,
although it is clear that microglia/macrophage activation is a consistent feature of CNS axonal
damage and dieback, their precise role in terms of the events, occurring in either the proximal or
distal disconnected axonal segments is not fully understood.
Previously, we utilized a model of traumatic brain injury evoking TAI within the mouse
optic nerve, demonstrating highly localized, post-TBI axonal swelling and disconnection, with
proximal and distal axonal dieback accompanied by the regression and reorganization of the
proximal axonal swelling segments, and degeneration and delayed clearance of the distal
swelling axonal segments (Wang et al., 2011). Given that our model is well characterized and in
that the sequence of axonal disconnection and dieback on both the anterograde and retrograde
fronts has been fully described within a well localized region of the optic nerve, we employed
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these unique features to better understand the potential spatial-temporal relationship that exists
between the microglia/macrophages and these axonal dynamic processes.

Material and Methods
Adult Thy1-YFP-16 transgenic mice, which expressed YFP under the promoter Thy1
within over 80% of the optic nerve fibers (Feng et al., 2000), were subjected to central fluid
percussion injury as described in the General Methods Section (Chapter 2), and allowed to
survive from 2 days to 28 days (at each time point, n = 3 in each injured group, n= 1 in the sham
injured group). Animals (the same animal from Chapter 4) were perfused and the optic nerve was
blocked and sectioned as described in Chapter 2 and Chapter 3 and processed for fluorescent
immunohistochemistry.

Fluorescent Immunohistochemistry.
To study the relationship between the YFP-linked axonal dieback and the activation of
microglia/macrophages, labeling of the optic nerve were performed utilizing an antibody
targeting the microglia/macrophage population (Iba1). Specifically, YFP fluorescent optic nerve
sections from 2 day to 28 day time point post injury were selected and rinsed 3 x 10 minutes in
PBS, and pretreated with 10% NGS with 2% BSA

and 0.5% Triton X in PBS at room

temperature for 2 hours. Endogenous mouse IgG was blocked by primary antibodies derived
from a mouse host (Mouse on Mouse Kit, MOMTM; Vector Laboratories; Burlingame, CA).
Then the sections were washed 3 x 10 minutes in 10% NGS with 2% BSA and 0.5% Triton X in
PBS, and then incubated overnight at 4oC with the primary antibody rabbit anti-Iba1 (1:1000;
Zymed, San Francisco, CA). Next, the sections were washed 6 x 10 minutes with 1% NGS with
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1% BSA and 0.2% Triton X in PBS at room temperature, followed by incubation with the
secondary antibody Alexa 568-conjugated goat anti-rabbit IgG (1:500, Molecular probes,
Invitrogen). The sections were then washed 4 x 5 minutes in PBS and 2 x 5 minutes in 0.1 M
sodium phosphate buffer, and cover-slipped with Vectashield Hardset Mounting Medium with
DAPI (Vector Laboratories) for analysis with a Leica TCS-SP2 AOBS confocal microscope
(Leica Microsystems). For the study of the spatial-temporal relationship between the injured
axons and their related macrophage/microglia, three-dimensional reconstructions were obtained
with the Volocity Software package (Perkin Elmer; Waltham, MA).

Results
Sham Injury-General Findings and Cellular Phenotype
In the optic nerve of sham-injured animals, the YFP-positive axons maintained continuity
without any evidence of axonal swellings through the length of the optic nerve. Along the length
of the optic nerve, no activation of microglia/macrophages could be observed at any time post
injury (Figure 5.1 A). Specifically, the microglia/macrophages demonstrated a resting
morphology, with their processes paralleling normal, aligned optic nerve axons (Figure 5.1 B and
5.1 C).

Microglia/Macrophage Responses to Diffuse TAI within the Optic Nerve
Initial activation of microglia/macrophage within 2 days post injury
As early as 2 days post injury, in the optic nerve of injured animals, activated
microglia/macrophages were found scattered among diffusely injured axons. At this time point,
they were confined to the site of initial axonal separation and dieback (Figure 5.2 A). Of note, at
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this post injury time frame, only limited evidence of direct microglia association with the
disconnected, distal axonal segments was found (Figure 5.2 B). As previously described in
Chapter 3, the proximal axonal segments, which were now truncated and apparently undergoing
reorganization, were not associated with or attached to this microglia/macrophage population
(Figure 5.2 C).

Activation of microglia/macrophage at 7 days post injury
By 7 days post injury, microglia/macrophage activation demonstrated a dramatic increase
and now numerous activated microglia/macrophages could be easily identified in the injured
optic nerve (Figure 5.3). As noted previously, the distal disconnected, swollen axonal segments
retained their rounded/spheroidal shape (Chapter 3), and again, these distal, degenerating axonal
segments were interspersed among adjacent intact fibers. In relation to these distal disconnected
and degenerating axonal segments, however, the related microglia/macrophages revealed
dramatic activation, with their cell bodies demonstrating rounded up profiles, consistent with
their activation. These activated microglia/macrophages established direct contact with the
degenerating distal axonal segments, with their processes attaching to and engulfing the swollen,
rounded distal axonal profiles (Figure 5.4). Of note, no evidence of microglia/macrophage
clustering was observed in relation to these degenerating axonal segments.
In contrast to this dramatic distal microglia/macrophage activation, the proximal axonal
segments, which again revealed a truncated configuration (Figure 5.5) (as previously described
in Chapter 3), retained an axonal profile distinct from the distal spheroid, degenerating axonal
segments. These proximal segments revealed shrinkage and resorption, consistent with
reorganization

overtime.

In

relation

to
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these

proximal

axonal

segments,

the

microglia/macrophages were significantly less active, with their processes paralleling but not
engulfing these axonal profiles (Figure 5.5).

Persistent activation of microglia/macrophages in the distal degenerating axonal segments at
14 and 28 days post injury
Up to 14 to 28 days post injury, activated microglia/macrophages persisted within the
distal disconnected, degenerating axonal segments (Figure 5.6 A and B). Again, their cell bodies
were rounded, with their processes engulfing the distal, swollen degenerating axonal segments
(Figure 5.6 A and B), consistent with their role in clearing these degenerating axonal segments.
The proximal axonal segments at 14 and 28 days post injury, manifested continued
reorganization, with the microglia/macrophages again maintaining a resting state. Their cell
bodies were compressed, and their processes paralleled the axonal profiles, without any evidence
of the proximal axonal segment engulfment (Figure 5.6 C and D).

Discussion
In the current study following TAI in the optic nerve, activation of the
microglia/macrophages was first observed at 2 days post injury, becoming dominant by 7 to 14
days and persisting up to 28 days post TBI. The distal, disconnected axonal segments, after the
acute dieback, transitioned into a pattern of Wallerian degeneration, with the distal damaged
axons encompassed by the processes of activated microglia/macrophages. In contrast, the
proximal axonal segments underwent reorganization and their related microglia/macrophages
remained markedly less active, with their processes paralleling but not enveloping these axonal
profiles. These varied responses in the distal and the proximal axonal segments, most likely
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speak to the fact that different signaling pathways were involved in these two regions and
therefore translated to differential microglia/macrophages responses.
At the early hours to 2 days post injury, both the proximal axonal segment and the distal
disconnected axonal segments underwent rapid dieback in both the rostral and caudal directions
as previously described in Chapter 3. Specifically, the acute axonal dieback of the proximal
axonal segment moved approximately 0.4-0.8mm within a 48 hours period following injury,
while the distal axonal segment retracted rapidly toward the chiasm at a similar speed (Chapter
3). Because of the rapidity of these events, local calcium dysregulation and calpain activation are
most likely involved in both of these acute axonal dieback processes during this early period post
injury. Others have demonstrated that a rapid increase of intra-axonal calcium is associated with
the initial axonal dieback following either in vitro laser-induced axonal damage (Hellman et al.,
2010) or in vivo optic nerve crush (Knöferle et al., 2010). This increased intra-axonal calcium,
activates calpain and overloads and damages mitochondria, which collectively promote axonal
dieback. In spinal cord transection studies, calpain inhibitors effectively inhibited acute axonal
dieback following cord transection in both the proximal and the distal directions
(Kerschensteiner et al., 2005), confirming the function of calpain in this acute axonal dieback
response. This is most likely related to calpain’s capacity in degrading microtubules,
neurofilaments and spectrin (Banik et al., 1997; Billger et al., 1988; Johnson et al., 1991;
McGinn et al., 2009; Roberts-Lewis et al., 1994; Siman et al., 1984). In addition to calciumactivated, calpain-mediated cytoskeletal proteolysis, calcium overloading can also destroy
mitochondria, resulting in ATP deficiency, compromising axonal transport, further facilitating
axonal dieback.
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After the rapid dieback, our proximal axonal segments manifested a rapid transition from
swollen enlarged segments to a truncated morphology (Chapter 3), which persisted from 7 – 28
days post injury (the current chapter). Consistent with this proximal axonal segment
reorganization and its attempt to repair, was the related finding that the associated
microglia/macrophages maintained a resting state from the 7 – 28 days post injury. The
underlining mechanisms for such phenomenon may be due to the rapid resealing of the axonal
membrane, the conversion of anterograde transport to retrograde axonal transport and the
continuity of these proximal axonal segments with viable RGCs (Chapter 4). The proximal
axonal reorganization/repair maybe preceded by a rapid resealing of the axolemmal membrane
(Liu et al., 2011, Meiri et al., 1983). Studies utilizing cockroach giant axon transection have
demonstrated that at the cut end of the nerve fiber, the axonal membrane reseals within 5 to 30
minutes after the transection at 23oC to 27oC, and this resealing depends on the influx of calcium
into the axoplasm and its subsequent activation of phospholipase A2 (Yawo and Kuno, 1983;
Yawo and Kuno, 1985). Such axonal membrane resealing also involves the Ca2+ mediated
calpain activity after the transection of the neurites of in vitro cultured rat septal neuron (Xie and
Barrett, 1991) and after crayfish medial giant axon transection (Godell et al., 1997).
Additionally, vesicle proteins, such as synaptotagmin, synaptobrevin and syntaxin, have also
been demonstrated to play an important role in membrane resealing (Fishman and Bittner, 2003).
Such axolemmal resealing could prevent the influx of extracellular molecules and inhibit the
release of intra-axonal components into the extra-axonal environment. Besides the rapid
resealing of the axolemmal membrane, anterograde axonal transport could be converted to
retrograde axonal transport (Tuck and Cavalli, 2010, Bisby and Bulger, 1977) via local
proteolysis (Sahenk and Lasek, 1988) and/or the modification of proteins on the transported
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vesicles (Martz et al., 1989), facilitating the reorganization of the proximal axonal segment.
Further, the proximal axonal segments, perhaps receive persistent support from viable RGC,
attenuating/inhibiting degeneration and promoting axonal reorganization, without generating
myelin debris. All these events most likely resulted in less dramatic alternation of the
microenvironment, translating to the minimal stimulus to microglia/macrophage and their
relatively resting status in the proximal axonal segments.
In

contrast,

in

the

distal

disconnected,

degenerating

axonal

segments,

the

microglia/macrophage manifested an activated phenotype from 7 to 28 days post injury, with
their processes attaching to and encompassing the distal disconnected, degenerating axonal
segments. The persistent activation of microglia/macrophage in this region is most likely linked
to the persistent production of myelin debris during axonal degeneration (Kelley et al., 2007,
Brück et al., 1995). Such microglia/macrophage activation is also consistent with their role in the
clearance of the degenerating axonal segments previously described following the brain and
spinal cord injury (Busch et al., 2009; Busch et al., 2010; Horn et al., 2008; Venkatesan et al.,
2010). In SCI studies, Horn (2008) reported a spatial-temporal correlation between macrophage
infiltration and the retraction of the injured ascending dorsal column sensory axon from 7 to 28
days after injury. Horn (2008) also demonstrated in an in vitro study direct adhesive contacts
between activated macrophages and dystrophic axons, with extensive axonal retraction induced
only when the macrophages were activated. Busch (2009) demonstrated the expression and
secretion of MMP-9 by the activated macrophages, and the specific inhibition of MMP-9 block
the macrophage-induced retraction of dystrophic axons. In addition to MMP-9, activated
microglia/macrophages also secrete cytokines, such as interleukin-1 (IL-1), IL-6 and tumor
necrosis factor-α (Gentleman et al., 2004; Kita et al., 2000; McClain et al., 1991). It has been
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demonstrated that IL-6 can increase microglia/macrophage’s phagocytotic activity (Shafer et al.,
2002-2003). Such positive feedback may further facilitate their engulfment of the distal
degenerating axonal segments and the clearance of myelin debris, and maybe associated with
potential synaptic plasticity in the downstream target.
Such close association of the distal axonal degeneration and dieback and
microglia/macrophage activation imply that blocking the activation of macrophage/microglia is a
potential therapeutic approach to attenuate distal axonal degeneration. For example, minocycline,
an anti-inflammatory and neuroprotective medication, inhibits microglial activation and
attenuates MMPs (Brundula et al., 2002; Yrjänheikki et al., 1998). When administered
intraperitoneally,

minocycline

is

effective

in

reducing

the

number

of

activated

microglia/macrophages, while also inhibiting axonal dieback, reducing lesion size and enhancing
functional performance at both 7 and 14 days after SCI (Stirling et al., 2004).
The morphology of microglia/macrophage transforming from the activated state in the
distal disconnected, degenerating axonal segments to the resting state in the proximal
reorganized axonal segments, suggests that their status is most likely modified by the adjacent
microenvironment. As discussed, it is possible that in the proximal axonal segments, the
microenvironment was not dramatically altered. On the other hand, in the distal degenerating
axonal segments, the microenvironment was obviously different due to the local generation of
myelin debris and the secretion of cytokines.
While it is likely that the activity of microglia/macrophage can be modified by the local
microenvironment, it is unclear whether distinct subtypes of microglia/macrophage reside in the
injured optic nerve. Previous studies in SCI, however, demonstrate that two distinct macrophage
subsets, namely proinflammatory type (M1) and anti-inflammatory type (M2), are activated
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differentially following SCI (Kigerl et al., 2009). The M1 macrophages are activated rapidly and
persist up to 28 days post SCI, in contrast to the M2 macrophages which are activated transiently
and recover to the preinjury levels by 14 days post injury (Kigerl et al., 2009). Further, inducing
macrophages to differentiate into the M2 phenotype by peroxisome proliferator activated
receptor (PPAR) agonists, has been demonstrated to promote anatomical and functional repair
after rodent SCI (McTigue et al., 2007; Odegaard et al., 2007; Vill Villanueva and Tontonoz,
2010). Although there is little evidence regarding the activation of M1 and M2 macrophage in
optic nerve injury studies, this SCI study suggests that the induction of a microglia/macrophage
transition into the resting phenotype, may be a potential therapeutic strategy to attenuate the
distal, disconnected axonal degeneration in our current study.
All the above findings of the differential activity of microglia/macrophages in the
disconnected proximal and distal axonal segments in the current communication were obtained
based upon the morphological change of microglia/macrophages via the utilization of antibodies
targeting Iba1 which label all microglia/macrophages. These results may further be confirmed
via the utilization of other markers that specifically stain activated microglia/macrophages,
affirming their activation at the disconnected distal axonal segments.
In summary, this study reveals differential microglia/macrophage response to the
disconnected proximal and distal axonal segments. These observations within the optic nerve
provide unique insight into the pathobiology associated with the TAI, particularly in terms of
activated microglia/macrophages in the distal disconnected axonal segments versus the resting
microglia/macrophages found in the proximal, reorganizing axonal segments.
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Figure 5.1 The microglia/macrophages maintain at a resting state throughout the length of the
optic nerve 2 days after sham injury (A). Note that all the scattered microglia/macrophages
reveal morphological features consistent with a resting state, with their processes paralleling the
normal YFP expressing axons (B and C). (Blue: DAPI; YFP: axon; Red: microglia/macrophage).
Scale bar: 300µm in A.
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Figure 5.2 Activated microglia/macrophages can be recognized in the optic nerve at 2 days post
TBI (A). Specifically, the activated microglia/macrophage can be seen scattered between injured
axons at the site of initial axonal injury (A arrow). Note that a few activated
microglia/macrophage lie adjacent to distal axonal segments in the process of dieback toward the
chiasm (B arrowhead), however, in the proximal axonal segments, no association exists between
microglia/macrophage and the reorganizing proximal axonal segments (C). Scale bar: 300µm in
A, 20µm in B and C.
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Figure 5.3 Activated microglia/macrophages predominate in the optic nerve at 7 days post TBI.
Specifically, note that the activated microglia/macrophages attach/engulf the distal, disconnected
degenerating axonal segments (arrow). (Red, Iba1 immunostaining, microglia/macrophage).
Scale bar: 300µm.
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Figure 5.4 At higher magnification, the activated microglia/macrophages can be seen to
approach and engulf the distal, disconnected swollen axonal segments within the optic nerve at 7
days post injury. The top image shows that at 7 days post injury, there are numerous persistent,
disconnected distal swollen axonal segments (white arrows). The activated
microglia/macrophages (red) appear reactive, and their related appendages contact and engulf the
swollen axonal segments. The lower two images show at even higher magnification that the
distal swollen axonal segments (YFP) are enveloped by the processes of activated
microglia/macrophages. Scale bar: 20µm.
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Figure 5.5 The microglia/macrophages appear less active in the proximal axonal segments of
the optic nerve at 7 days post injury. The top image reveals at 7 days post injury, that the
proximal axonal segments are truncated (white arrows), consistent with reorganization.
Microglia/macrophages are scattered between these proximal axonal segments. The lower two
images showed at a higher magnification, that in the proximal axonal segments, a
microglia/macrophage (red) maintain a resting state with its processes paralleling the alignment
of the axonal fibers. Scale bar: 20µm.
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Figure 5.6 Activated microglia/macrophages predominate in the distal disconnected axonal
segments of the optic nerve at 14 and 28 days post TBI. Specifically, activated
microglia/macrophages (Red, Iba1 immunostaining) can be seen attaching to and engulfing the
distal disconnected, degenerating axonal segments (A and B). In contrast, in the proximal axonal
segments, the microglia/macrophage again retains a resting state, compressed between the axonal
fibers, with their processes paralleling the aligned axonal profile (C and D).
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CHAPTER SIX: APPENDIX II

THE CLEARANCE OF OPTIC NERVE EDEMA AND THE RECOVERY OF YFP
FLUORESCENT AXONAL FIBERS OVERTIME POSTINJURY

Introduction

We have previously shown that our model of traumatic brain injury (TBI) evoked diffuse
traumatic axonal injury (TAI) within the mouse optic nerve, with the TAI eliciting progressive
axonal swelling and disconnection, together with proximal and distal axonal dieback (Chapter 3
and Wang et al., 2011). These processes were accompanied with an apparent focal loss of YFP
fluorescence in the region between the detached proximal and distal axonal segments. This loss
of YFP fluorescence was not the result of actual fiber dissolution. Rather it was due to local
fluorescence quenching, a sequelae of local blood-brain barrier (BBB) disruption. The barrier
disruption was demonstrated by the passage of immunoglobulin (IgG) into the optic nerve
(Figure 3.10), which was most likely accompanied by the movement of water, with the formation
of edema, consistent with previous electron microscopic (EM) observation of the expansion of
the interstitium (Figure 3.3).
To date it has been demonstrated that water and solvent properties of water can lead to
fluorescence quenching (Ebbesen and Ghiron, 1989; Oshima et al., 2006; Sadkowski and
Fleming, 1980; Seliskar and Brand, 1971; Tobita et al., 2001). Since optic nerve edema involves
significant generation of water, it is not unreasonable to hypothesize that this water can
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participate in fluorescence quenching. The correctness of this hypothesis is further supported by
previous observation of axonal profiles using antibodies to the endogenous YFP (Figure 3.11),
confirming that the loss of fluorescence was most likely due to quenching, and not actual fiber
loss.
In the current chapter, we employed the same YFP transgenic mice TBI model and
evaluated optic nerve axons at the electron microscopic level overtime post injury to better
appreciate the persistence of intact/unaltered axons and reconfirm the characteristics of diffuse
axonal injury of this model. In these studies, the intact axons were not separated by an expanded
interstitial space in later phases of injury, suggesting the clearance of edema overtime postinjury.
Further, in concert with this observation, we observed at the confocal fluorescent microscopic
level, the recovery of YFP fluorescent intact axons in the previously identified regions of
fluorescence loss, confirming the correctness of our hypothesis that water participates in
fluorescence quenching, as the clearance of edema apparently reversed fluorescence quenching.

Material and Methods
Adult Thy1-YFP-16 transgenic mice, which expressed YFP within the optic nerve fibers
(Feng et al., 2000), were subjected to central fluid percussion injury as described in the General
Methods Section (Chapter 2), and allowed to survive from 2 days to 90 days (at each time point,
n = 3 in the injured group, n = 1 in the sham injured group). Animals (the same animal from
Chapter 4/5) were perfused and the optic nerve was blocked and sectioned as described in
Chapter 2 and Chapter 3. The optic nerves were processed for electron microscopic analysis and
fluorescent confocal microscopic analysis.
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Electron Microscopy
For electron microscopic (EM) analysis, the YFP-16 transgenic mice were first perfused
with 100ml heparinized normal saline, followed by 200ml 2% paraformaldehyde and 2.5%
glutaraldehyde in Millonig’s buffer. Again, the brain and the optic nerves were post-fixed and
blocked as described in Chapter 2. These prepared YFP optic nerves were osmicated in 1%
OsO4, dehydrated, embedded in epoxy resins (Embed-812; Electron Microscopy Sciences,
Hatfield, PA), mounted on plastic slides (Thomas Scientific Co., Swedesboro, NJ) and coverslipped. After resin curing, the injured axonal segments including the locus of fluorescence
quenching, were excised, mounted on plastic studs, and thick sectioned to the depth of the sites
of interest using an ultramicrotome (Leica Ultracut R; Leica, Wien, Austria). Serial 40 nm
sections were cut and mounted onto Formvar-coated single-slotted grids. The grids were then
stained with 5% uranyl acetate in 50% methanol for 2 minutes and 0.5% lead citrate for 1
minutes, and visualized using a JEM 1230 electron microscope (JEOL Ltd., Tokyo, Japan).

Fluorescent Confocal Microscopy
The optic nerve sections from YFP-16 transgenic mice sustaining central fluid percussion
injury or sham injury, were prepared as described previously (See Chapter 2 Animal perfusion
and Optic nerve preparation). The cryo-dissected 10µm optic nerve sections were directly
mounted on glass slides with ProLong-Gold antifade reagent (Invitrogen, Carlsbad, CA), and
cover-slipped for image capture with a Leica TCS-SP2 AOBS confocal microscope (Leica
Microsystems), at 2 days, 7 days, 14 days, 28 days and 3 months post injury. The evaluation of
YFP fluorescent axonal fibers was specifically located at the locus of previous fluorescent loss,
the same locus of initial TAI (approximately 1mm proximal to the chiasm).
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Results
Electron microscopic observation of the optic nerve axon at the locus of fluorescence
quenching
As early as 5 minutes to 1 hour post injury, the optic nerve revealed initial axonal
swellings (see Chapter 3 Figure 3.3). This axonal injury was accompanied by the expansion of
the interstitial space (see Chapter 3 Figure 3.3 asterisk), consistent with the presence of edema
generated by the disruption of the blood-brain barrier (BBB) discussed before.
At 7 days (Figure 6.1) and 28 days (Figure 6.2) post injury, in the same locus of
fluorescence quenching, numerous intact axonal fibers were observed via EM analysis.
Specifically, at these time frames post injury, this region revealed numerous continuous
linear/non-swollen axonal profiles spanning the field, which revealed only occasional Wallerian
debris interspersed among the morphologically intact axons. Within the axonal cylinder of the
intact axons, microtubules and neurofilaments paralleled the longitudinal orientation of the axon,
with no evidence of microtubule misalignment or neurofilament compaction. Within these axons
no accumulations of either mitochondria, smooth endoplasmic reticulum or vesicles were found.
The intact mitochondria revealed normal morphology, with no findings of dilation or
disorganized cristae. This ultrastructural analysis confirmed the maintenance of axonal integrity
within the locus of fluorescence quenching, consistent with the characteristics of diffuse
traumatic axonal injury.
Of note, at 7 days and 28 days post injury timeframe, these same loci of YFP
fluorescence quenching, revealed no evidence of the expansion of the interstitial space (Figure
6.1 and Figure 6.2). This observation varied from previously described time frames in which the
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expansion of the interstitial space within the optic nerve was routinely observed (See Chapter 3
Figure 3.3). Such reduction of the interstitial space at these more chronic phases post injury (7
days and 28 days) is consistent with the resolution of edema overtime.

Confocal microscopic observation of YFP fluorescent axons in the region of fluorescence
quenching
Concomitant with our ultrastractural observation of intact axonal fibers and the clearance
of edema overtime in the region of fluorescence quenching, was the finding of a recovery of YFP
fluorescent axonal fibers within this same region.
At 2 days post injury, the optic nerve of the injured mice exhibited predominent axonal
swellings and disconnection. The proximal axonal swellings were truncated and shifted toward
the globe. The distal axonal swellings were rounded and redistributed toward the chiasm. These
reactive axonal changes and dieback were accompanied by an apparent focal loss of fluorescence
(Figure 6.3).
By 7 days post injury however, the optic nerve of the injured mice demonstrated an initial
recovery of the YFP fluorescent fibers at the locus of original fluorescence quenching.
Specifically, routine confocal analysis revealed more intact/unaltered YFP fluorescent axonal
profiles, as well as detached and fragmented axonal profiles in the same locus of fluorescence
loss described in the earlier time frame (Figure 6.3). Again, the proximal axonal swellings were
truncated, consistent with their reorganization.
From 14 days and 28 days post injury, within the locus of original YFP fluorescence
quenching, the restoration of YFP fluorescent axonal fibers continued (Figure 6.3), with more
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YFP fluorescent fibers together with occasional scattered fragmented axonals profiles were
revealed.
By 3 month post injury, this recovery of YFP fluorescent axons showed further
improvement at the locus of original fluorescence quenching, which was now crossed by
numerous linear/continuous unaltered YFP fluorescent axonal profiles, without evidence of
swollen axonal segments or fragmented axons (Figure 6.3).

Discussion
In this current study, we provide at more chronic time points the ultrastructural evidence
of numerous intact axonal fibers in the region of previously described YFP fluorescence
quenching. This occurred together with the reduction of the interstitial space overtime post injury,
consistent with the clearance of edema. This resolution of edema was also accompanied by the
recovery of YFP fluorescent axonal fibers overtime post injury.
The existence of numerous intact axonal fibers at the locus of original YFP fluorescence
loss confirmed that not all the axons within the optic nerve were injured by the initial traumatic
injury. Rather, apparently only a sub-population of axons within the optic nerve was
traumatically perturbed, an observation entirely consistent with the characteristics of diffuse
traumatic axonal injury wherein injured axons are interspersed by other adjacent intact fibers
(Buki and Povlishock, 2006; Greer et al., 2011).
Current observation of an initial expansion of the interstitial space followed by its closure
over time is consistent with a transient opening of the blood-brain-barrier (BBB) following TAI.
This observation is similar to previous research performed in a rat weight drop injury model in
which edema occurred becoming maximal by 5 hours post injury, thereafter resolving (Vink et
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al., 2003). Using the same rat weight drop model, Barzó (1997) observed that the water diffusion
distance, increased up to 45 minutes postinjury and thereafter decreased. Since water diffusion
distance is predominantly associated with the formation of vasogenic edema, which results from
the compromise of BBB, this transient increase of water diffusion distance/vasogenic edema
coincides with the BBB opening immediately upon brain trauma followed by a relatively rapid
BBB closure at later time points (Barzó et al., 1996).
The currently described clearance of edema within the injured optic nerve, was
accompanied by a recovery of YFP fluorescent axons in the same region of our previously
reported fluorescence quenching. Previous studies have demonstrated the relationship between
water and fluorescence quenching, through the hydrogen-bond interactions (Oshima et al., 2006),
the transition to a close-lying energy level (Tobita et al., 2001) and other mechanisms.
Accordingly, it is not unreasonable to assume that the reversal of fluorescence quenching could
be achieved through the reduction of water, herein the clearance of edema. Besides the resolution
of tissue water, other studies have also been demonstrated to recover fluorescence, such as the
removal of the quenching reagent (Chen et al., 1999), the addition of anions (SO32- and PO43-,
Xia et al., 2012) and the oxidation of ions (Kress et a., 2002). Whether these events are involved
in our recovery of YFP fluorescent fibers over time, requires further investigation.
In summary, this study demonstrated the maintenance of intact axonal fibers in the region
of YFP fluorescence quenching, consistent with the characteristic of TAI. The clearance of
edema was accompanied by the recovery of YFP fluorescent axons overtime post injury,
confirming the correctness of previous hypothesis that water result in fluorescence quenching.
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Figure 6.1 At 7 days post injury, the previous locus of fluorescent loss within the injured optic
nerve, reveals numerous intact axonal fibers. The neurofilaments and microtubules parallel the
long axis of axons. The mitochondria within the axons maintain normal morphology. Some
Wallerian debris can be seen scattered between intact axons, a finding consistent with TAI. Also
note that the interstitial space appears unremarkable at this time frame. Scale bar: 2µm.
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Figure 6.2 At 28 days post TBI, the original locus of fluorescence quenching within the optic
nerve again reveals numerous intact axonal fibers, without any swollen axonal segments. The
microtubules parallel the alignment of the axon, and the mitochondria maintain normal
morphology showing no dilation or disorganization of the mitochondrial cristae. Occasional
electron dense Wallerian debris are found interspersed between these intact axonal fibers,
consistent with TAI. Again, no expansion of the interstitial space is seen at this time point post
injury. Scale bar: 2µm.
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Figure 6.3 The recovery of the YFP fluorescent optic nerve fibers in the region of fluorescence
quenching overtime post injury. The optic nerve of the sham-injured mice reveals a robust
distribution of linear/continued YFP fluoresent axons, with no evidence of axonal swelling or
YFP fluorescent loss. At 2 days post injury, the locus of initial traumatic axonal injury (TAI)
within the optic nerve reveals disconnected axonal swellings and fragmented axonal profiles.
Note that the dramatic YFP fluorescent loss at this 2 days post injury time frame. By 7 days post
injury, initial recovery of YFP fluorescent axonal profiles can be seen at the same locus of YFP
fluorescent loss, with fragmented axonal profiles scattered among the intact axons. At 14 days
and 28 days post injury, the recovery of YFP fluorescent axonal fibers continues. By 3 months
post injury, more linear/continued YFP fluorescent axons are revealed at the same locus of YFP
fluorescence quenching, although recovery is not complete due to TAI and its attendent diffuse
axonal damage. Scale bar: 20µm.
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CHAPTER SEVEN
GENERAL DISCUSSION

Distinct from the discussion in each individual chapter, I integrate here the results of this
thesis and discuss fully those issues relevant to the reported axonal damage in visual system,
considering the pathological changes occurring both in the anterograde and retrograde directions,
as well as their implications for therapeutic intervention and axonal repair.

Synopsis of the Current Work and its Implications
The current thesis presents the first characterization of a mouse model of diffuse
traumatic axonal injury in the optic nerve following mild traumatic brain injury. By subjecting
transgenic mice expressing endogenous YFP fluorescent protein in the optic nerve to central
fluid percussion injury (cFPI), we consistently generated diffuse TAI in the optic nerve,
demonstrating overtime progressive axonal swelling and disconnection. This ultimately led to
proximal and distal axonal dieback, with regression and reorganization of the proximal
swellings, and the persisting degeneration and dieback in the distal axonal segments. In concert
with these development and characterization studies, we also demonstrated the limitations of
traditional APP immunohistochemical staining to routinely detect axonal injury. Specifically, we
convincingly demonstrated that antibodies targeting C-terminus of APP detect only the proximal
swollen axonal segment, without distal mapping.
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Equally important, this same APP

immunostaining diminished dramatically within 3 days post injury in the proximal region
(Chapter 3), further suggesting the more limited utility of this marker.
Of additional importance in this study was its finding that this diffuse TAI in the optic
nerve following cFPI, did not induce significant death of retinal ganglion cells (RGC), as
demonstrated by qualitative (TUNEL and caspase 3 immunostaining), quantitative (Brn3a
immunostaining) and ultrastructural analysis. Of parallel importance was the finding that this
RGC survival was accompanied by their persistent expression of phospho-c-Jun from 2 to 90
days post injury, which has been linked to neuronal survival and potential axonal repair in other
injury paradigms (Chapter 4). Lastly, in light of the fact that the observed axonal dieback was not
related to RGC death, other mechanisms must be evoked to explain this phenomenon.
In the early hours post injury, the acute axonal dieback observed in both the proximal and
distal segments, is most likely linked to local calcium dysregulation and activation of
proteinases. In the more chronic phases post injury, specifically 7 to 28 days post injury, the
observation within the distal disconnected, degenerating axonal segments, that activated
microglia/macrophages closely envelop/encompass these segments, suggests their potential role
in delayed axonal degeneration and dieback. In contrast, the microglia/macrophage appeared less
reactive in the proximal axonal segments, with their processes paralleling these axonal profiles
undergoing reorganization/repair (Chapter 5 Appendix I).
In concert, with all the above this optic nerve injury was also associated with blood-brain
barrier disruption and local edema formation that resolved overtime (Chapter 6 Appendix II).
Although this barrier disruption did not appear to influence the pathogenesis in the optic nerve,
the edema interfered with the observation of intact YFP expressing axons in the site of initial
TAI (Chapter 3).
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In the following passages we expand the above, providing a more thorough evaluation of
our findings and their overall implications for the field of TBI research and its associated axonal
injury, while also setting the stage for future investigations in this area. Specifically, for the
purpose of this component of the thesis we organize this chapter around our central findings
which include model characterization, its utility for studying TAI, the occurrence of anterograde
and retrograde responses to injury, its association with blood-brain-barrier disruption as well as
future directions focusing on therapeutic intervention, neuroplasticity and axonal regeneration.

Characterization of a Mouse Model of TAI within the Visual System
This optic nerve TAI model induced by TBI using YFP expressing mice provided
unprecedented insight into the pathogenesis of TAI. The observed optic nerve TAI was generated
from a common TBI model modified from rat (Dixon et al., 1987) to mice (Greer et al., 2011,
Wang et al., 2011). In this model, optic nerve TAI occurred immediately following mild TBI,
and was accompanied by concomitant scattered axonal damage in the neocortex, the dorsolateral
thalamus and subcortical white matter, all of which were consistent with mild TBI (Greer et al.,
2011; Greer et al., 2012). The site of the initiation of TAI in the optic nerve always
approximated the optic nerve segment 1mm proximal to the chiasm, which made the critical
assessment of this phenomenon all the more feasible. While unknown, the localization of the
TAI to this region of the visual axis is most likely linked to brain deformation and compression
of the optic nerve, occurring when the dorsal cortex was impacted by the fluid injury pulse.
Importantly, the described optic nerve TAI following cFPI replicates the optic nerve
damage described in shaken baby syndrome, wherein the optic nerve from infants sustaining
fatal whiplash shaking, reveals strong beta amyloid precursor protein (beta-APP)
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immunoreactivity in swollen axonal segments within the optic nerve (Gleckman et al., 2000).
Our optic nerve diffuse axonal swollen segments, specifically the proximal axonal segments,
were also APP immunoreactive. Of note, the antibodies utilized in our research targeted the Cterminus of APP protein and only detected the proximal swollen axonal segments which lost
immunoreactivity over 3 days post injury (Chapter 3). This accumulation of beta-APP, which
undergoes anterograde axonal transport, is consistent with a trauma-induced impaired axonal
transport. Ultrastructurally, these injured axonal segments revealed swollen mitochondria,
misaligned neurofilaments and microtubules, as well as the accumulation of SER, mitochondria
and vesicles (Chapter 3), all of which are consistent with focal axonal cytoskeletal damage/
disorganization with the compromise of axonal transport.
The reactive axonal changes seen within the optic nerve following cFPI, are also similar
to those seen with optic nerve stretch. Previous to the development of the current optic nerve
TAI model, optic nerve stretch has been utilized to study traumatic axonal injury, and has
provided important insight into the pathogenesis of TAI (Gennarelli et al., 1989; Maxwell et al.,
1990; Maxwell and Graham, 1997; Saatman et al., 2003; Serbest et al., 2007; Sulaiman et al.,
2010). Gennarelli and colleagues (1989) created an optic nerve stretch injury model using albino
guinea pigs via a rapid controlled elongation (tensile strain) of the optic nerve. This was achieved
by placing a sling over the posterior pole of the globe. After the stretch injury, Gennarelli et al
(1989) demonstrated that the anterograde axonal transport of horseradish peroxidase (HRP) was
impaired from the RGC to the chiasm and superior colliculi. In these studies, the optic nerve
demonstrated axonal swellings with the accumulation of organelles, sitting adjacent to axons
revealing normal morphology. Importantly, however, this stretch injury model did not replicate
the characteristics of either human or subhuman primate diffuse axonal injury because this model
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failed to generate concomitant change within the brain parenchyma. Specifically, unlike fluid
percussion injury, optic nerve stretch was not accompanied by TAI in either the brain or brain
stem, which are typically involved in human and animal TBI. Utilizing guinea pig optic nerve
stretch injury, Maxwell (2003) noted that traumatic axonal injury occurred approximately half
way along the length of the nerve, with the site of axonal injury associated with axonal
mitochondrial abnormalities and neurofilament compaction. Other injured axons demonstrated
the loss of neurofilaments and microtubules (Maxwell et al., 2003). Saatman (2003) stretched the
mouse optic nerve, and demonstrated a two phase calpain activation associated with TAI, with an
early phase of calpain activation occurring within minutes to hours after injury, associated with
intra-axonal structural damage. A later phase of calpain activation observed at 4 days post injury,
was linked to axonal degeneration. In addition to calpain-mediated spectrin proteolysis, Serbest
(2007) also observed the loss of neurofilaments and microtubules in optic nerve axons after
stretch injury.
However, despite similarities between our model and those described above, important
differences exist between these model systems. As discussed in Chapter 3, dissimilar to optic
nerve stretch which induces TAI within the optic nerve alone, our cFPI model also evoked TAI
throughout the related brain parenchyma, involving the neocortex, the dorsolateral thalamus and
subcortical white matter, findings consistent with other reports from our laboratory (Kelley et al.,
2006 and 2007, Buki and Povlishock, 2006, Greer et al, 2011). This characteristic
diffuse/scattered axonal injury within the optic nerve as well as the brain parenchyma arguably
makes our model more similar to human TBI, with the caveat that our model may offer the
potential for preclinical drug screening to target TAI within the visual system and cerebrum
given its more human-like pattern of axonal injury.
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Utility of this mouse model of TAI within the optic nerve to probe TAI
pathogenesis
Besides the relevance of our model to the pathobiology of mild TBI, our current
utilization of the YFP-16 transgenic mice, expressing endogenous YFP fluorescent protein
within the majority of retinal ganglion cells and the optic nerve (Feng et al., 2000), allowed for
the detailed and ready observation of the events starting from the initiation of axonal swelling to
ultimate axonal disconnection, as well as any subsequent proximal and distal axonal dieback
overtime (Chapter 3). Our use of the YFP-16 transgenic mice obviated the limitations associated
with the use of APP immunohistochemistry which detected only the proximal, swollen axonal
segments which typically lost immunoreactivity over 3 days post injury (Greer et al., 2011,
Wang et al., 2011). The advantage associated with the expression of the YFP fluorescent protein
by the Thy1 promoter, resided in its complete transport throughout the axons of the optic nerve.
Accordingly, any morphological change associated with axonal injury was reflected in an
altered/abnormal YFP fluorescent signal, directly visualized via fluorescent microscopy in both
the proximal and the distal axonal segments.
Distinct from our current YFP expressing approach, the above described optic nerve
stretch models utilized guinea pigs or wild type mice (Gennarelli et al., 1989, Maxwell et al.,
2003, Saatman et al., 2003, Serbest et al., 2007). In these studies, the identification of axonal
swellings relied completely upon immunohistochemical approaches and ultrastructural analysis
which as noted previously, posed limitations (Gennarelli et al., 1989, Maxwell et al., 2003,
Saatman et al., 2003, Serberst et al., 2007). Further, these methods did not allow for the precise
identification of either the proximal or distal origins of any observed axonal swellings.
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Specifically once the axon disconnected, it was virtually impossible to determine if the axonal
swellings occurred in the proximal vs. distal disconnected segments. Consequently, this model
did not allow for the clear delineation of the pathological changes occurring either anterogradely
or retrogradely.

Implications of the current TAI model for understanding the anterograde and
retrograde sequelae of TAI
Utilizing YFP expressing mice, our current optic nerve TAI model allowed the ready
comparison of the pathological differences seen in the disconnected axonal segments in both the
anterograde and the retrograde directions.
1) Anterograde responses - distal axonal dieback/degeneration and microglia/macrophage
activation
As described in Chapter 3, once disconnected, the anterograde/downstream distal axonal
segments, underwent acute dieback toward the chiasm overtime. Ultrastructually, the distal
swollen axonal segments revealed increased electron density, an accumulation of vesicles and
swollen degenerating mitochondria, as well as disorganized microtubules and neurofilaments, all
of which were consistent with dieback and degeneration, as a prelude to Wallerian change.
The acute dieback of the distal disconnected axonal segments in the first hours post
injury, is most likely due to an initial increase in intra-axonal calcium and sodium. In vitro laserinduced axonal damage studies demonstrate that calcium dysregulation plays an important role in
the initial axonal dieback (Hellman et al., 2010). A rapid increase of intra-axonal calcium has
also been observed in the acute axonal degeneration following optic nerve crush, with its
inhibition by calcium channel inhibitors markedly attenuating axonal degeneration (Knöferle et
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al., 2010). Similar to the increase of intra-axonal calcium, a rise in the intra-axonal sodium may
also play a role in the acute axonal dieback. A close relationship has been demonstrated between
the increase of intra-axonal calcium and the rise in the intra-axonal sodium, which is further
supported by the findings that the sodium channel inhibitor, tetrodotoxin, can also block the
increase of calcium (LoPachin and Lehning, 1997). Again, such sodium channel blockers,
dramatically ameliorate the number of acute axonal swellings following optic nerve crush
(Beirowski et al., 2010).
In addition to the role of calcium and sodium dysregulation in the acute axonal dieback,
calpain mediated proteolytic damage to the axonal cytoskeleton may also promote and perhaps,
accelerate the acute axonal dieback. Specifically, calpains have been demonstrated to participate
in the degradation of axonal cytoskeleton spectrin, microtubules and neurofilaments (Buki and
Povlishock, 2006; Buki et al., 1999; Saatman et al., 2003). Further, such calpain activity has been
directly linked to the degeneration of the distal, disconnected downstream axonal segments, as
demonstrated by the finding that calpain inhibition attenuates the degeneration of the distal,
disconnected downstream optic nerve fibers after crush injury (Couto et al., 2004).
In addition to the involvement of calcium and sodium dysregulation, as well as the
activation of the calpain protease, other factors must also be taken into consideration in the
process of the acute axonal dieback. In the current study, we also frequently observed in the
distal disconnected axonal segment, that the mitochondria remained swollen, in response to the
injury. This mitochondrial damage was most likely related to calcium overloading and
subsequent mitochondrial perturbation. Given the fact that mitochondria are the major source of
ATP production which is essential for axonal transport and the maintenance of the axolemma,
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the injured mitochondria may also be linked to an ATP deficit, causing a failure in axonal
transport, thereby further promoting axonal dieback.
Some equate this acute distal axonal dieback with the initial phases of Wallerian
degeneration, however, in the strict sense, Wallerian degeneration is a more delayed event. In the
acute axonal dieback period, the currently used optic nerve TAI model revealed only singular
distal axonal swelling in continuity with axons projecting toward the chiasm. This is distinctly
different from the Wallerian degeneration, which is associated with multiple loci of axonal
swelling and fragmentation along the axonal segment distal to optic nerve transection (Beirowski
et al., 2010).
Although the acute axonal dieback as described in the current study differs from
Wallerian degeneration, at least in its acute phase response, it is most likely followed by
Wallerian degeneration, which occurs as a delayed event. Mechanistically, transgenic mice with
the slow Wallerian degeneration (WldS) protein have provided insight into the basic molecular
and cellular mechanisms of Wallerian degeneration (Coleman and Freeman, 2010). The Wld S
protein (slow Wallerian degeneration) consists of a fragment of the ubiquitin assembly protein
UFD2a/UBE4B and nicotinamide mononucleotide adenylyl-transferase-1 (Nmnat1), which is an
enzyme promoting the synthesis of nicotinamide mononucleotide adenine dinucleotide (NAD)
(Conforti et al., 2000; Mack et al., 2001; Wang and He, 2009). The speed of Wallerian
degeneration is slowed in the WldS mouse to one tenth of the speed in the wild type animal
(Perry et al., 1990, Glass et al., 1993). Using WldS mouse, Kerschensteiner (2005) found in both
the proximal and distal disconnected axonal segments, that the acute axonal degeneration was
delayed following spinal cord transection. Similarly, utilizing the transgenic Wld S rodents,
Beirowski (2010) observed in the distal axonal segments that the axonal swellings and
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dystrophic axons were substantially reduced in number following optic nerve crush or
transection. Recent studies demonstrate that WldS prevents axonal degeneration via several
mechanisms, including increasing nuclear NAD biosynthesis (Araki et al., 2004), increasing the
WldS mitochondrial Ca2+ buffering capacity and improving basal mitochondrial motility in axons
(Avery et al., 2012). These findings indirectly suggest that the mechanisms of Wallerian
degeneration are related to mitochondrial dysfunction. It has been demonstrated that the
activation of the mitochondrial permeability transition pore (mPTP) within the Wlds axon
triggers its degeneration, while the depletion of the mPTP protein cyclophilin D effectively
inhibits axonal degeneration (Barrientos et al., 2011).
In addition to these described factors associated with the initial axonal dieback and
delayed axonal degeneration, other factors are most likely involved in the continued pathological
progression here reported in the distal axonal segments. At 2 days postinjury, an initial activation
of microglia/macrophages occurred at the site of the initiation of axonal injury, suggesting their
potential involvement in the subacute phase of axonal dieback. In the current study, from 7 days
to 28 days post injury, the injured optic nerve revealed a close spatiotemporal relationship
between

the

distal

disconnected,

degenerating

axonal

segments

and

activated

microglia/macrophages (Chapter 5). During this time frame, the distal swollen axonal segments
were routinely encompassed/engulfed by the processes of activated microglia/macrophages,
consistent with a comparable phagocytic role of microglia/macrophages described following
injury in the corpus callosum (Venkatesan et al., 2010) as well as the spinal cord (Busch et al.,
2009; Busch et al., 2010; Horn et al., 2008).
A well-known stimulus for continued macrophage activation, is the onset of delayed
Wallerian degeneration in the distal disconnected axonal segment (Brück et al., 1995; Kelley et
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al., 2007). Here the breakdown products of Wallerian degeneration, such as the myelin debris,
most likely contribute to the long term, persistent activation of microglia and macrophages. Such
activated microglia/macrophages are known to release proinflammatory cytokines, including
interleukin-1, interleukin-6 and tumor necrosis factor-α (Gentleman et al., 2004; McClain et al.,
1991; Kita et al., 2000), with cytokines, such as interleukin-6, further upregulating the
phagocytic activity of microglia/macrophage (Shafer et al., 2002-2003). These activated
microglia/macrophages can also release MMP9, which has been linked with axonal retraction
(Busch et al., 2009).

2) Retrograde responses - the reorganization / repair of the proximal axonal segments and
the survival of retinal ganglion cells
In contrast to the continued degeneration of the disconnected, distal axonal segment, as
noted in our study, the retrograde/upstream proximal axonal segments underwent rapid dieback
toward the retina, yet then transitioned to reorganization/repair overtime. As described, the
proximal axonal segment transitioned from a spheroidal swollen segment into a truncated
appendage (Chapter 3). These distinct morphological differences in the distal and the proximal
axonal segments suggest the involvement of different pathological signaling pathways in the
anterograde vs. retrograde directions.

2.1) Acute dieback of the proximal axonal segment
Like the dieback of the distal segment in the first hours post injury, the proximal axonal
segment also underwent retraction toward the retina. This acute axonal dieback of the proximal
axonal segment spanned approximately 0.4 - 0.8mm within a 48 hours period following injury
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(Chapter 3). In its initial phases, this process most likely shares similar mechanisms to those
described for the acute dieback of the distal axonal segment, including local calcium
dysregulation and calpain activation. It has been shown that in the presence of calpain inhibitors,
the acute axonal dieback of the proximal axonal segments is blocked following spinal cord
transection (Kerschensteiner et al., 2005). In addition to the influx of calcium and calpain
activation, other processes such as the formation of autophagosomes are also induced by the
initial Ca2+ influx after axonal injury, and as such, may also contribute to the acute proximal
axonal dieback (Knöferle et al., 2010). This premise is been supported by Koch (2010) who
demonstrated that inhibition of the formation of autophagosomes by the autophagy inhibitor can
attenuate acute axonal dieback.

2.2) The proximal axonal segment reorganization/repair
In contrast to the persistent distal rounded, degenerating axonal segments, the proximal
axonal segments evaluated in our studies underwent a relatively rapid transition from an enlarged
and swollen segment into a thinned and truncated appendage. Ultrastructurally, these proximal
truncated appendages contained normal / unaltered mitochondria and other organelles and
vesicles, none of which were consistent with degeneration. Rather, their appearance suggested
reorganization / repair of the proximal segment (Chapter 3). Accordingly, such morphological
differences in the proximal vs. the distal axonal segments suggest the activation of different
pathological signaling pathways.
A possible basis for this proximal vs. distal difference may be related to postinjury
proximal axolemmal resealing and its ability to restore local ionic homeostasis. Some have
suggested that rapid proximal axonal reorganization/repair is preceded by a rapid resealing of the
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axolemma (Liu et al., 2011, Meiri et al., 1983). Studies utilizing guinea-pig spinal cord
transection/compression demonstrate that axonal membrane resealing process is related to the
influx of calcium through the voltage dependent calcium channels(VDCC) (Nehrt et al., 2007).
Calcium triggered calpain activity has also been described in the process of axonal membrane
resealing following neurite transection in cultured rat septal neurons (Xie and Barrett, 1991).
Calcium can also facilitate axolemma resealing via the activation of vesicle proteins, such as
synaptotagmin, synaptobrevin and syntaxin (Detrait et al., 2000; Fishman and Bittner, 2003).
Squid and crayfish giant axon injury studies show that when axons are injected with an antibody
to block synaptotagmin binding to Ca2+, the severed axons do not seal (Detrait et al., 2000).
Similarly, when axons are injected with an antibody to syntaxin, the severed axon also fails to
seal (Detrait et al., 2000). In contrast, when axons are injected with either denatured antibody to
synaptotagmin or denatured antibody to syntaxin, the severed axons seal (Detrait et al., 2000),
supporting the premise that axolemmal resealing may be mediated by Ca2+-induced fusion of
vesicle proteins. On note, this rapid resealing of the axolemma also occurred in the disconnected
distal axonal segments; however, it did not inhibit the degeneration process of these distal axonal
segments. In contrast, this rapid axolemma resealing is required for the reorganization of the
proximal axonal segment.
Besides this rapid resealing of the axolemma, the conversion of anterograde to retrograde
axonal transport may also participate in the proximal axonal reorganization and recovery (Tuck
and Cavalli, 2010). Early nerve crush studies demonstrate that upon injury, the anterograde
intra-axonal organelle transport is converted to the retrograde direction (Bisby and Bulger,
1977). Such conversion could in part, be related to local proteolysis at the site of injury (Sahenk
and Lasek, 1988), or the modification of proteins on the transported vesicles (Martz et al., 1989).
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Through these mechanisms, it is most likely that the conversion of anterograde to retrograde
axonal transport attenuates vesicle and organelle accumulation at the injured axonal tip,
transforming the proximal axonal segment from the enlarged and swollen segment into a more
thinned and truncated morphology reminiscent of that described in the current communication.

2.3) Resting microglia/macrophage in the proximal axonal segment
Consistent with the proximal axonal segment’s attempt to reorganize/repair overtime,
was our parallel finding that the microglia/macrophages found in relation to proximal axonal
segments, retained at a resting state throughout our 7 - 28 days post injury observation, a
response in contrast to the activated macrophages seen in the distal, degenerating segments
(Chapter 5). The reasons for this different response in the proximal vs. distal segments are not
entirely clear. However, rapid axolemmal closure of the proximal axonal segment may be a
factor. Such rapid axolemmal resealing could prevent the influx of damaging extracellular
molecules into the axonal segments, or alternatively it could inhibit the release of intra-axonal
components into the extra-axonal environment, thus preserving the microenvironment. Further,
the observed reorganization/repair of the proximal axonal segments, was not associated with
sustained generation of myelin debris, a well-known stimulus for continued macrophage
activation.

2.4) The survival of retinal ganglion cells following TAI within the optic nerve
The proximal axonal segment reorganization and repair/recovery described in the current
study could also be partially related to the fact that axons maintained continuity with a viable
neuronal cell body of origin within the RGCs. As described in Chapter 4, the multiple qualitative
(TUNEL and Caspase-3 immunostaining) and quantitative (Brn3a immunostaining) as well as
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ultrastructural studies performed in the current study did not demonstrate any evidence of RGC
loss. Further their persistent expression of phospho-C-Jun, a marker associated with neuronal
survival and axonal regeneration (Greer et al., 2011), was entirely consistent with RGC survival
and the described proximal axonal repair/reorganization.
Our description of RGCs survival post TAI within the employed optic nerve injury model
is strikingly different from previous studies following other forms of optic nerve injury, which
all were followed by significant RGC loss. We believe that this difference resides primarily in
the model systems themselves. Our optic nerve TAI evoked a secondary process that involved
progressive axonal swelling and delayed disconnection. Such delayed axonal injury was
interspersed among other morphologically intact fibers. Thus, we believe that the more subtle
and secondary progressive axonal injury occurring in our model of TAI, did not lead to the
massive ionic disruption thereby proving supportive of RGC survival. In contrast to our model,
optic nerve transection and crush evoked primary axonal injury, in which the axons disconnected
immediately, with all the axonal fibers sustaining comparable injury and disconnection. Such
primary axonal injury immediately exposed the injured axons to the extracellular environment,
followed by an avalanche of sodium and calcium influx and the activation of proteases which
then overwhelms cellular defense mechanisms leading to neuronal death (Emery et al., 1991,
Lucas et al., 1990, Rosenberg et al., 2001, Strautman et al., 1990, Leybaert and de Hemptinne,
1996).
In addition to the differences between our optic nerve TAI and transection/crush injury
models, our description of RGCs survival following TAI, is also dissimilar from the dramatic
RGCs loss previously described following optic nerve stretch injury. In our cFPI model, the
globe was shielded from injury. However, in the optic nerve stretch model, which employs a
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sling at the posterior pole of the globe, direct injury to the retina and its vasculature most likely
occurs at the moment of stretch, thereby contributing to retinal damage and the RGC loss.
(Gennarelli et al., 1989; Maxwell et al., 1990; Maxwell and Graham, 1997; Saatman et al., 2003;
Serbest et al., 2007; Sulaiman et al., 2010).
Besides retinal sparing, our current TAI model offers additional differences from other
models of injury involving either stretch or transection/crush injury. In our model, the TAI was
generated approximately 1 mm proximal to the optic chiasm. In contrast, with optic nerve
stretch, the axonal injury was found more rostrally, midway between the globe and the optic
chiasm (Maxwell et al., 2003). Similarly, with the optic nerve crush or transection, the axonal
injure was generated in the intraorbital segment, approximating the retina, wherein the neuronal
cell bodies of the RGCs reside. This difference in the initial site of axonal injury, may influence
neuronal fate in terms of either life or death. Evidence to support this premise is found in
neocortical axonal and spinal cord transection studies, which demonstrate higher neuronal
survival rates when the axotomy occurs more distant from its cell body of origin (Dale et al.,
1995; Liu et al., 2003). Thus, in our current study, the relative long distance between the initial
site of TAI and the RGC could explain the enhanced RGCs survival relative to that seen
following optic nerve stretch, transection or crush.
The RGC survival described in the current study also bears similarities to the survival of
neocortical neurons described following diffuse TAI (Greer et al., 2011; Lifshitz et al., 2007;
Singleton et al., 2002). Utilizing the same rodent central fluid percussion injury model, Greer and
colleagues demonstrated within the neocortex perisomatic diffuse traumatic axonal injury, that
did not translate into cell death, but rather progressed to atrophy (Greer et al., 2011; Lifshitz et
al., 2007; Singleton et al., 2002). Such surviving neocortical neurons upregulated the expression
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of phospho-c-Jun (Greer et al., 2011). Similar to these studies following TAI in the neocortex,
our surviving RGCs revealed persistent phospho-c-Jun expression up to 90 days following injury
(Chapter 4), and the reorganization and attempt repair of the proximal axonal segments overtime
(Chapter 3 and Chapter 5), consistent with other reports of the link of phospho-c-Jun to neuronal
survival, axonal sprouting and regeneration (Fitzgerald et al., 2009 and 2010; Greer et al., 2011;
Herdegen et al., 1993; Hull and Bahr, 1994; Lu et al., 2003; Robinson, 1994 and 1995).
Paradoxically, the activation of c-Jun has been related to not only axon regeneration but
also neuronal death (Bessero et al., 2010; Biermann et al., 2011; Herdegen et al., 1997; Liu et al.,
2011; Raivich, 2008; Ribas et al., 2011; Sun et al., 2011). Genetic inactivation of c-Jun reduces
axotomy-induced neuronal death but decreases the axon regenerative potential for surviving
neurons (Raivich et al., 2004). Importantly, in our studies ATF-3, another transcription factor
associated with axonal regeneration, was also upregulated in the RGCs at early time points post
injury (data not shown), an observation again consistent with ATF-3 activation in the neocortical
neurons following TAI (Greer et al, 2011). It has been demonstrated that ATF3 cooperate with cJun to enhance neurite outgrowth (Pearson et al., 2003; Lindwall et al., 2004). Takeda (2000)
observed the colocalization of ATF-3 with c-Jun mRNA 5 days after optic nerve crush injury,
suggesting that the heterodimer formation of ATF-3 with C-Jun may support RGC survival and
axonal regeneration. It has also been demonstrated that ATF-3 binds to c-Jun, and activates the
expression of the anti-apoptotic factor - the heat shock protein 27 (Hsp27), which most likely
activates Akt, accordingly probably inhibits apoptosis and promotes neuronal survival and nerve
elongation (Brunet et al., 1999; Datta et al., 1997; Nakagomi et al., 2003).

Other features of this model and their relevance to TAI
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As described above, our current studies demonstrated that TBI-induced diffuse TAI
within the optic nerve was not followed by dramatic RGC death/loss, but rather persistent RGC
survival with the proximal axonal segment’s reorganization and its attempt to repair. This unique
feature of optic nerve TAI is similar to brain neocortical TAI that is also not followed by
neocortical neuron death, but rather atrophy and persistent expression of phospho-c-Jun and
reactive axonal sprouting and elongation (Greer et al., 2011). In addition to this unique
characteristic, current optic nerve TAI model also revealed transient blood-brain barrier
disruption, local edema formation and its association with YFP fluorescence quenching in the
acute phase post injury, and thereafter the closure of blood-brain barrier, the resolution of edema
and the recovery of YFP fluorescent fibers at the chronic phase post injury.

1) Transient blood-brain barrier disruption
In concert with all the above abnormalities occurring in our optic nerve injury model was
the occurrence of focal non-hemorrhagic blood-brain barrier (BBB) disruption and local edema
formation which clearly approximated the site of ongoing axonal change and dieback. As noted
in Chapter 3, we observed the extravasation of IgG within the optic nerve at 1 hour to 3 hours
post injury. This occurred together with the expansion of the interstitial space at these early
time points post injury (Chapter 3, Wang et al., 2011), suggesting local edema formation.
Because this barrier perturbation occurred at the site of initial optic nerve axonal damage, this
suggested that both events were triggered by the same forces of injury most likely maximally
distorting the axons and microvessels at this point along the optic nerve’s length. By 7 and 28
day post injury, the interstitial space had decreased in diameter, taking on a more control-like
appearance, consistent with the resolution of edema at these later time points (Chapter 6). Such
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traumatic barrier disruption described within the optic nerve is consistent with the brain
parenchymal barrier disruption seen following fluid-percussion brain injury that has been linked
to concomitant brain deformation and compression (Povlishock, et al., 1978, Kelley et al., 2007).

2) Blood–brain barrier disruption and the retention of axons in the region of YFP
fluorescence quenching.
As noted, the observed blood-brain barrier disruption and edema formation in the current
optic nerve model of diffuse TAI was not linked to the presence of either overt or petechial
hemorrhage, suggesting a more subtle form of BBB perturbation. However, although subtle, this
blood-brain barrier disruption did interfere with the detection of intact YFP expressing axons at
the site of axonal injury via local fluorescent quenching (Chapter 3). In our study, the
relationship between BBB disruption and fluorescent quenching was confirmed by the
observation that those regions of local fluorescence loss mapped precisely to those zones of
increased vascular permeability, as assessed by the passage of the endogenous immunoglobulin
IgG (Chapter 3). We further confirmed this premise by utilizing antibodies targeting endogenous
YFP independent of its fluorescent properties, a strategy which revealed in the same locus of
fluorescent quenching the existence of intact/unaltered axons. These events suggested that the
parallel movement of water and other molecules (e.g. ions) with the IgG participated in the
fluorescent quenching, which confounded YFP use in our model system. Previously, although
not well appreciated in the literature, it has been shown that water and solvent properties of water
can lead to fluorescence quenching by multiple mechanisms, including but not limited to,
hydrogen-bond interactions (Oshima et al., 2006), photoionization (Sadkowski and Fleming,
1980), the transition to a close-lying energy level (Tobita et al., 2001), intersystem crossing
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(Seliskar and Brand, 1971), and specific solute–solvent interactions (Ebbesen and Ghiron, 1989).
A recent study has also demonstrated that mild acidic conditions can alter the structural
arrangement of yellow fluorescent protein, leading to fluorescence quenching (Hsu et al., 2010).
Thus, it is not unreasonable to posit that either one or several of the above-described mechanisms
result in fluorescence quenching in our current optic nerve injury model.

3) The clearance of edema and the recovery of YFP fluorescent axons
As noted, the observed blood-brain barrier disruption was transient, with the edema in the
interstitial space of the optic nerve resolving overtime (Chapter 6), in a fashion similar to the
transient brain edema described following weight drop TBI (Vink et al., 2003, Barzó et al.,
1997). Specifically, by diffusion-weighted imaging in the cerebral cortex, Barzó (1997) observed
that water diffusion distance, predominantly associated with the formation of vasogenic edema,
increased over 45minutes postinjury, and thereafter, decreased, reaching minimum values by 7 to
14 days post injury. Such a vasogenic edema profile coincides with a process in which the BBB
opens immediately following TBI with its subsequent closure moments later (Barzó et al., 1996).
The observed rapid BBB closure most likely helped restore the microenvironment of both
the injured and non-injured axonal segments, promoting the recovery of the YFP fluorescence of
intact axonal fibers in the original region of fluorescence quenching. The closure of BBB most
likely resulted in the resolution of edema via several mechanisms. It has been demonstrated that
the extravasated plasma proteins, including but not limited to immunoglobulin, are rapidly taken
up by the glial cells from the extracellular/interstitial space (Del Bigio et al., 2000; Jensen et al.,
1997), and degraded by glia, consequently attenuating the interstitial osmotic force that has
induced edema (Betz et al., 1989; Klatzo et al., 1980). These processes are accompanied with the
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closure/restoration of BBB, creating a permissive osmotic gradient, for water to move from the
interstitial space back into the blood (Duvdevani et al., 1995).
This resolution of water is most likely associated with the alteration of pH and other
solvent content (e.g. ions and anions) in the microenvironment. Given the relationship between
water, the acidic environment and fluorescence quenching described before, it is not
unreasonable to assume that the resolution of water, the change of pH and other solvent could
reverse fluorescence quenching. Previous studies have demonstrated that fluorescence quenching
can be reversed by the removal of the quenching reagent (Chen et al., 1999), the addition of
anions such as SO32- and PO43- (Xia et al., 2012), as well as the oxidation of ions (Kress et a.,
2002). Whether these processes are involved in the recovery of YFP fluorescent fibers over time,
or do other mechanisms participate in this reversal of YFP fluorescence quenching, requires
further investigation.

Future directions targeting therapeutic intervention and neuroplasticity
In summary, our current studies demonstrate optic nerve TAI induced by TBI and
provide new insight into the pathogenesis of diffuse traumatic axonal injury, particularly in terms
of its progressive swelling, disconnection and dieback proximally and distally. This optic nerve
TAI is also accompanied with diffuse traumatic axonal injury in the brain parenchyma, making
our model comparable to human TBI, offering the potential for more rational preclinical drug
screening to target TAI with the caveat that optic nerve axonal protection should translate into
comparable axonal protection within the brain.

1) Potential utility of the optic nerve TAI model for therapeutic screening
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As noted above, a further benefit of our model system may reside in its usefulness for
drug screening targeting axonal injury. The ability to treat the injured optic nerve via CSF and
intraocular routes provides multiple portals for drugs that may not readily cross the BBB due to
molecular weight, charge or protein binding. In this case, due to the bathing of the optic nerve by
the CSF, neuroprotective drugs could be applied directly via intrathecal pathway, to obviate any
difficulty sometimes encountered when penetrating blood-brain-barrier via intravenous or
intraperitoneal routes (Gabathuler, 2010; Misra et al., 2003; Hossain et al., 2010; Okonkwo and
Povlishock, 1999). Specifically, this model could allow us to reexamine various purported
axonal protective drugs, such as poloxamer 188, mitochondrial permeability transition (MPT)
inhibitors, calpain inhibitors, caspase inhibitors, calcineurin inhibitors and progesterone. For
example, previous in vitro studies utilizing mechanical trauma to cultured neurons, have
demonstrated that Poloxamer 188 promotes membrane resealing and reduces axonal injury
(Kilinc et al., 2007, Maskarinec et al., 2005). Another axonal protective drug, Cyclosporine A, a
mitochondrial permeability transition (MPT) inhibitor, has been shown to attenuate axonal
damage following mild axonal stretch injury (Staal et al., 2007) while reducing rat traumatic
axonal injury following experimental TBI (Okonkwo et al., 2003), and protecting compound
action potentials in rats corpus callosum following experimental TBI (Colley et al., 2010).
Further, the immunophilin ligand FK506, is not only able to reduce mitochondrial permeability
transition (MPT), but also attenuate the activity of calcineurin. FK506 has been demonstrated to
ameliorate axonal damage following diffuse TBI (Marmarou and Povlishock, 2006), and exert
neuroprotective effect on both myelinated and unmyelinated axons (Reeves et al., 2007).
Additionally, progesterone has been proven to have beneficial axonal protective effects in animal
TBI studies and is now in Phase III ProTECT clinical trials which should be started within 4
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hours of TBI (Espinoza and Wright, 2011; O’Connor et al., 2007; Hua et al., 2012). Besides
these various drugs axonal protective effect, hypothermia has also been demonstrated to provide
long term benefit to TAI if performed immediately post injury (Ma et al., 2009), and further the
therapeutic window is effectively extended when the above described axonal protective drugs
were combined with hypothermia (Fujita et al., 2011, Oda et al., 2011). Thus, it is possible to
hypothesize that the therapeutic window of progesterone could also be prolonged when it is
combined with hypothermia.
Lastly, our current optic nerve TAI model should readily allow the incorporation of
various genetic modifications. Specifically, gene transfection or knockout paradigm can be
utilized to upregulate the intrinsic growth pathway to enhance axonal regeneration. For example,
the inhibition of the PTEN (phosphatase and tensin homologue), the activation of mTOR
(mammalian target of rapamycin) pathway, and the deletion of SOCS3 (suppressor of cytokine
signaling) pathway have been proven effective to promote optic nerve axonal regeneration after
optic nerve lesion (Park et al., 2008, Sun et al., 2011). The potential optic nerve axonal
regeneration will reinnervate the downstream target including lateral geniculate nucleus, help
recover the retinal-geniculate projection.

2) Anterograde degeneration and potential downstream plasticity

In addition to its therapeutic screening benefits, this optic nerve diffuse TAI model
should also allow for the mapping of diffuse deafferentation of the downstream targets, such as
the lateral geniculate nucleus (LGN) and superior colliculi, allowing a detailed assessment of the
ensuing synaptic loss as well as any potential synaptic rearrangement. Previous studies have
demonstrated following TAI a diffuse pattern of axon terminal degeneration and subsequent
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deafferentation in the cat dorsal lateral vestibular nucleus (Erb and Povlishock, 1991).
Specifically, following TAI a marked reduction occurred in the perisomatic vestibular nuclear
terminals (Erb and Povlishock, 1991). Interestingly, this axon terminal loss and synaptic
deafferentation were followed by the return of some puncta/terminals in the deafferented somata
by 60 days postinjury, with these terminals reaching 75% of control values by 6 months
postinjury, and virtually recovering by the 7 to 12 month postinjury period (Erb and Povlishock,
1991). These results suggest that mild to moderate TBI with its attendant TAI and associated
diffuse deafferentation create a unique environment for adaptive synaptic recovery (Erb and
Povlishock, 1991).
Although these studies suggested adaptive recovery, it remains to be seen if other forms
of TAI elicit comparable synaptic repair. To this end, our model of TAI in the optic nerve should
allow for a critical assessment of any terminal/synaptic loss in its target LGN, while considering
any potential for synaptic recovery therein. In this approach LM silver salt, immunocytochemical
and TEM studies can be used to follow the specific patterns of synaptic loss occurring in the
LGN overtime. Then once the pattern of deafferentation is established, contemporary tracer
approach could be used to map the LGN’s synaptic reorganization and repair.
Conceivably, the domains originally occupied by the degenerating axon terminals, will be
replaced by the regenerating synapses in an adaptive manner. Via the intra- vitreous injection of
the anterograde tracer-cholera toxin beta conjugated with different fluorescent probes, the tracer
can be moved along the optic nerve overtime, with the downstream targets of the retinalprojection mapped by the tracer. This technique should allow for a thorough assessment of
downstream target deafferentation and potential synaptic plasticity following the diffuse TAI in
the optic nerve.
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Summary
In summary, this optic nerve TAI following diffuse brain injury model provides unique
insight into the pathogenesis of diffuse traumatic axonal injury, from its progressive swelling and
disconnection, to rapid axonal dieback in both the proximal and distal direction. Overtime, the
anterograde/downstream disconnected distal axonal segments underwent persisting degeneration.
In contrast, the retrograde/upstream proximal

axonal segments transitioned rapidly to

reorganization. Of note, this optic nerve TAI model was also accompanied with diffuse traumatic
axonal injury in the brain parenchyma, indicating its utility for various treatment screening. In
addition to these events, the optic nerve diffuse TAI was not followed by retrograde RGC death
overtime. Moreover, these sustaining RGCs revealed the persistent expression of phospho-c-Jun,
consistent with neuronal survival. Affirmaion that the RGCs survival was associated with the
reorganization and potential repair of the proximal axonal segments, was provided by the finding
that the microglia/macrophages maintained a resting state within this same segment. In contrast
to these proximal axonal segment reorganization, the downstream distal disconnected axonal
segment underwent continued dieback and degeneration, and spatial-temporally related to the
activation of microglia/macrophage, suggesting that specific inhibition of microglia/macrophage
would be a potential therapeutic strategy to prevent distal axonal degeneration and dieback.
Collectively, we believe that our current model will allow the exploration of potential axonal
regeneration and synaptic plasticity in future studies.
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